<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Rheumatoid arthritis - Wikipedia, the free encyclopedia</title>
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />
<meta name="generator" content="MediaWiki 1.23wmf19" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Rheumatoid_arthritis" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/wiki/Rheumatoid_arthritis" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.ui.button%7Cskins.common.interface%7Cskins.vector.styles&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>

<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Rheumatoid_arthritis","wgTitle":"Rheumatoid arthritis","wgCurRevisionId":601395711,"wgRevisionId":601395711,"wgArticleId":25875,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with links needing disambiguation from February 2014","Pages containing cite templates with deprecated parameters","CS1 errors: dates","All articles with unsourced statements","Articles with unsourced statements from October 2013","Articles with unsourced statements from November 2009","Articles with unsourced statements from December 2010","Articles with unsourced statements from March 2014","Articles with unsourced statements from July 2008","Articles with unsourced statements from September 2010","Articles needing additional references from February 2014","All articles needing additional references","Articles using fixed number of columns in reflist","Commons category with local link same as on Wikidata","Articles with Open Directory Project links","Connective tissue diseases","Arthritis","Autoimmune diseases","Diseases involving the fasciae"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Rheumatoid_arthritis","wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"templateEditor":false,"templates":false,"preview":false,"previewDialog":false,"publish":false,"toc":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"isPageWatched":false,"magnifyClipIconURL":"//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png","pageLanguageCode":"en","pageLanguageDir":"ltr","svgMaxSize":2048},"wikilove-recipient":"","wikilove-anon":0,"wgGuidedTourHelpGuiderUrl":"Help:Guided tours/guider","wgFlowTermsOfUseEdit":"By saving changes, you agree to our \u003Ca class=\"external text\" href=\"//wikimediafoundation.org/wiki/Terms_of_use\"\u003ETerms of Use\u003C/a\u003E and agree to irrevocably release your text under the \u003Ca rel=\"nofollow\" class=\"external text\" href=\"//creativecommons.org/licenses/by-sa/3.0\"\u003ECC BY-SA 3.0 License\u003C/a\u003E and \u003Ca class=\"external text\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License\"\u003EGFDL\u003C/a\u003E","wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q187255"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function(){mw.user.options.set({"ccmeonemails":0,"cols":80,"date":"default","diffonly":0,"disablemail":0,"editfont":"default","editondblclick":0,"editsectiononrightclick":0,"enotifminoredits":0,"enotifrevealaddr":0,"enotifusertalkpages":1,"enotifwatchlistpages":0,"extendwatchlist":0,"fancysig":0,"forceeditsummary":0,"gender":"unknown","hideminor":0,"hidepatrolled":0,"imagesize":2,"math":0,"minordefault":0,"newpageshidepatrolled":0,"nickname":"","norollbackdiff":0,"numberheadings":0,"previewonfirst":0,"previewontop":1,"rcdays":7,"rclimit":50,"rememberpassword":0,"rows":25,"showhiddencats":false,"shownumberswatching":1,"showtoolbar":1,"skin":"vector","stubthreshold":0,"thumbsize":4,"underline":2,"uselivepreview":0,"usenewrc":0,"watchcreations":1,"watchdefault":0,"watchdeletion":0,"watchlistdays":3,"watchlisthideanons":0,"watchlisthidebots":0,"watchlisthideliu":0,"watchlisthideminor":0,"watchlisthideown":0,"watchlisthidepatrolled":0,"watchmoves":0,
"wllimit":250,"useeditwarning":1,"prefershttps":1,"flaggedrevssimpleui":1,"flaggedrevsstable":0,"flaggedrevseditdiffs":true,"flaggedrevsviewdiffs":false,"usebetatoolbar":1,"usebetatoolbar-cgd":1,"visualeditor-enable":0,"visualeditor-enable-experimental":0,"visualeditor-betatempdisable":0,"wikilove-enabled":1,"echo-subscriptions-web-page-review":true,"echo-subscriptions-email-page-review":false,"ep_showtoplink":false,"ep_bulkdelorgs":false,"ep_bulkdelcourses":true,"ep_showdyk":true,"echo-subscriptions-web-education-program":true,"echo-subscriptions-email-education-program":false,"echo-notify-show-link":true,"echo-show-alert":true,"echo-email-frequency":0,"echo-email-format":"html","echo-subscriptions-email-system":true,"echo-subscriptions-web-system":true,"echo-subscriptions-email-other":false,"echo-subscriptions-web-other":true,"echo-subscriptions-email-edit-user-talk":false,"echo-subscriptions-web-edit-user-talk":true,"echo-subscriptions-email-reverted":false,
"echo-subscriptions-web-reverted":true,"echo-subscriptions-email-article-linked":false,"echo-subscriptions-web-article-linked":false,"echo-subscriptions-email-mention":false,"echo-subscriptions-web-mention":true,"echo-subscriptions-web-edit-thank":true,"echo-subscriptions-email-edit-thank":false,"echo-subscriptions-web-flow-discussion":true,"echo-subscriptions-email-flow-discussion":false,"gettingstarted-task-toolbar-show-intro":true,"uls-preferences":"","language":"en","variant-gan":"gan","variant-iu":"iu","variant-kk":"kk","variant-ku":"ku","variant-shi":"shi","variant-sr":"sr","variant-tg":"tg","variant-uz":"uz","variant-zh":"zh","searchNs0":true,"searchNs1":false,"searchNs2":false,"searchNs3":false,"searchNs4":false,"searchNs5":false,"searchNs6":false,"searchNs7":false,"searchNs8":false,"searchNs9":false,"searchNs10":false,"searchNs11":false,"searchNs12":false,"searchNs13":false,"searchNs14":false,"searchNs15":false,"searchNs100":false,"searchNs101":false,"searchNs108":false,
"searchNs109":false,"searchNs118":false,"searchNs119":false,"searchNs446":false,"searchNs447":false,"searchNs710":false,"searchNs711":false,"searchNs828":false,"searchNs829":false,"gadget-teahouse":1,"gadget-ReferenceTooltips":1,"gadget-DRN-wizard":1,"gadget-charinsert":1,"gadget-mySandbox":1,"variant":"en"});},{},{});mw.loader.implement("user.tokens",function(){mw.user.tokens.set({"editToken":"+\\","patrolToken":false,"watchToken":false});},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:868e43d07ede2616d2d1dc3507cd8145 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","skins.vector.compactPersonalBar.defaultTracking","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","wikibase.client.init","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" /><!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.23wmf19/skins/vector/csshover.min.htc")}</style><![endif]--></head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Rheumatoid_arthritis skin-vector action-view vector-animateLayout">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>
			<div id="mw-js-message" style="display:none;"></div>
						<div id="siteNotice"><!-- CentralNotice --></div>
						<h1 id="firstHeading" class="firstHeading" lang="en"><span dir="auto">Rheumatoid arthritis</span></h1>
						<div id="bodyContent">
								<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-navigation">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" cellspacing="3" style="border-spacing:3px;width:22em;">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey;">Rheumatoid arthritis</th>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><i>Classification and external resources</i></td>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/File:Rheumatoid_Arthritis.JPG" class="image"><img alt="Rheumatoid Arthritis.JPG" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/70/Rheumatoid_Arthritis.JPG/230px-Rheumatoid_Arthritis.JPG" width="230" height="173" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/70/Rheumatoid_Arthritis.JPG/345px-Rheumatoid_Arthritis.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/70/Rheumatoid_Arthritis.JPG/460px-Rheumatoid_Arthritis.JPG 2x" /></a><br />
<div>A hand affected by rheumatoid arthritis</div>
</td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_M" title="ICD-10 Chapter M" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/M05">05</a>-<a href="/wiki/ICD-10_Chapter_M" title="ICD-10 Chapter M" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/M06">06</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=714">714</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/180300">180300</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb11506.htm">11506</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000431.htm">000431</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/331715-overview">article/331715</a> <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/1266195-overview">article/1266195</a> <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/305417-overview">article/305417</a> <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/401271-overview">article/401271</a> <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/335186-overview">article/335186</a> <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/808419-overview">article/808419</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&amp;term=D001172">D001172</a></td>
</tr>
</table>
<p><b>Rheumatoid arthritis</b> (<b>RA</b>) is an <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune disease</a> that results in a chronic, <a href="/wiki/Systemic_disease" title="Systemic disease">systemic</a> <a href="/wiki/Inflammation" title="Inflammation">inflammatory disorder</a> that may affect many tissues and organs, but principally attacks flexible (<a href="/wiki/Synovial_joints" title="Synovial joints" class="mw-redirect">synovial</a>) joints. It can be a disabling and <a href="/wiki/Pain" title="Pain">painful</a> condition, which can lead to substantial loss of functioning and mobility if not adequately treated.</p>
<p>The process involves an inflammatory response of the capsule around the joints (<a href="/wiki/Synovium" title="Synovium" class="mw-redirect">synovium</a>) secondary to swelling (<a href="/wiki/Turgescence" title="Turgescence" class="mw-redirect">turgescence</a>) of synovial cells, excess synovial fluid, and the development of fibrous tissue (<a href="/wiki/Pannus" title="Pannus">pannus</a>) in the synovium. The <a href="/wiki/Pathology" title="Pathology">pathology</a> of the disease process often leads to the destruction of articular cartilage and <a href="/wiki/Ankylosis" title="Ankylosis">ankylosis</a> (fusion) of the joints. RA can also produce diffuse inflammation in the <a href="/wiki/Lung" title="Lung">lungs</a>, the membrane around the heart (<a href="/wiki/Pericardium" title="Pericardium">pericardium</a>), the membranes of the lung (<a href="/wiki/Pleura" title="Pleura" class="mw-redirect">pleura</a>), and white of the eye (<a href="/wiki/Sclera" title="Sclera">sclera</a>), and also nodular lesions, most common in <a href="/wiki/Subcutaneous_tissue" title="Subcutaneous tissue">subcutaneous tissue</a>. Although the cause of RA is unknown, <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a> plays a big part, and RA is a <a href="/wiki/Systemic_autoimmune_disease" title="Systemic autoimmune disease" class="mw-redirect">systemic autoimmune disease</a>. It is a <a href="/wiki/Clinical_diagnosis" title="Clinical diagnosis" class="mw-redirect">clinical diagnosis</a> made on the basis of symptoms, physical exam, radiographs (<a href="/wiki/Medical_imaging" title="Medical imaging">X-rays</a>) and labs.<sup id="cite_ref-Majithia2007_1-0" class="reference"><a href="#cite_note-Majithia2007-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Treatments are pharmacological and non-pharmacological. Non-pharmacological treatment includes <a href="/wiki/Physical_therapy" title="Physical therapy">physical therapy</a>, <a href="/wiki/Orthoses" title="Orthoses" class="mw-redirect">orthoses</a>, <a href="/wiki/Occupational_therapy" title="Occupational therapy">occupational therapy</a> and nutritional therapy but these don't stop the progression of joint destruction. <a href="/wiki/Analgesics" title="Analgesics" class="mw-redirect">Analgesics</a> (painkillers) and <a href="/wiki/Anti-inflammatory" title="Anti-inflammatory">anti-inflammatory</a> drugs, including <a href="/wiki/Glucocorticoid" title="Glucocorticoid">steroids</a>, suppress symptoms, but don't stop the progression of joint destruction either. <a href="/wiki/Disease-modifying_antirheumatic_drug" title="Disease-modifying antirheumatic drug">Disease-modifying antirheumatic drugs</a> (DMARDs) slow or halt the progress of the disease. The newer <a href="/wiki/Biologic_medical_product" title="Biologic medical product">biologics</a> are DMARDs.<sup id="cite_ref-Majithia2007_1-1" class="reference"><a href="#cite_note-Majithia2007-1"><span>[</span>1<span>]</span></a></sup> The evidence for <a href="/wiki/Complementary_and_alternative_medicine" title="Complementary and alternative medicine" class="mw-redirect">complementary and alternative medicine</a> (CAM) treatments for RA related pain is weak,<sup id="cite_ref-Efthimiou_2-0" class="reference"><a href="#cite_note-Efthimiou-2"><span>[</span>2<span>]</span></a></sup> with the lack of high quality evidence leading to the conclusions that their use is currently not supported by the evidence.<sup id="cite_ref-Macfarlane_3-0" class="reference"><a href="#cite_note-Macfarlane-3"><span>[</span>3<span>]</span></a></sup> Patients should inform their health care provider of any CAM treatments and continue taking traditional treatments.<sup id="cite_ref-NCCAM_4-0" class="reference"><a href="#cite_note-NCCAM-4"><span>[</span>4<span>]</span></a></sup></p>
<p>About 0.6% of the United States adult population has RA, women two to three times as often as men.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> Onset is most frequent during middle age, but people of any age can be affected.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup></p>
<p>The name is based on the term "<a href="/wiki/Rheumatic_fever" title="Rheumatic fever">rheumatic fever</a>", an illness which includes joint pain and is derived from the Greek word <i>ῥεύμα-rheuma (nom.), ῥεύματος-rheumatos (gen.)</i> ("flow, current"). The suffix -<i>oid</i> ("resembling") gives the translation as <i>joint inflammation that resembles rheumatic fever</i>. The first recognized description of RA was made in 1800 by Dr. <a href="/wiki/Augustin_Jacob_Landr%C3%A9-Beauvais" title="Augustin Jacob Landré-Beauvais">Augustin Jacob Landré-Beauvais</a> (1772–1840) of Paris.<sup id="cite_ref-Landre1800_7-0" class="reference"><a href="#cite_note-Landre1800-7"><span>[</span>7<span>]</span></a></sup></p>
<div class="toclimit-3">
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Joints"><span class="tocnumber">1.1</span> <span class="toctext">Joints</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Skin"><span class="tocnumber">1.2</span> <span class="toctext">Skin</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Lungs"><span class="tocnumber">1.3</span> <span class="toctext">Lungs</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Kidneys"><span class="tocnumber">1.4</span> <span class="toctext">Kidneys</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Heart_and_blood_vessels"><span class="tocnumber">1.5</span> <span class="toctext">Heart and blood vessels</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Other"><span class="tocnumber">1.6</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Causes"><span class="tocnumber">2</span> <span class="toctext">Causes</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Abnormal_immune_response"><span class="tocnumber">3.1</span> <span class="toctext">Abnormal immune response</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-12"><a href="#Imaging"><span class="tocnumber">4.1</span> <span class="toctext">Imaging</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Blood_tests"><span class="tocnumber">4.2</span> <span class="toctext">Blood tests</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Criteria"><span class="tocnumber">4.3</span> <span class="toctext">Criteria</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Differential_diagnoses"><span class="tocnumber">4.4</span> <span class="toctext">Differential diagnoses</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Monitoring_progression"><span class="tocnumber">4.5</span> <span class="toctext">Monitoring progression</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-17"><a href="#Management"><span class="tocnumber">5</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-18"><a href="#Lifestyle"><span class="tocnumber">5.1</span> <span class="toctext">Lifestyle</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Disease_modifying_agents"><span class="tocnumber">5.2</span> <span class="toctext">Disease modifying agents</span></a></li>
<li class="toclevel-2 tocsection-20"><a href="#Anti-inflammatory_agents"><span class="tocnumber">5.3</span> <span class="toctext">Anti-inflammatory agents</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Surgery"><span class="tocnumber">5.4</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Alternative_medicine"><span class="tocnumber">5.5</span> <span class="toctext">Alternative medicine</span></a>
<ul>
<li class="toclevel-3 tocsection-23"><a href="#Dietary_supplements"><span class="tocnumber">5.5.1</span> <span class="toctext">Dietary supplements</span></a></li>
<li class="toclevel-3 tocsection-24"><a href="#Manual_therapies"><span class="tocnumber">5.5.2</span> <span class="toctext">Manual therapies</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-25"><a href="#Prevention"><span class="tocnumber">6</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-26"><a href="#Prognosis"><span class="tocnumber">7</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-27"><a href="#Prognostic_factors"><span class="tocnumber">7.1</span> <span class="toctext">Prognostic factors</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#Mortality"><span class="tocnumber">7.2</span> <span class="toctext">Mortality</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-29"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>RA primarily affects <a href="/wiki/Joints" title="Joints" class="mw-redirect">joints</a>, however it also affects other <a href="/wiki/Organ_(anatomy)" title="Organ (anatomy)">organs</a> in 15–25% of individuals.<sup id="cite_ref-pmid12860726_8-0" class="reference"><a href="#cite_note-pmid12860726-8"><span>[</span>8<span>]</span></a></sup> It can be difficult to determine whether disease manifestations are directly caused by the rheumatoid process itself, or from side effects of the medications used to treat it – for example, <a href="/wiki/Lung_fibrosis" title="Lung fibrosis" class="mw-redirect">lung fibrosis</a> from <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> or <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> from corticosteroids.</p>
<h3><span class="mw-headline" id="Joints">Joints</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=2" title="Edit section: Joints">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Rheumatoid_arthritis_joint.gif" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Rheumatoid_arthritis_joint.gif/220px-Rheumatoid_arthritis_joint.gif" width="220" height="427" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/7/7e/Rheumatoid_arthritis_joint.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/7/7e/Rheumatoid_arthritis_joint.gif 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Rheumatoid_arthritis_joint.gif" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A diagram showing how rheumatoid arthritis affects a joint</div>
</div>
</div>
<p><a href="/wiki/Arthritis" title="Arthritis">Arthritis</a> of joints involves inflammation of the <a href="/wiki/Synovial_membrane" title="Synovial membrane">synovial membrane</a>. Joints become swollen, tender and warm, and stiffness limits their movement. With time, multiple joints are affected (it is a <a href="/wiki/Polyarthritis" title="Polyarthritis">polyarthritis</a>). Most commonly involved are the small joints of the <a href="/wiki/Hand" title="Hand">hands</a>, <a href="/wiki/Foot" title="Foot">feet</a> and <a href="/wiki/Cervical_spine" title="Cervical spine" class="mw-redirect">cervical spine</a>, but larger joints like the shoulder and knee can also be involved.<sup id="cite_ref-DAVIDSONS2010_9-0" class="reference"><a href="#cite_note-DAVIDSONS2010-9"><span>[</span>9<span>]</span></a></sup> <sup class="reference" style="white-space:nowrap;">:1089</sup> Synovitis can lead to <a href="/wiki/Tether_(cell_biology)" title="Tether (cell biology)">tethering</a> of tissue with loss of movement and erosion of the joint surface causing deformity and loss of function.<sup id="cite_ref-Majithia2007_1-2" class="reference"><a href="#cite_note-Majithia2007-1"><span>[</span>1<span>]</span></a></sup></p>
<p>RA typically manifests with signs of inflammation, with the affected joints being swollen, warm, painful and stiff, particularly early in the morning on waking or following prolonged inactivity. Increased stiffness early in the morning is often a prominent feature of the disease and typically lasts for more than an hour. Gentle movements may relieve symptoms in early stages of the disease. These signs help distinguish rheumatoid from non-inflammatory problems of the joints, often referred to as <a href="/wiki/Osteoarthritis" title="Osteoarthritis">osteoarthritis</a> or "wear-and-tear" arthritis. In arthritis of non-inflammatory causes, signs of inflammation and early morning stiffness are less prominent with stiffness typically less than 1 hour, and movements induce pain caused by mechanical arthritis.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> The pain associated with RA is induced at the site of inflammation and classified as nociceptive as opposed to neuropathic.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup> The joints are often affected in a fairly symmetrical fashion, although this is not specific, and the initial presentation may be asymmetrical.<sup id="cite_ref-DAVIDSONS2010_9-1" class="reference"><a href="#cite_note-DAVIDSONS2010-9"><span>[</span>9<span>]</span></a></sup> <sup class="reference" style="white-space:nowrap;">:1089</sup></p>
<p>As the pathology progresses the inflammatory activity leads to tendon tethering and erosion and destruction of the joint surface, which impairs range of movement and leads to deformity. The fingers may suffer from almost any deformity depending on which joints are most involved. Specific deformities, which also occur in osteoarthritis, include <a href="/wiki/Ulnar_deviation" title="Ulnar deviation">ulnar deviation</a>, <a href="/wiki/Boutonniere_deformity" title="Boutonniere deformity">boutonniere deformity</a>, <a href="/wiki/Swan_neck_deformity" title="Swan neck deformity">swan neck deformity</a> and "Z-thumb." "Z-thumb" or "Z-deformity" consists of <a href="/wiki/Hyperextension" title="Hyperextension" class="mw-redirect">hyperextension</a> of the <a href="/wiki/Interphalangeal_joint" title="Interphalangeal joint">interphalangeal joint</a>, fixed <a href="/wiki/Flexion" title="Flexion" class="mw-redirect">flexion</a> and <a href="/wiki/Subluxation" title="Subluxation">subluxation</a> of the <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joint</a> and gives a "Z" appearance to the thumb.<sup id="cite_ref-DAVIDSONS2010_9-2" class="reference"><a href="#cite_note-DAVIDSONS2010-9"><span>[</span>9<span>]</span></a></sup> <sup class="reference" style="white-space:nowrap;">:1089</sup> The <a href="/wiki/Hammer_toe" title="Hammer toe">hammer toe</a> deformity may be seen. In the worst case, joints are known as <a href="/wiki/Arthritis_mutilans" title="Arthritis mutilans">arthritis mutilans</a> due to the mutilating nature of the deformities.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2013)">citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Skin">Skin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=3" title="Edit section: Skin">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <i><a href="/wiki/Rheumatoid_nodule" title="Rheumatoid nodule">rheumatoid nodule</a></i>, which is sometimes <a href="/wiki/Cutaneous" title="Cutaneous" class="mw-redirect">cutaneous</a>, is the feature most characteristic of RA. It is a type of inflammatory reaction known to pathologists as a "<a href="/wiki/Necrotizing" title="Necrotizing" class="mw-redirect">necrotizing</a> <a href="/wiki/Granuloma" title="Granuloma">granuloma</a>". The <a href="/wiki/Initial" title="Initial">initial</a> pathologic process in nodule formation is unknown but may be essentially the same as the synovitis, since similar structural features occur in both. The nodule has a central area of <a href="/wiki/Fibrinoid_necrosis" title="Fibrinoid necrosis">fibrinoid necrosis</a> that may be <a href="/wiki/Fissure" title="Fissure">fissured</a> and which corresponds to the <a href="/wiki/Fibrin" title="Fibrin">fibrin</a>-rich necrotic material found in and around an affected synovial space. Surrounding the necrosis is a layer of <a href="/w/index.php?title=Palisading&amp;action=edit&amp;redlink=1" class="new" title="Palisading (page does not exist)">palisading</a> <a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a> and <a href="/wiki/Fibroblasts" title="Fibroblasts" class="mw-redirect">fibroblasts</a>, corresponding to the <a href="/w/index.php?title=Intimal_layer&amp;action=edit&amp;redlink=1" class="new" title="Intimal layer (page does not exist)">intimal layer</a> in synovium and a cuff of <a href="/wiki/Connective_tissue" title="Connective tissue">connective tissue</a> containing clusters of <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a> and <a href="/wiki/Plasma_cell" title="Plasma cell">plasma cells</a>, corresponding to the <a href="/w/index.php?title=Subintimal_zone&amp;action=edit&amp;redlink=1" class="new" title="Subintimal zone (page does not exist)">subintimal zone</a> in synovitis. The typical rheumatoid nodule may be a few millimetres to a few centimetres in diameter and is usually found over bony prominences, such as the <a href="/wiki/Olecranon" title="Olecranon">olecranon</a>, the <a href="/wiki/Calcaneal_tuberosity" title="Calcaneal tuberosity" class="mw-redirect">calcaneal tuberosity</a>, the <a href="/wiki/Metacarpophalangeal_joints" title="Metacarpophalangeal joints" class="mw-redirect">metacarpophalangeal joint</a>, or other areas that sustain repeated mechanical stress. Nodules are associated with a positive RF (<a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factor</a>) <a href="/wiki/Titer" title="Titer">titer</a> and severe erosive arthritis. Rarely, these can occur in internal organs or at diverse sites on the body.</p>
<p>Several forms of <i><a href="/wiki/Vasculitis" title="Vasculitis">vasculitis</a></i> occur in RA. A <a href="/wiki/Benign" title="Benign" class="mw-redirect">benign</a> form occurs as <a href="/w/index.php?title=Microinfarct&amp;action=edit&amp;redlink=1" class="new" title="Microinfarct (page does not exist)">microinfarcts</a> around the <a href="/wiki/Paronychium" title="Paronychium">nailfolds</a>. More severe forms include <a href="/wiki/Livedo_reticularis" title="Livedo reticularis">livedo reticularis</a>, which is a network (reticulum) of <a href="/wiki/Erythematous" title="Erythematous" class="mw-redirect">erythematous</a> to purplish discoloration of the skin caused by the presence of an obliterative cutaneous <a href="/wiki/Capillaropathy" title="Capillaropathy" class="mw-redirect">capillaropathy</a>.</p>
<p>Other, rather rare, skin associated symptoms include <a href="/wiki/Pyoderma_gangrenosum" title="Pyoderma gangrenosum">pyoderma gangrenosum</a>, <a href="/wiki/Sweet%27s_syndrome" title="Sweet's syndrome" class="mw-redirect">Sweet's syndrome</a>, drug reactions, <a href="/wiki/Erythema_nodosum" title="Erythema nodosum">erythema nodosum</a>, lobe <a href="/wiki/Panniculitis" title="Panniculitis">panniculitis</a>, <a href="/wiki/Atrophy" title="Atrophy">atrophy</a> of finger skin, <a href="/wiki/Palmar_erythema" title="Palmar erythema">palmar erythema</a>, diffuse thinning (rice paper skin), and skin fragility (often worsened by corticosteroid use).</p>
<h3><span class="mw-headline" id="Lungs">Lungs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=4" title="Edit section: Lungs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Fibrosis" title="Fibrosis">Fibrosis</a> of the <a href="/wiki/Lungs" title="Lungs" class="mw-redirect">lungs</a> is a recognized response to rheumatoid disease. It is also a rare but well recognized consequence of therapy (for example with <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> and <a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a>). <a href="/wiki/Caplan%27s_syndrome" title="Caplan's syndrome">Caplan's syndrome</a> describes lung nodules in individuals with RA and additional exposure to <a href="/wiki/Coal" title="Coal">coal</a> dust. <a href="/wiki/Pleural_effusion" title="Pleural effusion">Pleural effusions</a> are also associated with RA. Another complication of RA is <a href="/wiki/Rheumatoid_Lung_Disease" title="Rheumatoid Lung Disease" class="mw-redirect">Rheumatoid Lung Disease</a>. It is estimated that about one quarter of Americans with RA develop Rheumatoid Lung Disease.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Kidneys">Kidneys</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=5" title="Edit section: Kidneys">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Renal <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a> can occur as a consequence of chronic inflammation.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup> RA may affect the kidney <a href="/wiki/Glomerulus" title="Glomerulus">glomerulus</a> directly through a <a href="/wiki/Vasculopathy" title="Vasculopathy" class="mw-redirect">vasculopathy</a> or a <a href="/wiki/Mesangium" title="Mesangium">mesangial</a> <a href="/wiki/Infiltration_(medical)" title="Infiltration (medical)">infiltrate</a> but this is less well documented (though this is not surprising, considering immune complex-mediated hypersensitivities are known for <a href="/wiki/Pathogenic" title="Pathogenic" class="mw-redirect">pathogenic</a> deposition of immune complexes in organs where blood is filtered at high pressure to form other fluids, such as urine and synovial fluid<sup id="cite_ref-Robbins.26Cotran2010_14-0" class="reference"><a href="#cite_note-Robbins.26Cotran2010-14"><span>[</span>14<span>]</span></a></sup>). Treatment with <a href="/wiki/Penicillamine" title="Penicillamine">Penicillamine</a> and <a href="/wiki/Gold_salts" title="Gold salts">gold salts</a> are recognized causes of <a href="/wiki/Membranous_nephropathy" title="Membranous nephropathy" class="mw-redirect">membranous nephropathy</a>.</p>
<h3><span class="mw-headline" id="Heart_and_blood_vessels">Heart and blood vessels</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=6" title="Edit section: Heart and blood vessels">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>People with RA are more prone to <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>, and risk of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> (heart attack) and <a href="/wiki/Stroke" title="Stroke">stroke</a> is markedly increased.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> Other possible complications that may arise include: <a href="/wiki/Pericarditis" title="Pericarditis">pericarditis</a>, <a href="/wiki/Endocarditis" title="Endocarditis">endocarditis</a>, left ventricular failure, valvulitis and <a href="/wiki/Fibrosis" title="Fibrosis">fibrosis</a>.<sup id="cite_ref-Gupta_17-0" class="reference"><a href="#cite_note-Gupta-17"><span>[</span>17<span>]</span></a></sup> Many people with RA do not experience the same chest pain that others feel when they have angina or myocardial infarction. To reduce cardiovascular risk, it is crucial to maintain optimal control of the inflammation caused by RA (which may be involved in causing the cardiovascular risk), and to use exercise and medications appropriately to reduce other cardiovascular risk factors such as blood lipids and blood pressure. Doctors who treat RA patients should be sensitive to cardiovascular risk when prescribing anti-inflammatory medications, and may want to consider prescribing routine use of low doses of aspirin if the gastrointestinal effects are tolerable.<sup id="cite_ref-Gupta_17-1" class="reference"><a href="#cite_note-Gupta-17"><span>[</span>17<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=7" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<dl>
<dt>Ocular</dt>
<dd>The eye is directly affected in the form of <a href="/wiki/Episcleritis" title="Episcleritis">episcleritis</a> which when severe can very rarely progress to perforating <a href="/w/index.php?title=Scleromalacia&amp;action=edit&amp;redlink=1" class="new" title="Scleromalacia (page does not exist)">scleromalacia</a>. Rather more common is the indirect effect of <a href="/wiki/Keratoconjunctivitis_sicca" title="Keratoconjunctivitis sicca">keratoconjunctivitis sicca</a>, which is a dryness of eyes and mouth caused by <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocyte</a> infiltration of <a href="/wiki/Lacrimal_gland" title="Lacrimal gland">lacrimal</a> and <a href="/wiki/Salivary_gland" title="Salivary gland">salivary glands</a>. When severe, dryness of the cornea can lead to <a href="/wiki/Keratitis" title="Keratitis">keratitis</a> and loss of vision. Preventive treatment of severe dryness with measures such as <a href="/wiki/Nasolacrimal_duct" title="Nasolacrimal duct">nasolacrimal duct</a> blockage is important.</dd>
</dl>
<dl>
<dt><a href="/wiki/Hepatic" title="Hepatic" class="mw-redirect">Hepatic</a></dt>
<dd><a href="/wiki/Cytokine" title="Cytokine">Cytokine</a> production in joints and/or hepatic (liver) <a href="/wiki/Kupffer_cells" title="Kupffer cells" class="mw-redirect">Kupffer cells</a> leads to increased activity of <a href="/wiki/Hepatocyte" title="Hepatocyte">hepatocytes</a> with increased production of <a href="/wiki/Acute-phase_protein" title="Acute-phase protein">acute-phase proteins</a>, such as <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a>, and increased release of <a href="/wiki/Enzyme" title="Enzyme">enzymes</a> such as <a href="/wiki/Alkaline" title="Alkaline" class="mw-redirect">alkaline</a> <a href="/wiki/Phosphatase" title="Phosphatase">phosphatase</a> into the blood. In <a href="/wiki/Felty%27s_syndrome" title="Felty's syndrome">Felty's syndrome</a>, Kupffer cell activation is so marked that the resulting increase in hepatocyte activity is associated with nodular <a href="/wiki/Hyperplasia" title="Hyperplasia">hyperplasia</a> of the liver, which may be palpably enlarged. Although Kupffer cells are within the hepatic <a href="/wiki/Parenchyma" title="Parenchyma">parenchyma</a>, they are separate from hepatocytes. As a result there is little or no microscopic evidence of <a href="/wiki/Hepatitis" title="Hepatitis">hepatitis</a> (immune-mediated destruction of hepatocytes). Hepatic involvement in RA is essentially asymptomatic.</dd>
</dl>
<dl>
<dt><a href="/wiki/Hematology" title="Hematology">Hematological</a></dt>
<dd><a href="/wiki/Anemia" title="Anemia">Anemia</a> is by far the most common abnormality of the blood cells which can be caused by a variety of mechanisms. The chronic inflammation caused by RA leads to raised <a href="/wiki/Hepcidin" title="Hepcidin">hepcidin</a> levels, leading to <a href="/wiki/Anemia_of_chronic_disease" title="Anemia of chronic disease">anemia of chronic disease</a> where iron is poorly absorbed and also sequestered into <a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a>. RA may also cause a <a href="/wiki/Warm_autoimmune_hemolytic_anemia" title="Warm autoimmune hemolytic anemia">warm autoimmune hemolytic anemia</a>.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> The red cells are of normal size and colour (normocytic and normochromic). A low white blood cell count (<a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a>) usually only occurs in patients with <a href="/wiki/Felty%27s_syndrome" title="Felty's syndrome">Felty's syndrome</a> with an enlarged liver and spleen. The mechanism of neutropenia is complex. An increased <a href="/wiki/Platelet" title="Platelet">platelet</a> count (<a href="/wiki/Thrombocytosis" title="Thrombocytosis">thrombocytosis</a>) occurs when inflammation is uncontrolled.</dd>
</dl>
<dl>
<dt>Neurological</dt>
<dd><a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">Peripheral neuropathy</a> and <a href="/wiki/Mononeuritis_multiplex" title="Mononeuritis multiplex" class="mw-redirect">mononeuritis multiplex</a> may occur. The most common problem is <a href="/wiki/Carpal_tunnel_syndrome" title="Carpal tunnel syndrome">carpal tunnel syndrome</a> caused by compression of the median nerve by swelling around the wrist. <a href="/wiki/Atlanto-axial_joint" title="Atlanto-axial joint">Atlanto-axial</a> <a href="/wiki/Subluxation" title="Subluxation">subluxation</a> can occur, owing to erosion of the <a href="/wiki/Odontoid_process" title="Odontoid process" class="mw-redirect">odontoid process</a> and/or <a href="/wiki/Transverse_ligament" title="Transverse ligament">transverse ligaments</a> in the <a href="/wiki/Cervical_spine" title="Cervical spine" class="mw-redirect">cervical spine</a>'s connection to the skull. Such an erosion (&gt;3mm) can give rise to <a href="/wiki/Vertebrae" title="Vertebrae" class="mw-redirect">vertebrae</a> slipping over one another and compressing the spinal cord. Clumsiness is initially experienced, but without due care this can progress to <a href="/wiki/Quadriplegia" title="Quadriplegia" class="mw-redirect">quadriplegia</a>.</dd>
</dl>
<dl>
<dt>Constitutional symptoms</dt>
<dd><a href="/wiki/Constitutional_symptoms" title="Constitutional symptoms">Constitutional symptoms</a> including <a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">fatigue</a>, low grade <a href="/wiki/Fever" title="Fever">fever</a>, <a href="/wiki/Malaise" title="Malaise">malaise</a>, <a href="/wiki/Morning_stiffness" title="Morning stiffness" class="mw-redirect">morning stiffness</a>, <a href="/wiki/Loss_of_appetite" title="Loss of appetite" class="mw-redirect">loss of appetite</a> and <a href="/wiki/Loss_of_weight" title="Loss of weight" class="mw-redirect">loss of weight</a> are common systemic manifestations seen in patients with active RA.</dd>
</dl>
<dl>
<dt>Osteoporosis</dt>
<dd>Local <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> occurs in RA around inflamed joints. It is postulated to be partially caused by inflammatory cytokines. More general osteoporosis is probably contributed to by immobility, systemic cytokine effects, local cytokine release in bone marrow and corticosteroid therapy.</dd>
</dl>
<dl>
<dt>Lymphoma</dt>
<dd>The incidence of <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a> is increased in RA, although it is still uncommon.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></dd>
</dl>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=8" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>RA is a form of autoimmunity, the causes of which are still not completely known. It is a systemic (whole body) disorder principally affecting synovial tissues. There is no evidence that physical and emotional effects or stress could be a trigger for the disease. The many negative findings suggest that either the trigger varies, or that it might in fact be a chance event inherent with the immune response<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup></p>
<p>Half of the risk for RA is believed to be genetic.<sup id="cite_ref-Lancet2010_22-0" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> It is strongly associated with the inherited tissue type <a href="/wiki/Major_histocompatibility_complex" title="Major histocompatibility complex">major histocompatibility complex</a> (MHC) antigen <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">HLA</a>-DR4 (most specifically DR0401 and 0404), and the genes PTPN22 and PADI4—hence family history is an important risk factor.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup> Inheriting the PTPN22 gene has been shown to double a person's susceptibility to RA. PADI4 has been identified as a major risk factor in people of Asian descent, but not in those of European descent.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup> First-degree relatives prevalence rate is 2–3% and disease <a href="/wiki/Genetic_concordance" title="Genetic concordance" class="mw-redirect">genetic concordance</a> in <a href="/wiki/Monozygotic_twins" title="Monozygotic twins" class="mw-redirect">monozygotic twins</a> is approximately 15–20%.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></p>
<p>Smoking is the most significant non-genetic risk<sup id="cite_ref-Lancet2010_22-1" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> with RA being up to three times more common in smokers than non-smokers, particularly in men, heavy smokers, and those who are rheumatoid factor positive.<sup id="cite_ref-Sugiyama2010_28-0" class="reference"><a href="#cite_note-Sugiyama2010-28"><span>[</span>28<span>]</span></a></sup> Modest alcohol consumption may be protective.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup></p>
<p>Epidemiological studies have confirmed a potential association between RA and two <a href="/wiki/Herpesvirus" title="Herpesvirus" class="mw-redirect">herpesvirus</a> infections:<a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">Epstein-Barr virus</a> (EBV) and <a href="/wiki/Human_Herpesvirus_Six" title="Human Herpesvirus Six" class="mw-redirect">Human Herpes Virus 6</a> (HHV-6).<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> Individuals with RA are more likely to exhibit an abnormal immune response to EBV and have high levels of anti-EBV antibodies.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup></p>
<p><a href="/wiki/Vitamin_D_deficiency" title="Vitamin D deficiency" class="mw-redirect">Vitamin D deficiency</a> is common in those with RA and may be causally associated.<sup id="cite_ref-Wen2011_32-0" class="reference"><a href="#cite_note-Wen2011-32"><span>[</span>32<span>]</span></a></sup> Some trials have found a decreased risk for RA with vitamin D supplementation while others have not.<sup id="cite_ref-Wen2011_32-1" class="reference"><a href="#cite_note-Wen2011-32"><span>[</span>32<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=9" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The key pieces of evidence relating to pathogenesis are:</p>
<ol>
<li>A genetic link with <a href="/wiki/HLA-DR4" title="HLA-DR4">HLA-DR4</a> and related allotypes of <a href="/wiki/MHC_Class_II" title="MHC Class II" class="mw-redirect">MHC Class II</a> and the T cell-associated protein <a href="/wiki/PTPN22" title="PTPN22">PTPN22</a>.</li>
<li>An undeniable link to the pathogenesis of vascular disease of many types, including the possibility of a strong causal connection to rheumatoid vasculitis, a typical feature of this condition.<sup id="cite_ref-AlbanoSantana-Sahagun2001_33-0" class="reference"><a href="#cite_note-AlbanoSantana-Sahagun2001-33"><span>[</span>33<span>]</span></a></sup></li>
<li>A remarkable deceleration of disease progression in many cases by blockade of the cytokine <a href="/wiki/Tumor_necrosis_factors" title="Tumor necrosis factors">TNF</a> (alpha).</li>
<li>A similar dramatic response in many cases to depletion of <a href="/wiki/B_lymphocyte" title="B lymphocyte" class="mw-redirect">B lymphocytes</a>, but no comparable response to depletion of <a href="/wiki/T_lymphocyte" title="T lymphocyte" class="mw-redirect">T lymphocytes</a>.</li>
<li>A more or less random pattern of whether and when predisposed individuals are affected.</li>
<li>The presence of autoantibodies to IgGFc, known as <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factors</a> (RF), and <a href="/wiki/Anti-citrullinated_protein_antibody" title="Anti-citrullinated protein antibody">antibodies to citrullinated peptides</a> (ACPA).</li>
</ol>
<p>These data suggest that the disease involves abnormal B cell–T cell interaction, with presentation of antigens by B cells to T cells via HLA-DR eliciting T cell help and consequent production of RF and ACPA. Inflammation is then driven either by B cell or T cell products stimulating release of TNF and other cytokines. The process may be facilitated by an effect of smoking on <a href="/wiki/Citrullination" title="Citrullination">citrullination</a> but the stochastic (random) epidemiology suggests that the rate limiting step in genesis of disease in predisposed individuals may be an inherent stochastic process within the immune response such as immunoglobulin or T cell receptor gene recombination and mutation. (See entry under <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a> for general mechanisms.)</p>
<p>If TNF release is stimulated by B cell products in the form of RF or ACPA -containing immune complexes, through activation of immunoglobulin <a href="/wiki/Fc_receptor" title="Fc receptor">Fc receptors</a>, then RA can be seen as a form of <a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III hypersensitivity</a>.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>35<span>]</span></a></sup> If TNF release is stimulated by T cell products such as <a href="/wiki/Interleukin-17" title="Interleukin-17" class="mw-redirect">interleukin-17</a> it might be considered closer to <a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">type IV hypersensitivity</a> although this terminology may be getting somewhat dated and unhelpful.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup> The debate on the relative roles of immune complexes and T cell products in inflammation in RA has continued for 30 years. There is little doubt that both B and T cells are essential to the disease. However, there is good evidence for neither cell being necessary at the site of inflammation. This tends to favour immune complexes (based on antibody synthesised elsewhere) as the initiators, even if not the sole perpetuators of inflammation. Moreover, work by Thurlings and others in Paul-Peter Tak's group and also by Arthur Kavanagh's group suggest that if any immune cells are relevant locally they are the plasma cells, which derive from B cells and produce in bulk the antibodies selected at the B cell stage.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2009)">citation needed</span></a></i>]</sup></p>
<p>Although TNF appears to be the dominant, other <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a> (chemical mediators) are likely to be involved in inflammation in RA. Blockade of TNF does not benefit all patients or all tissues (lung disease and nodules may get worse). Blockade of IL-1, <a href="/wiki/Interleukin_15" title="Interleukin 15">IL-15</a> and <a href="/wiki/Interleukin_6" title="Interleukin 6">IL-6</a> also have beneficial effects and <a href="/wiki/Interleukin_17" title="Interleukin 17">IL-17</a> may be important. Constitutional symptoms such as fever, malaise, loss of appetite and weight loss are also caused by cytokines released into the blood stream.</p>
<p>As with most autoimmune diseases, it is important to distinguish between the cause(s) that trigger the process, and those that may permit it to persist and progress.</p>
<h3><span class="mw-headline" id="Abnormal_immune_response">Abnormal immune response</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=10" title="Edit section: Abnormal immune response">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The factors that allow an abnormal immune response, once initiated, to become permanent and chronic, are becoming more clearly understood. The genetic association with HLA-DR4, as well as the newly discovered associations with the gene <a href="/wiki/PTPN22" title="PTPN22">PTPN22</a> and with two additional genes,<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup> all implicate altered thresholds in regulation of the adaptive immune response. It has also become clear from recent studies that these genetic factors may interact with the most clearly defined environmental risk factor for RA, namely cigarette smoking<sup id="cite_ref-Sugiyama2010_28-1" class="reference"><a href="#cite_note-Sugiyama2010-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup> Other environmental factors also appear to modulate the risk of acquiring RA, and hormonal factors in the individual may explain some features of the disease, such as the higher occurrence in women, the not-infrequent onset after child-birth, and the (slight) modulation of disease risk by hormonal medications. Exactly how altered regulatory thresholds allow the triggering of a specific autoimmune response remains uncertain. However, one possibility is that negative feedback mechanisms that normally maintain tolerance of self are overtaken by aberrant positive feedback mechanisms for certain antigens such as IgG Fc (bound by RF) and citrullinated fibrinogen (bound by ACPA) (see entry on <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmunity</a>).</p>
<p>Once the abnormal immune response has become established (which may take several years before any symptoms occur), plasma cells derived from B lymphocytes produce rheumatoid factors and ACPA of the IgG and IgM classes in large quantities. These are not deposited in the way that they are in systemic lupus. Rather, they activate macrophages through Fc receptor and complement binding, which seems to play an important role in the intense inflammatory response present in RA.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup> This contributes to inflammation of the synovium, in terms of edema, vasodilation and infiltration by activated T-cells (mainly CD4 in nodular aggregates and CD8 in diffuse infiltrates). Synovial macrophages and dendritic cells further function as antigen presenting cells by expressing MHC class II molecules, leading to an established local immune reaction in the tissue. The disease progresses in concert with formation of granulation tissue at the edges of the synovial lining (<a href="/wiki/Pannus" title="Pannus">pannus</a>) with extensive angiogenesis and production of enzymes that cause tissue damage. Modern pharmacological treatments of RA target these mediators. Once the inflammatory reaction is established, the synovium thickens, the cartilage and the underlying bone begins to disintegrate and evidence of joint destruction accrues.</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=11" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Imaging">Imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=12" title="Edit section: Imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:RheumatoideArthritisAP.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/RheumatoideArthritisAP.jpg/220px-RheumatoideArthritisAP.jpg" width="220" height="365" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/RheumatoideArthritisAP.jpg/330px-RheumatoideArthritisAP.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3e/RheumatoideArthritisAP.jpg/440px-RheumatoideArthritisAP.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:RheumatoideArthritisAP.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
X-ray of the hand in rheumatoid arthritis.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Inflamatory_arthritis2010.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Inflamatory_arthritis2010.JPG/220px-Inflamatory_arthritis2010.JPG" width="220" height="293" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Inflamatory_arthritis2010.JPG/330px-Inflamatory_arthritis2010.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Inflamatory_arthritis2010.JPG/440px-Inflamatory_arthritis2010.JPG 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Inflamatory_arthritis2010.JPG" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Appearance of synovial fluid from a joint with inflammatory arthritis.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif/220px-Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" width="220" height="318" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif/330px-Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/09/Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif/440px-Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Rheumatoid_arthritis_ultrasound_MRI_MCP_joint_ar1904-2.gif" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Signs of destruction and inflammation on <a href="/wiki/Medical_ultrasound" title="Medical ultrasound" class="mw-redirect">ultrasonography</a> and <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> in the second <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joint</a> in established RA. Thin arrows indicate an erosive change; thick arrows indicate <a href="/wiki/Synovitis" title="Synovitis">synovitis</a>. Ultrasonography (left side of image) in the (a) longitudinal and (b) the transverse planes shows both signs of destruction and inflammation. Axial T1-weighted magnetic resonance images were obtained (c) before and (d) after contrast administration, also demonstrating synovitis. Additionally, a coronal T1-weighted magnetic resonance image (e) before contrast administration visualizes the same bone erosion as shown in panels c and d.</div>
</div>
</div>
<p><a href="/wiki/X-ray" title="X-ray">X-rays</a> of the hands and feet are generally performed in people with a polyarthritis. In RA, there may be no changes in the early stages of the disease, or the x-ray may demonstrate juxta-articular osteopenia, soft tissue swelling and loss of joint space. As the disease advances, there may be bony erosions and subluxation. X-rays of other joints may be taken if symptoms of pain or swelling occur in those joints.</p>
<p>Other medical imaging techniques such as magnetic resonance imaging (MRI) and ultrasound are also used in RA.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2010)">citation needed</span></a></i>]</sup></p>
<p>There have been technical advances in ultrasonography. High-frequency transducers (10&#160;MHz or higher) have improved the spatial resolution of ultrasound images; these images can depict 20% more erosions than conventional radiography. Also, color Doppler and power Doppler ultrasound, which show vascular signals of active synovitis depending on the degree of inflammation, are useful in assessing synovial inflammation. This is important, since in the early stages of RA, the synovium is primarily affected, and synovitis seems to be the best predictive marker of future joint damage.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>40<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Blood_tests">Blood tests</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=13" title="Edit section: Blood tests">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>When RA is clinically suspected, <a href="/wiki/Immunology" title="Immunology">immunological</a> studies are required, such as testing for the presence of <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factor</a> (RF, a non-specific <a href="/wiki/Antibody" title="Antibody">antibody</a>).<sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>41<span>]</span></a></sup> A negative RF does not rule out RA; rather, the arthritis is called <i><a href="/wiki/Seronegative" title="Seronegative" class="mw-redirect">seronegative</a></i>. This is the case in about 15% of patients.<sup id="cite_ref-Nishimura_42-0" class="reference"><a href="#cite_note-Nishimura-42"><span>[</span>42<span>]</span></a></sup> During the first year of illness, rheumatoid factor is more likely to be negative with some individuals converting to seropositive status over time. RF is also seen in other illnesses, for example <a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a>, <a href="/wiki/Hepatitis_C" title="Hepatitis C">hepatitis C</a>, <a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a>, chronic infections and in approximately 10% of the healthy population, therefore the test is not very specific.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2014)">citation needed</span></a></i>]</sup></p>
<p>Because of this low <a href="/wiki/Specificity_(tests)" title="Specificity (tests)" class="mw-redirect">specificity</a>, new serological tests have been developed, which test for the presence of the anti-citrullinated protein antibodies (<a href="/wiki/Anti-citrullinated_protein_antibodies" title="Anti-citrullinated protein antibodies" class="mw-redirect">ACPAs</a>) or anti-CCP. Like RF, these tests are positive in only a proportion (67%) of all RA cases, but are rarely positive if RA is not present, giving it a specificity of around 95%.<sup id="cite_ref-Nishimura_42-1" class="reference"><a href="#cite_note-Nishimura-42"><span>[</span>42<span>]</span></a></sup> As with RF, there is evidence for ACPAs being present in many cases even before onset of clinical disease.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2008)">citation needed</span></a></i>]</sup></p>
<p>The most common tests for ACPAs are the anti-CCP (<a href="/wiki/Cyclic_citrullinated_peptide" title="Cyclic citrullinated peptide" class="mw-redirect">cyclic citrullinated peptide</a>) test and the <a href="/wiki/Mutated_citrullinated_vimentin" title="Mutated citrullinated vimentin">Anti-MCV</a> assay (antibodies against mutated citrullinated Vimentin). Recently a serological <a href="/wiki/Point-of-care_testing" title="Point-of-care testing">point-of-care test</a> (POCT) for the early detection of RA has been developed. This assay combines the detection of rheumatoid factor and anti-MCV for diagnosis of RA and shows a sensitivity of 72% and specificity of 99.7%.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup></p>
<p>Also, several other blood tests are usually done to allow for other causes of arthritis, such as <a href="/wiki/Lupus_erythematosus" title="Lupus erythematosus">lupus erythematosus</a>. The <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a> (ESR), <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a>, <a href="/wiki/Full_blood_count" title="Full blood count" class="mw-redirect">full blood count</a>, <a href="/wiki/Renal_function" title="Renal function">renal function</a>, <a href="/wiki/Liver_enzyme" title="Liver enzyme" class="mw-redirect">liver enzymes</a> and other immunological tests (e.g., <a href="/wiki/Antinuclear_antibody" title="Antinuclear antibody" class="mw-redirect">antinuclear antibody</a>/ANA) are all performed at this stage. Elevated <a href="/wiki/Ferritin" title="Ferritin">ferritin</a> levels can reveal <a href="/wiki/Hemochromatosis" title="Hemochromatosis" class="mw-redirect">hemochromatosis</a>, a mimic of RA, or be a sign of <a href="/wiki/Adult-onset_Still%27s_disease" title="Adult-onset Still's disease">Still's disease</a>, a seronegative, usually juvenile, variant of rheumatoid arthritis.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2008)">citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Criteria">Criteria</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=14" title="Edit section: Criteria">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2010 the <i>2010 ACR / EULAR Rheumatoid Arthritis Classification Criteria</i> were introduced.<sup id="cite_ref-acr-eular_45-0" class="reference"><a href="#cite_note-acr-eular-45"><span>[</span>45<span>]</span></a></sup> These new classification criteria overruled the "old" ACR criteria of 1987 and are adapted for early RA diagnosis. The "new" classification criteria, jointly published by the <a href="/wiki/American_College_of_Rheumatology" title="American College of Rheumatology">American College of Rheumatology</a> (ACR) and the <a href="/wiki/European_League_Against_Rheumatism" title="European League Against Rheumatism">European League Against Rheumatism</a> (EULAR) establish a point value between 0 and 10. Every patient with a point total of 6 or higher is unequivocally classified as an RA patient, provided he has synovitis in at least one joint and given that there is no other diagnosis better explaining the synovitis. Four areas are covered in the diagnosis:<sup id="cite_ref-acr-eular_45-1" class="reference"><a href="#cite_note-acr-eular-45"><span>[</span>45<span>]</span></a></sup></p>
<ul>
<li>joint involvement, designating the <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joints</a>, <a href="/wiki/Proximal_interphalangeal_joint" title="Proximal interphalangeal joint" class="mw-redirect">proximal interphalangeal joints</a>, the <a href="/wiki/Interphalangeal_articulations_of_hand" title="Interphalangeal articulations of hand">interphalangeal joint</a> of the thumb, second through fifth <a href="/wiki/Metatarsophalangeal_joint" title="Metatarsophalangeal joint" class="mw-redirect">metatarsophalangeal joint</a> and <a href="/wiki/Wrist" title="Wrist">wrist</a> as <i>small joints</i>, and <a href="/wiki/Shoulder" title="Shoulder">shoulders</a>, <a href="/wiki/Elbow" title="Elbow">elbows</a>, <a href="/wiki/Hip_joint" title="Hip joint" class="mw-redirect">hip joints</a>, <a href="/wiki/Knee" title="Knee">knees</a>, and <a href="/wiki/Ankle" title="Ankle">ankles</a> as <i>large joints</i>:
<ul>
<li>Involvement of 1 large joint gives 0 points</li>
<li>Involvement of 2–10 large joints gives 1 point</li>
<li>Involvement of 1–3 small joints (with or without involvement of large joints) gives 2 points</li>
<li>Involvement of 4–10 small joints (with or without involvement of large joints) gives 3 points</li>
<li>Involvement of more than 10 joints (with involvement of at least 1 small joint) gives 5 points</li>
</ul>
</li>
<li>serological parameters – including the <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factor</a> as well as <a href="/wiki/Anti-citrullinated_protein_antibody" title="Anti-citrullinated protein antibody">ACPA</a> – "ACPA" stands for "anti-citrullinated protein antibody":
<ul>
<li>Negative RF <i>and</i> negative ACPA gives 0 points</li>
<li>Low-positive RF <i>or</i> low-positive ACPA gives 2 points</li>
<li>High-positive RF <i>or</i> high-positive ACPA gives 3 points</li>
</ul>
</li>
<li>acute phase reactants: 1 point for elevated erythrocyte sedimentation rate, <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">ESR</a>, or elevated <a href="/wiki/C-reactive_protein" title="C-reactive protein">CRP</a> value (c-reactive protein)</li>
<li>duration of <a href="/wiki/Arthritis" title="Arthritis">arthritis</a>: 1 point for symptoms lasting six weeks or longer</li>
</ul>
<p>The new criteria accommodate to the growing understanding of RA and the improvements in diagnosing RA and disease treatment. In the "new" criteria serology and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diagnostics</a> carries major weight, as ACPA detection is appropriate to diagnose the disease in an early state, before joints destructions occur. Destruction of the joints viewed in radiological images was a significant point of the ACR criteria from 1987.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span>[</span>46<span>]</span></a></sup> This criterion no longer is regarded to be relevant, as this is just the type of damage that treatment is meant to avoid.</p>
<p>The criteria are not intended for the diagnosis for routine clinical care; they were primarily intended to categorize research (<i>classification</i> criteria). In clinical practice, the following criteria apply:<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (September 2010)">citation needed</span></a></i>]</sup></p>
<ul>
<li>two or more swollen joints</li>
<li>morning stiffness lasting more than one hour for at least six weeks</li>
<li>the detection of <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">rheumatoid factors</a> or <a href="/wiki/Autoantibody" title="Autoantibody">autoantibodies</a> against <a href="/wiki/Anti-citrullinated_protein_antibody" title="Anti-citrullinated protein antibody">ACPA</a> such as autoantibodies to <a href="/wiki/Anti-MCV" title="Anti-MCV" class="mw-redirect">mutated citrullinated vimentin</a> can confirm the suspicion of RA. A negative autoantibody result does not exclude a diagnosis of RA.</li>
</ul>
<h3><span class="mw-headline" id="Differential_diagnoses">Differential diagnoses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=15" title="Edit section: Differential diagnoses">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several other medical conditions can resemble RA, and usually need to be distinguished from it at the time of diagnosis:<sup id="cite_ref-Merckmanual_47-0" class="reference"><a href="#cite_note-Merckmanual-47"><span>[</span>47<span>]</span></a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></p>
<ul>
<li>Crystal induced arthritis (<a href="/wiki/Gout" title="Gout">gout</a>, and <a href="/wiki/Pseudogout" title="Pseudogout" class="mw-redirect">pseudogout</a>) – usually involves particular joints (knee, MTP1, heels) and can be distinguished with aspiration of joint fluid if in doubt. Redness, asymmetric distribution of affected joints, pain occurs at night and the starting pain is less than an hour with gout.</li>
<li><a href="/wiki/Osteoarthritis" title="Osteoarthritis">Osteoarthritis</a> – distinguished with <a href="/wiki/X-ray" title="X-ray">X-rays</a> of the affected joints and blood tests, age (mostly older patients), starting pain less than an hour, a-symmetric distribution of affected joints and pain worsens when using joint for longer periods.</li>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a> (SLE) – distinguished by specific clinical symptoms and blood tests (antibodies against double-stranded DNA)</li>
<li>One of the several types of <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a> resembles RA – nail changes and skin symptoms distinguish between them</li>
<li><a href="/wiki/Lyme_disease" title="Lyme disease">Lyme disease</a> causes erosive arthritis and may closely resemble RA – it may be distinguished by blood test in endemic areas</li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a> (previously Reiter's disease) – asymmetrically involves heel, <a href="/wiki/Sacroiliac" title="Sacroiliac" class="mw-redirect">sacroiliac</a> joints, and large joints of the leg. It is usually associated with <a href="/wiki/Urethritis" title="Urethritis">urethritis</a>, <a href="/wiki/Conjunctivitis" title="Conjunctivitis">conjunctivitis</a>, <a href="/wiki/Iritis" title="Iritis" class="mw-redirect">iritis</a>, painless buccal ulcers, and <a href="/wiki/Keratoderma_blennorrhagica" title="Keratoderma blennorrhagica" class="mw-redirect">keratoderma blennorrhagica</a>.</li>
<li><a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">Ankylosing spondylitis</a> – this involves the spine, although a RA-like symmetrical small-joint polyarthritis may occur in the context of this condition.</li>
<li><a href="/wiki/Hepatitis_C" title="Hepatitis C">Hepatitis C</a> – RA-like symmetrical small-joint polyarthritis may occur in the context of this condition. Hepatitis C may also induce Rheumatoid Factor auto-antibodies</li>
</ul>
<p>Rarer causes that usually behave differently but may cause joint pains:<sup id="cite_ref-Merckmanual_47-1" class="reference"><a href="#cite_note-Merckmanual-47"><span>[</span>47<span>]</span></a></sup></p>
<ul>
<li><a href="/wiki/Sarcoidosis" title="Sarcoidosis">Sarcoidosis</a>, amyloidosis, and <a href="/wiki/Whipple%27s_disease" title="Whipple's disease">Whipple's disease</a> can also resemble RA.</li>
<li><a href="/wiki/Hemochromatosis" title="Hemochromatosis" class="mw-redirect">Hemochromatosis</a> may cause hand joint arthritis.</li>
<li>Acute rheumatic fever can be differentiated from RA by a migratory pattern of joint involvement and evidence of antecedent <a href="/wiki/Streptococcal" title="Streptococcal" class="mw-redirect">streptococcal</a> infection. Bacterial arthritis (such as streptococcus) is usually asymmetric, while RA usually involves both sides of the body symmetrically.</li>
<li><a href="/wiki/Gonococcal" title="Gonococcal" class="mw-redirect">Gonococcal</a> arthritis (another bacterial arthritis) is also initially migratory and can involve <a href="/wiki/Tendons" title="Tendons" class="mw-redirect">tendons</a> around the wrists and ankles.</li>
</ul>
<h3><span class="mw-headline" id="Monitoring_progression">Monitoring progression</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=16" title="Edit section: Monitoring progression">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The progression of RA can be followed using scores such as <i>Disease Activity Score of 28 joints</i> (<span id="DAS28">DAS28</span>). It is widely used as an indicator of RA disease activity and response to treatment, but is not always a reliable indicator of treatment effect.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> The joints included in DAS28 are (<a href="/wiki/Bilateral_symmetry" title="Bilateral symmetry" class="mw-redirect">bilaterally</a>): <a href="/wiki/Proximal_interphalangeal_joint" title="Proximal interphalangeal joint" class="mw-redirect">proximal interphalangeal joints</a> (10 joints), <a href="/wiki/Metacarpophalangeal_joint" title="Metacarpophalangeal joint">metacarpophalangeal joints</a> (10), <a href="/wiki/Wrist" title="Wrist">wrists</a> (2), <a href="/wiki/Elbow" title="Elbow">elbows</a> (2), <a href="/wiki/Shoulder" title="Shoulder">shoulders</a> (2) and <a href="/wiki/Knee" title="Knee">knees</a> (2). When looking at these joints, both the number of joints with tenderness upon touching (<b>TEN28</b>) and swelling (<b>SW28</b>) are counted. In addition, the <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a> (<b>ESR</b>) is measured. Also, the patient makes a subjective assessment (<b>SA</b>) of disease activity during the preceding 7 days on a scale between 0 and 100, where 0 is "no activity" and 100 is "highest activity possible". With these parameters, DAS28 is calculated as:<sup id="cite_ref-Prevoo1995_50-0" class="reference"><a href="#cite_note-Prevoo1995-50"><span>[</span>50<span>]</span></a></sup> <img class="tex" alt="DAS28=0.56 \times \sqrt{TEN28} + 0.28 \times \sqrt{SW28} + 0.70 \times \ln(ESR) + 0.014 \times SA" src="//upload.wikimedia.org/math/7/7/d/77dfcf915bf977dfdffe015fd6326298.png" /></p>
<p>From this, the disease activity of the patient can be classified as follows:<sup id="cite_ref-Prevoo1995_50-1" class="reference"><a href="#cite_note-Prevoo1995-50"><span>[</span>50<span>]</span></a></sup></p>
<table class="wikitable">
<tr>
<th colspan="2" rowspan="2">Current<br />
DAS28</th>
<th colspan="3">DAS28 decrease from initial value</th>
</tr>
<tr>
<td><a href="/wiki/More_than" title="More than" class="mw-redirect">&gt;</a> 1.2</td>
<td>&gt; 0.6 but <a href="/wiki/Less_than_or_equal_to" title="Less than or equal to" class="mw-redirect">≤</a> 1.2</td>
<td>≤ 0.6</td>
</tr>
<tr>
<td><a href="/wiki/Less_than_or_equal_to" title="Less than or equal to" class="mw-redirect">≤</a> 3.2</td>
<td>Inactive</td>
<td>Good improvement</td>
<td>Moderate improvement</td>
<td>No improvement</td>
</tr>
<tr>
<td><a href="/wiki/More_than" title="More than" class="mw-redirect">&gt;</a> 3.2 but ≤ 5.1</td>
<td>Moderate</td>
<td>Moderate improvement</td>
<td>Moderate improvement</td>
<td>No improvement</td>
</tr>
<tr>
<td>&gt; 5.1</td>
<td>Very active</td>
<td>Moderate improvement</td>
<td>No improvement</td>
<td>No improvement</td>
</tr>
</table>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=17" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no cure for RA, but treatments can improve symptoms and slow the progress of the disease. Disease-modifying treatment has the best results when it is started early and aggressively.<sup id="cite_ref-ACR2008_51-0" class="reference"><a href="#cite_note-ACR2008-51"><span>[</span>51<span>]</span></a></sup></p>
<p>The goals of treatment are to minimize symptoms such as pain and swelling, to prevent bone deformity (for example, bone erosions visible in X-rays), and to maintain day-to-day functioning.<sup id="cite_ref-Wasserman_52-0" class="reference"><a href="#cite_note-Wasserman-52"><span>[</span>52<span>]</span></a></sup> This can often be achieved using two main classes of medications: analgesics such as NSAIDs, and <a href="/wiki/Disease-modifying_antirheumatic_drugs" title="Disease-modifying antirheumatic drugs" class="mw-redirect">disease-modifying antirheumatic drugs</a> (DMARDs).<sup id="cite_ref-NICEguidelines_53-0" class="reference"><a href="#cite_note-NICEguidelines-53"><span>[</span>53<span>]</span></a></sup> RA should generally be treated with at least one specific anti-rheumatic medication.<sup id="cite_ref-ACR2008_51-1" class="reference"><a href="#cite_note-ACR2008-51"><span>[</span>51<span>]</span></a></sup> The use of <a href="/wiki/Benzodiazepines" title="Benzodiazepines" class="mw-redirect">benzodiazepines</a> (such as <a href="/wiki/Diazepam" title="Diazepam">diazepam</a>) to treat the pain is not recommended as it does not appear to help and is associated with risks.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>54<span>]</span></a></sup> <a href="/wiki/Analgesics" title="Analgesics" class="mw-redirect">Analgesics</a>, other than NSAIDs, offer lesser, but some benefit with respect to pain.<sup id="cite_ref-Lancet2010_22-2" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> whilst not causing the same level of gastrointestinal irritation.</p>
<h3><span class="mw-headline" id="Lifestyle">Lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=18" title="Edit section: Lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Regular exercise is recommended as both safe and useful to maintain muscles strength and overall physical function.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup> It is uncertain if specific dietary measures have an effect.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Disease_modifying_agents">Disease modifying agents</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=19" title="Edit section: Disease modifying agents">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Disease-modifying_antirheumatic_drugs" title="Disease-modifying antirheumatic drugs" class="mw-redirect">Disease-modifying antirheumatic drugs</a> (DMARD) are the primary treatment for RA.<sup id="cite_ref-Lancet2010_22-3" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> They are a diverse collection of drugs, grouped by use and convention. They have been found to improve symptoms, decrease joint damage, and improve overall functional abilities.<sup id="cite_ref-Lancet2010_22-4" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> They should be started very early in the disease as when they result in disease remission in approximately half of people and improved outcomes overall.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup></p>
<p>The most commonly used agent is <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> with other frequently used agents including <a href="/wiki/Sulfasalazine" title="Sulfasalazine">sulfasalazine</a> and <a href="/wiki/Leflunomide" title="Leflunomide">leflunomide</a>. <a href="/wiki/Sodium_aurothiomalate" title="Sodium aurothiomalate">Sodium aurothiomalate</a> (Gold) and <a href="/wiki/Cyclosporin" title="Cyclosporin" class="mw-redirect">cyclosporin</a> are less commonly used due to more common adverse effects. Agents may be used in combinations.<sup id="cite_ref-Lancet2010_22-5" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup></p>
<p>Methotrexate is the most important and useful DMARD and is usually the first treatment.<sup id="cite_ref-Wasserman_52-1" class="reference"><a href="#cite_note-Wasserman-52"><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-NICEguidelines_53-1" class="reference"><a href="#cite_note-NICEguidelines-53"><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-chapter94_58-0" class="reference"><a href="#cite_note-chapter94-58"><span>[</span>58<span>]</span></a></sup> Adverse effects should be monitored regularly with toxicity including gastrointestinal, hematologic, pulmonary, and hepatic.<sup id="cite_ref-chapter94_58-1" class="reference"><a href="#cite_note-chapter94-58"><span>[</span>58<span>]</span></a></sup> Side effects such as nausea, vomiting or abdominal pain can be reduced by taking folic acid.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup> The most common undesirable affect is that it increases liver enzymes in almost 15% of people.<sup id="cite_ref-chapter94_58-2" class="reference"><a href="#cite_note-chapter94-58"><span>[</span>58<span>]</span></a></sup> It is thus recommended that those who consistently demonstrate abnormal levels of liver enzymes or have a history of liver disease or alcohol use undergo liver biopsies.<sup id="cite_ref-ACR2002_60-0" class="reference"><a href="#cite_note-ACR2002-60"><span>[</span>60<span>]</span></a></sup> Methotrexate is also considered a <a href="/wiki/Teratogenic" title="Teratogenic" class="mw-redirect">teratogenic</a> and as such, it is recommended women of childbearing age should use contraceptives to avoid pregnancy and to discontinue its use if pregnancy is planned.<sup id="cite_ref-Wasserman_52-2" class="reference"><a href="#cite_note-Wasserman-52"><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-chapter94_58-3" class="reference"><a href="#cite_note-chapter94-58"><span>[</span>58<span>]</span></a></sup></p>
<p><a href="/wiki/Biological_agents" title="Biological agents" class="mw-redirect">Biological agents</a> should generally only be used if methotrexate and other conventional agents are not effective after a trial of three months.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup> These agents include: <a href="/wiki/Tumor_necrosis_factor_alpha" title="Tumor necrosis factor alpha">tumor necrosis factor alpha</a> (TNFα) blockers<sup id="cite_ref-Lancet2010_22-6" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> such as <a href="/wiki/Infliximab" title="Infliximab">infliximab</a>; <a href="/wiki/Interleukin_1" title="Interleukin 1" class="mw-redirect">interleukin 1</a> blockers such as <a href="/wiki/Anakinra" title="Anakinra">anakinra</a>, <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibodies</a> against <a href="/wiki/B_cell" title="B cell">B cells</a> such as <a href="/wiki/Rituximab" title="Rituximab">rituximab</a>,<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup> <a href="/wiki/T_cell" title="T cell">T cell</a> costimulation blocker such as <a href="/wiki/Abatacept" title="Abatacept">abatacept</a> among others. They are often used in combination with either methotrexate or leflunomide.<sup id="cite_ref-Lancet2010_22-7" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup></p>
<p><a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF blockers</a> and <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> appear to have similar effectiveness when used alone and better results are obtained when used together. TNF blockers appear to have equivalent effectiveness with <a href="/wiki/Etanercept" title="Etanercept">etanercept</a> appearing to be the safest.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup> <a href="/wiki/Abatacept" title="Abatacept">Abatacept</a> appears effective for RA with 20% more people improving with treatment than without.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup> There however is a lack of evidence to distinguish between the biologics available for RA.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65"><span>[</span>65<span>]</span></a></sup> Issues with the biologics include their high cost and association with infections including <a href="/wiki/Tuberculosis" title="Tuberculosis">tuberculosis</a>.<sup id="cite_ref-Lancet2010_22-8" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Anti-inflammatory_agents">Anti-inflammatory agents</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=20" title="Edit section: Anti-inflammatory agents">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/NSAIDs" title="NSAIDs" class="mw-redirect">NSAIDs</a> reduce both pain and stiffness in those with RA.<sup id="cite_ref-Lancet2010_22-9" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> Generally they appear to have no effect on people's long term disease course and thus are no longer first line agents.<sup id="cite_ref-Lancet2010_22-10" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span>[</span>66<span>]</span></a></sup> NSAIDs should be used with caution in those with <a href="/wiki/Gastrointestinal" title="Gastrointestinal" class="mw-redirect">gastrointestinal</a>, <a href="/wiki/Cardiovascular" title="Cardiovascular" class="mw-redirect">cardiovascular</a>, or kidney problems.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup><sup id="cite_ref-68" class="reference"><a href="#cite_note-68"><span>[</span>68<span>]</span></a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup></p>
<p><a href="/wiki/COX-2_inhibitor" title="COX-2 inhibitor">COX-2 inhibitors</a>, such as <a href="/wiki/Celecoxib" title="Celecoxib">celecoxib</a>, and NSAIDs are equally effective.<sup id="cite_ref-Job2008_70-0" class="reference"><a href="#cite_note-Job2008-70"><span>[</span>70<span>]</span></a></sup> They have a similar gastrointestinal risk as an NSAIDs plus a <a href="/wiki/Proton_pump_inhibitor" title="Proton pump inhibitor" class="mw-redirect">proton pump inhibitor</a>.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71"><span>[</span>71<span>]</span></a></sup> In the elderly there is less gastrointestinal intolerance to celecoxib than to NSAIDs alone.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span>[</span>72<span>]</span></a></sup> There however is an increased risk of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> with COX-2 inhibitors.<sup id="cite_ref-Job2008_70-1" class="reference"><a href="#cite_note-Job2008-70"><span>[</span>70<span>]</span></a></sup> Anti-ulcer medications are not recommended routinely but only in those high risk of gastrointestinal problems.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span>[</span>73<span>]</span></a></sup></p>
<p><a href="/wiki/Glucocorticoids" title="Glucocorticoids" class="mw-redirect">Glucocorticoids</a> can be used in the short term for flare-ups, while waiting for slow-onset drugs to take effect.<sup id="cite_ref-Lancet2010_22-11" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> Injection of glucocorticoids into individual joints is also effective.<sup id="cite_ref-Lancet2010_22-12" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> While long-term use reduces joint damage it also results in osteoporosis and susceptibility to infections, and thus is not recommended.<sup id="cite_ref-Lancet2010_22-13" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Surgery">Surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=21" title="Edit section: Surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In early phases of the disease, an arthroscopic or open <a href="/wiki/Synovectomy" title="Synovectomy">synovectomy</a> may be performed. It consists of the removal of the inflamed <a href="/wiki/Synovia" title="Synovia" class="mw-redirect">synovia</a> and prevents a quick destruction of the affected joints. Severely affected joints may require <a href="/wiki/Joint_replacement" title="Joint replacement">joint replacement</a> surgery, such as knee replacement.<sup id="cite_ref-Lancet2010_22-14" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> Postoperatively, <a href="/wiki/Physiotherapy" title="Physiotherapy" class="mw-redirect">physiotherapy</a> is always necessary.</p>
<h3><span class="mw-headline" id="Alternative_medicine">Alternative medicine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=22" title="Edit section: Alternative medicine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There has been an increasing interest in the use of complementary and alternative medicine interventions for the treatment of pain in rheumatoid arthritis. While there have been multiple studies showing beneficial effects in RA on a wide variety of CAM modalities, these studies are often affected by <a href="/wiki/Publication_bias" title="Publication bias">publication bias</a> and are generally not high quality evidence such as <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized controlled trials</a> (RCTs), making definitive conclusions difficult to reach.<sup id="cite_ref-Efthimiou_2-1" class="reference"><a href="#cite_note-Efthimiou-2"><span>[</span>2<span>]</span></a></sup></p>
<p>The <a href="/wiki/National_Center_for_Complementary_and_Alternative_Medicine" title="National Center for Complementary and Alternative Medicine">National Center for Complementary and Alternative Medicine</a> has concluded, "In general, there is not enough scientific evidence to prove that any complementary health approaches are beneficial for RA, and there are safety concerns about some of them. Some mind and body practices and dietary supplements may help people with RA manage their symptoms and therefore may be beneficial additions to conventional RA treatments, but there is not enough evidence to draw conclusions."<sup id="cite_ref-NCCAM_4-1" class="reference"><a href="#cite_note-NCCAM-4"><span>[</span>4<span>]</span></a></sup> A <a href="/wiki/Systematic_review" title="Systematic review">systematic review</a> of CAM modalities (excluding fish oil) found "The major limitation in reviewing the evidence for CAMs is the paucity of RCTs in the area. The available evidence does not support their current use in the management of RA."<sup id="cite_ref-Macfarlane_3-1" class="reference"><a href="#cite_note-Macfarlane-3"><span>[</span>3<span>]</span></a></sup> One review suggests that of the various alternative medicine treatments evaluated, only <a href="/wiki/Acupuncture" title="Acupuncture">acupuncture</a>, <a href="/wiki/Apitherapy#Clinical_practice" title="Apitherapy">bee venom acupuncture</a>, herbal remedies, dietary <a href="/wiki/Omega-3_fatty_acids" title="Omega-3 fatty acids" class="mw-redirect">omega-3 fatty acids</a>, and <a href="/wiki/Pulsed_electromagnetic_field_therapy" title="Pulsed electromagnetic field therapy">pulsed electromagnetic field therapy</a> have been studied with RCTs and show promise in treating the pain of RA, though no definitive conclusions could be reached.<sup id="cite_ref-Efthimiou_2-2" class="reference"><a href="#cite_note-Efthimiou-2"><span>[</span>2<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Dietary_supplements">Dietary supplements</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=23" title="Edit section: Dietary supplements">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The <a href="/wiki/American_College_of_Rheumatology" title="American College of Rheumatology">American College of Rheumatology</a> states that no herbal medicines have health claims supported by high quality evidence and thus they do not recommend their use.<sup id="cite_ref-ACRCAM_74-0" class="reference"><a href="#cite_note-ACRCAM-74"><span>[</span>74<span>]</span></a></sup> There is no scientific basis to suggest that herbal supplements advertised as "natural" are safer for use than conventional medications as both are chemicals. Herbal medications, although labelled "natural", may be toxic or fatal if consumed.<sup id="cite_ref-ACRCAM_74-1" class="reference"><a href="#cite_note-ACRCAM-74"><span>[</span>74<span>]</span></a></sup> Some evidence supports omega-3 fatty acids and gamma-linolenic acid in RA.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span>[</span>75<span>]</span></a></sup> The benefit from omega-3 appears modest but consistent,<sup id="cite_ref-76" class="reference"><a href="#cite_note-76"><span>[</span>76<span>]</span></a></sup> though the current evidence is not strong enough to determine that supplementation with <a href="/wiki/Omega-3_fatty_acid" title="Omega-3 fatty acid">omega-3 polyunsaturated fatty acids</a> (found in fish oil) is an effective treatment for RA.<sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span>[</span>77<span>]</span></a></sup> Gamma-linolenic acid, which may reduce pain, tender joint count and stiffness, is generally safe.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78"><span>[</span>78<span>]</span></a></sup></p>
<p>The following show promise as treatments for RA, based on preliminary studies: <a href="/wiki/Boswellic_acid" title="Boswellic acid">boswellic acid</a>,<sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span>[</span>79<span>]</span></a></sup> <a href="/wiki/Curcumin" title="Curcumin">curcumin</a>,<sup id="cite_ref-80" class="reference"><a href="#cite_note-80"><span>[</span>80<span>]</span></a></sup> <a href="/wiki/Harpagophytum" title="Harpagophytum">Devil's claw</a>,<sup id="cite_ref-81" class="reference"><a href="#cite_note-81"><span>[</span>81<span>]</span></a></sup><sup id="cite_ref-82" class="reference"><a href="#cite_note-82"><span>[</span>82<span>]</span></a></sup> <a href="/wiki/Euonymus_alatus" title="Euonymus alatus">Euonymus alatus</a>,<sup id="cite_ref-83" class="reference"><a href="#cite_note-83"><span>[</span>83<span>]</span></a></sup> and <a href="/wiki/Tripterygium_wilfordii" title="Tripterygium wilfordii">Thunder god vine (<i>Tripterygium wilfordii</i>)</a>.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span>[</span>84<span>]</span></a></sup></p>
<p>Herbal supplements can often have significant side effects, and can interact with prescription medications being taken at the same time. These risks are often exacerbated by the false general belief by patients that herbal supplements are always safe and the hesitancy by patients in reporting the use of herbal supplements to physicians.<sup id="cite_ref-Efthimiou_2-3" class="reference"><a href="#cite_note-Efthimiou-2"><span>[</span>2<span>]</span></a></sup> NCCAM has noted that, "In particular, the herb thunder god vine (Tripterygium wilfordii) can have serious side effects."<sup id="cite_ref-NCCAM_4-2" class="reference"><a href="#cite_note-NCCAM-4"><span>[</span>4<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Manual_therapies">Manual therapies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=24" title="Edit section: Manual therapies">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The evidence for acupuncture is inconclusive<sup id="cite_ref-85" class="reference"><a href="#cite_note-85"><span>[</span>85<span>]</span></a></sup> with it appearing to be equivalent to sham acupuncture.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>86<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=25" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no known prevention for the contraction. Reduction of risk factors and aggressive treatment after diagnosis are recommended actions.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>87<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=26" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The course of the disease varies greatly. Some people have mild short-term symptoms, but in most the disease is progressive for life. Around 20%–30% will have subcutaneous nodules (known as <a href="/wiki/Rheumatoid_nodule" title="Rheumatoid nodule">rheumatoid nodules</a>); this is associated with a poor prognosis.</p>
<h3><span class="mw-headline" id="Prognostic_factors">Prognostic factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=27" title="Edit section: Prognostic factors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Poor prognostic factors include persistent synovitis, early erosive disease, extra-articular findings (including subcutaneous rheumatoid nodules), positive serum RF findings, positive serum anti-CCP autoantibodies, carriership of HLA-DR4 "Shared Epitope" alleles, family history of RA, poor functional status, socioeconomic factors, elevated acute phase response (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]), and increased clinical severity.</p>
<h3><span class="mw-headline" id="Mortality">Mortality</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=28" title="Edit section: Mortality">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>RA is known to reduce the lifespan of patients by anywhere from three to 12 years.<sup id="cite_ref-Wasserman_52-3" class="reference"><a href="#cite_note-Wasserman-52"><span>[</span>52<span>]</span></a></sup> A new line of research does, however, show that the use of new biologic drug therapies extend the lifespan of patients with RA and reduce the risk and progression of atherosclerosis.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88"><span>[</span>88<span>]</span></a></sup> According to the UK's National Rheumatoid Arthritis Society, "Young age at onset, long disease duration, the concurrent presence of other health problems (called co-morbidity), and characteristics of severe RA—such as poor functional ability or overall health status, a lot of joint damage on x-rays, the need for hospitalisation or involvement of organs other than the joints—have been shown to associate with higher mortality".<sup id="cite_ref-89" class="reference"><a href="#cite_note-89"><span>[</span>89<span>]</span></a></sup> Positive responses to treatment may indicate a better prognosis. A 2005 study by the <a href="/wiki/Mayo_Clinic" title="Mayo Clinic">Mayo Clinic</a> noted that RA sufferers suffer a doubled risk of heart disease,<sup id="cite_ref-90" class="reference"><a href="#cite_note-90"><span>[</span>90<span>]</span></a></sup> independent of other risk factors such as <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a>, alcohol abuse, and elevated <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a>, blood pressure and <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a>. The mechanism by which RA causes this increased risk remains unknown; the presence of chronic inflammation has been proposed as a contributing factor.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91"><span>[</span>91<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=29" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg/220px-Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg.png" width="220" height="97" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg/330px-Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg/440px-Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Rheumatoid_arthritis_world_map_-_DALY_-_WHO2004.svg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Disability-adjusted_life_year" title="Disability-adjusted life year">Disability-adjusted life year</a> for RA per 100,000&#160;inhabitants in 2004.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92"><span>[</span>92<span>]</span></a></sup>
<div>
<table style="width: 100%; background-color:transparent;table-layout:fixed; border:none; border-spacing:0;" role="presentation">
<tr style="vertical-align: top;">
<td>
<div style="margin-right:20px;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;no data</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;&lt;40</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;40–50</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;50–60</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;60–70</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;70–80</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;80–90</div>
</div>
</td>
<td>
<div style="margin-right: 20px;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;90–100</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;100–110</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;110–120</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;120–130</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;130–140</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;&gt;140</div>
</div>
</td>
</tr>
</table>
</div>
</div>
</div>
</div>
<p>RA affects between 0.5 and 1% of adults in the developed world with between 5 and 50 per 100,000 people newly developing the condition each year.<sup id="cite_ref-Lancet2010_22-15" class="reference"><a href="#cite_note-Lancet2010-22"><span>[</span>22<span>]</span></a></sup> In 2010 it resulted in about 49,000 deaths globally.<sup id="cite_ref-Loz2012_93-0" class="reference"><a href="#cite_note-Loz2012-93"><span>[</span>93<span>]</span></a></sup></p>
<p>Onset is uncommon under the age of 15 and from then on the incidence rises with age until the age of 80. Women are affected three to five times as often as men.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2014)">citation needed</span></a></i>]</sup></p>
<p>Some <a href="/wiki/Indigenous_peoples_of_the_Americas" title="Indigenous peoples of the Americas">Native American</a> groups have higher prevalence rates (5–6%) and people from the <a href="/wiki/Caribbean" title="Caribbean">Caribbean</a> region have lower prevalence rates.</p>
<p>The age at which the disease most commonly starts is in women between 40 and 50 years of age, and for men somewhat later.<sup id="cite_ref-94" class="reference"><a href="#cite_note-94"><span>[</span>94<span>]</span></a></sup> RA is a chronic disease, and although rarely, a spontaneous remission may occur, the natural course is almost invariably one of persistent symptoms, waxing and waning in intensity, and a progressive deterioration of joint structures leading to deformations and disability.</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=30" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks ambox ambox-content ambox-Refimprove" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px;"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" /></a></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">This section <b>needs additional citations for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a></b>. <span class="hide-when-compact">Please help <a class="external text" href="//en.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;action=edit">improve this article</a> by <a href="/wiki/Help:Introduction_to_referencing/1" title="Help:Introduction to referencing/1">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span> <small><i>(February 2014)</i></small></span></td>
</tr>
</table>
<p>The first known traces of arthritis date back at least as far as 4500 BC. A text dated <a href="/wiki/123_AD" title="123 AD" class="mw-redirect">123 AD</a> first describes <a href="/wiki/Symptom" title="Symptom">symptoms</a> very similar to RA. It was noted in skeletal remains of Native Americans found in <a href="/wiki/Tennessee" title="Tennessee">Tennessee</a>.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95"><span>[</span>95<span>]</span></a></sup> In the Old World, the disease is vanishingly rare before the 17th century.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96"><span>[</span>96<span>]</span></a></sup> and on this basis investigators believe it spread across the Atlantic during the <a href="/wiki/Age_of_Exploration" title="Age of Exploration" class="mw-redirect">Age of Exploration</a>. In 1859 the disease acquired its current name.</p>
<p>An anomaly has been noticed from investigation of Pre-Columbian bones. The bones from the Tennessee site show no signs of tuberculosis even though it was prevalent at the time throughout the Americas.<sup id="cite_ref-pmid14528501_97-0" class="reference"><a href="#cite_note-pmid14528501-97"><span>[</span>97<span>]</span></a></sup> Jim Mobley, at Pfizer, has discovered a historical pattern of epidemics of tuberculosis followed by a surge in the number of RA cases a few generations later.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98"><span>[</span>98<span>]</span></a></sup> Mobley attributes the spikes in arthritis to selective pressure caused by tuberculosis. A hypervigilant immune system is protective against tuberculosis at the cost of an increased risk of autoimmune disease.</p>
<p>The art of <a href="/wiki/Peter_Paul_Rubens" title="Peter Paul Rubens">Peter Paul Rubens</a> may possibly depict the effects of RA. In his later paintings, his rendered hands show, in the opinion of some physicians, increasing deformity consistent with the symptoms of the disease.<sup id="cite_ref-pmid7005475_99-0" class="reference"><a href="#cite_note-pmid7005475-99"><span>[</span>99<span>]</span></a></sup><sup id="cite_ref-100" class="reference"><a href="#cite_note-100"><span>[</span>100<span>]</span></a></sup> RA appears to some to have been depicted in 16th-century paintings.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101"><span>[</span>101<span>]</span></a></sup> However, it is generally recognised in art historical circles that the painting of hands in the 16th and 17th century followed certain stylised conventions, most clearly seen in the Mannerist movement. It was conventional, for instance to show the upheld right hand of Christ in what now appears a deformed posture. These conventions are easily misinterpreted as portrayals of disease.</p>
<p>The first recognized description of RA was in 1800 by the French physician <a href="/wiki/Augustin_Jacob_Landr%C3%A9-Beauvais" title="Augustin Jacob Landré-Beauvais">Dr Augustin Jacob Landré-Beauvais</a> (1772–1840) who was based in the famed <a href="/wiki/Piti%C3%A9-Salp%C3%AAtri%C3%A8re_Hospital" title="Pitié-Salpêtrière Hospital">Salpêtrière Hospital</a> in Paris.<sup id="cite_ref-Landre1800_7-1" class="reference"><a href="#cite_note-Landre1800-7"><span>[</span>7<span>]</span></a></sup> The name "rheumatoid arthritis" itself was coined in 1859 by British rheumatologist Dr <a href="/wiki/Alfred_Baring_Garrod" title="Alfred Baring Garrod">Alfred Baring Garrod</a>.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102"><span>[</span>102<span>]</span></a></sup></p>
<p>Historic treatments for RA have also included: <a href="/wiki/RICE_(medicine)" title="RICE (medicine)">rest, ice, compression and elevation</a>, <a href="/wiki/Apple" title="Apple">apple</a> diet, <a href="/wiki/Nutmeg" title="Nutmeg">nutmeg</a>, some light exercise every now and then, <a href="/wiki/Urtica" title="Urtica">nettles</a>, <a href="/wiki/Bee" title="Bee">bee</a> venom, <a href="/wiki/Copper" title="Copper">copper</a> bracelets, <a href="/wiki/Rhubarb_diet" title="Rhubarb diet">rhubarb diet</a>, extractions of teeth, <a href="/wiki/Fasting" title="Fasting">fasting</a>, <a href="/wiki/Honey" title="Honey">honey</a>, <a href="/wiki/Vitamin" title="Vitamin">vitamins</a>, <a href="/wiki/Insulin" title="Insulin">insulin</a>, <a href="/wiki/Magnet" title="Magnet">magnets</a>, and <a href="/wiki/Electroconvulsive_therapy" title="Electroconvulsive therapy">electroconvulsive therapy</a> (ECT).<sup id="cite_ref-103" class="reference"><a href="#cite_note-103"><span>[</span>103<span>]</span></a></sup> Most of these have either had no effect at all, or their effects have been modest and transient, while not being generalizable.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (September 2010)">citation needed</span></a></i>]</sup> The <a href="/wiki/Prosorba_column" title="Prosorba column">Prosorba column</a> blood filtering device (removing <a href="/wiki/IgG" title="IgG" class="mw-redirect">IgG</a>) was approved by the FDA in 1999 for treatment of RA<sup id="cite_ref-104" class="reference"><a href="#cite_note-104"><span>[</span>104<span>]</span></a></sup> However it was discontinued at the end of 2006.<sup id="cite_ref-105" class="reference"><a href="#cite_note-105"><span>[</span>105<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=31" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Majithia2007-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Majithia2007_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Majithia2007_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Majithia2007_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Majithia V, Geraci SA (2007). "Rheumatoid arthritis: diagnosis and management". <i>Am. J. Med.</i> <b>120</b> (11): 936–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.amjmed.2007.04.005">10.1016/j.amjmed.2007.04.005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17976416">17976416</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis%3A+diagnosis+and+management&amp;rft.aulast=Majithia+V%2C+Geraci+SA&amp;rft.au=Majithia+V%2C+Geraci+SA&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2007.04.005&amp;rft_id=info%3Apmid%2F17976416&amp;rft.issue=11&amp;rft.jtitle=Am.+J.+Med.&amp;rft.pages=936%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Efthimiou-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Efthimiou_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Efthimiou_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Efthimiou_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Efthimiou_2-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Efthimiou, P; Kukar, M (2010). "Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used <a href="/wiki/Sensory_modality" title="Sensory modality" class="mw-redirect">modalities</a><sup class="plainlinks noprint Inline-Template" style="vertical-align:text-top;white-space:nowrap;">[<i><a rel="nofollow" class="external text" href="//toolserver.org/%7Edispenser/cgi-bin/dab_solver.py?page=Rheumatoid_arthritis&amp;editintro=Template:Disambiguation_needed/editintro&amp;client=Template:Dn"><span title="Link needs disambiguation. (February 2014)">disambiguation needed</span></a></i>]</sup>.". <i>Rheumatology international</i> <b>30</b> (5): 571–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00296-009-1206-y">10.1007/s00296-009-1206-y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19876631">19876631</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Complementary+and+alternative+medicine+use+in+rheumatoid+arthritis%3A+proposed+mechanism+of+action+and+efficacy+of+commonly+used+modalitiesCategory%3AArticles+with+links+needing+disambiguation+from+February+2014%3Csup+class%3D%22plainlinks+noprint+Inline-Template%22+style%3D%22vertical-align%3Atext-top%3Bwhite-space%3Anowrap%3B%22%3E%26%2391%3B%3Ci%3E%5B%2F%2Ftoolserver.org%2F%257Edispenser%2Fcgi-bin%2Fdab_solver.py%3Fpage%3DRheumatoid_arthritis%26editintro%3DTemplate%3ADisambiguation_needed%2Feditintro%26client%3DTemplate%3ADn+%3Cspan+title%3D%22Link+needs+disambiguation.%7FUNIQ69d5b1bb8eb0eca2-nowiki-000001CA-QINU%7F+%28February+2014%29%22%3Edisambiguation+needed%3C%2Fspan%3E%5D%3C%2Fi%3E%26%2393%3B%3C%2Fsup%3E.&amp;rft.au=Efthimiou%2C+P&amp;rft.aufirst=P&amp;rft.aulast=Efthimiou&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00296-009-1206-y&amp;rft_id=info%3Apmid%2F19876631&amp;rft.issue=5&amp;rft.jtitle=Rheumatology+international&amp;rft.pages=571%E2%80%9386&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Macfarlane-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Macfarlane_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Macfarlane_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Macfarlane GJ, El-Metwally A, De Silva V, Ernst E, Dowds GL, Moots RJ (2011). "Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review". <i>Rheumatology (Oxford)</i> <b>50</b> (9): 1672–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Frheumatology%2Fker119">10.1093/rheumatology/ker119</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21652584">21652584</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Evidence+for+the+efficacy+of+complementary+and+alternative+medicines+in+the+management+of+rheumatoid+arthritis%3A+a+systematic+review&amp;rft.aulast=Macfarlane+GJ%2C+El-Metwally+A%2C+De+Silva+V%2C+Ernst+E%2C+Dowds+GL%2C+Moots+RJ&amp;rft.au=Macfarlane+GJ%2C+El-Metwally+A%2C+De+Silva+V%2C+Ernst+E%2C+Dowds+GL%2C+Moots+RJ&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fker119&amp;rft_id=info%3Apmid%2F21652584&amp;rft.issue=9&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.pages=1672%E2%80%9383&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NCCAM-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCCAM_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCCAM_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NCCAM_4-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://nccam.nih.gov/health/RA/getthefacts.htm">"Rheumatoid Arthritis and Complementary Health Approaches"</a>. National Center for Complementary and Alternative Medicine<span class="reference-accessdate">. Retrieved 21 April 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Rheumatoid+Arthritis+and+Complementary+Health+Approaches&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fnccam.nih.gov%2Fhealth%2FRA%2Fgetthefacts.htm&amp;rft.pub=National+Center+for+Complementary+and+Alternative+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation journal">Helmick, CG; Felson, DT; Lawrence, RC; Gabriel, S; Hirsch, R; Kwoh, CK; Liang, MH; Kremers, HM; Mayes, MD; Merkel, PA; Pillemer, SR; Reveille, JD; Stone, JH; National Arthritis Data, Workgroup (January 2008). "Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I". <i>Arthritis and rheumatism</i> <b>58</b> (1): 15–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.23177">10.1002/art.23177</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18163481">18163481</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Estimates+of+the+prevalence+of+arthritis+and+other+rheumatic+conditions+in+the+United+States.+Part+I&amp;rft.aufirst=CG&amp;rft.au=Helmick%2C+CG&amp;rft.aulast=Helmick&amp;rft.date=January+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.23177&amp;rft_id=info%3Apmid%2F18163481&amp;rft.issue=1&amp;rft.jtitle=Arthritis+and+rheumatism&amp;rft.pages=15%E2%80%9325&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.niams.nih.gov/Health_Info/Rheumatic_Disease/default.asp">"Handout on Health: Rheumatoid Arthritis"</a>. <a href="/wiki/National_Institute_of_Arthritis_and_Musculoskeletal_and_Skin_Diseases" title="National Institute of Arthritis and Musculoskeletal and Skin Diseases">National Institute of Arthritis and Musculoskeletal and Skin Diseases</a>. April 2009<span class="reference-accessdate">. Retrieved 2013-03-26</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Handout+on+Health%3A+Rheumatoid+Arthritis&amp;rft.date=April+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.niams.nih.gov%2FHealth_Info%2FRheumatic_Disease%2Fdefault.asp&amp;rft.pub=National+Institute+of+Arthritis+and+Musculoskeletal+and+Skin+Diseases&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Landre1800-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Landre1800_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Landre1800_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Landré-Beauvais AJ (1800). <i>La goutte asthénique primitive (doctoral thesis)</i>. Paris.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Landr%C3%A9-Beauvais+AJ&amp;rft.aulast=Landr%C3%A9-Beauvais+AJ&amp;rft.btitle=La+goutte+asth%C3%A9nique+primitive+%28doctoral+thesis%29&amp;rft.date=1800&amp;rft.genre=book&amp;rft.place=Paris&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> reproduced in <span class="citation journal">Landré-Beauvais AJ (2001). "The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800". <i>Joint Bone spine</i> <b>68</b> (2): 130–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS1297-319X%2800%2900247-5">10.1016/S1297-319X(00)00247-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11324929">11324929</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+first+description+of+rheumatoid+arthritis.+Unabridged+text+of+the+doctoral+dissertation+presented+in+1800&amp;rft.au=Landr%C3%A9-Beauvais+AJ&amp;rft.aulast=Landr%C3%A9-Beauvais+AJ&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1297-319X%2800%2900247-5&amp;rft_id=info%3Apmid%2F11324929&amp;rft.issue=2&amp;rft.jtitle=Joint+Bone+spine&amp;rft.pages=130%E2%80%9343&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12860726-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12860726_8-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1754626">"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years"</a>. <i>Ann. Rheum. Dis.</i> <b>62</b> (8): 722–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fard.62.8.722">10.1136/ard.62.8.722</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1754626">1754626</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12860726">12860726</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Extra-articular+disease+manifestations+in+rheumatoid+arthritis%3A+incidence+trends+and+risk+factors+over+46+years&amp;rft.aulast=Turesson+C%2C+O%27Fallon+WM%2C+Crowson+CS%2C+Gabriel+SE%2C+Matteson+EL&amp;rft.au=Turesson+C%2C+O%27Fallon+WM%2C+Crowson+CS%2C+Gabriel+SE%2C+Matteson+EL&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1754626&amp;rft_id=info%3Adoi%2F10.1136%2Fard.62.8.722&amp;rft_id=info%3Apmc%2F1754626&amp;rft_id=info%3Apmid%2F12860726&amp;rft.issue=8&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.pages=722%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=62" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DAVIDSONS2010-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-DAVIDSONS2010_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DAVIDSONS2010_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-DAVIDSONS2010_9-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book"><i>Davidson's principles and practice of medicine.</i> (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. 2010. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7020-3084-0" title="Special:BookSources/978-0-7020-3084-0">978-0-7020-3084-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Davidson%27s+principles+and+practice+of+medicine.&amp;rft.date=2010&amp;rft.edition=21st&amp;rft.genre=book&amp;rft.isbn=978-0-7020-3084-0&amp;rft.place=Edinburgh&amp;rft.pub=Churchill+Livingstone%2FElsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20100527035630/http://pn.lifehugger.com/doc/459/An_approach_to_Early_Arthritis">"An approach to Early Arthritis"</a>. Pn.lifehugger.com. 12 January 2009. Archived from <a rel="nofollow" class="external text" href="http://pn.lifehugger.com/doc/459/An_approach_to_Early_Arthritis">the original</a> on 2010-05-27.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=An+approach+to+Early+Arthritis&amp;rft.date=12+January+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fpn.lifehugger.com%2Fdoc%2F459%2FAn_approach_to_Early_Arthritis&amp;rft.pub=Pn.lifehugger.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Gaffo A, Saag KG, Curtis JR; Saag; Curtis (2006). "Treatment of rheumatoid arthritis". <i>Am J Health Syst Pharm</i> <b>63</b> (24): 2451–2465. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2146%2Fajhp050514">10.2146/ajhp050514</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17158693">17158693</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Treatment+of+rheumatoid+arthritis&amp;rft.au=Curtis&amp;rft.au=Gaffo+A%2C+Saag+KG%2C+Curtis+JR&amp;rft.aulast=Gaffo+A%2C+Saag+KG%2C+Curtis+JR&amp;rft.au=Saag&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2146%2Fajhp050514&amp;rft_id=info%3Apmid%2F17158693&amp;rft.issue=24&amp;rft.jtitle=Am+J+Health+Syst+Pharm&amp;rft.pages=2451%E2%80%932465&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://arthritis.about.com/od/rheumatoidarthritis/a/rheumatoidlung.htm">"Rheumatoid Lung Disease – What Is Rheumatoid Lung Disease?"</a>. Arthritis.about.com. February 27, 2011<span class="reference-accessdate">. Retrieved March 3, 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Rheumatoid+Lung+Disease+%E2%80%93+What+Is+Rheumatoid+Lung+Disease%3F&amp;rft.date=February+27%2C+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Farthritis.about.com%2Fod%2Frheumatoidarthritis%2Fa%2Frheumatoidlung.htm&amp;rft.pub=Arthritis.about.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">de Groot K (August 2007). "[Renal manifestations in rheumatic diseases]". <i>Internist (Berl)</i> <b>48</b> (8): 779–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00108-007-1887-9">10.1007/s00108-007-1887-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17571244">17571244</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=%5BRenal+manifestations+in+rheumatic+diseases%5D&amp;rft.au=de+Groot+K&amp;rft.aulast=de+Groot+K&amp;rft.date=August+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00108-007-1887-9&amp;rft_id=info%3Apmid%2F17571244&amp;rft.issue=8&amp;rft.jtitle=Internist+%28Berl%29&amp;rft.pages=779%E2%80%9385&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Robbins.26Cotran2010-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Robbins.26Cotran2010_14-0">^</a></b></span> <span class="reference-text"><span class="citation book">Robbins, Stanley Leonard; Kumar, Vinay; Abbas, Abdul K.; Cotran, Ramzi S.; Fausto, Nelson (2010). "Robbins and Cotran pathologic basis of disease". In Vinay Kumar, Abul K. Abbas, Nelson Fausto. <i>Robbins Pathology Series</i> (Elsevier). p.&#160;205. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4160-3121-5" title="Special:BookSources/978-1-4160-3121-5">978-1-4160-3121-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Robbins+and+Cotran+pathologic+basis+of+disease&amp;rft.au=Abbas%2C+Abdul+K.&amp;rft.au=Cotran%2C+Ramzi+S.&amp;rft.au=Fausto%2C+Nelson&amp;rft.aufirst=Stanley+Leonard&amp;rft.au=Kumar%2C+Vinay&amp;rft.aulast=Robbins&amp;rft.au=Robbins%2C+Stanley+Leonard&amp;rft.date=2010&amp;rft.genre=article&amp;rft.isbn=978-1-4160-3121-5&amp;rft.jtitle=Robbins+Pathology+Series&amp;rft.pages=205&amp;rft.pub=Elsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Wolfe F; Mitchell DM; Sibley JT; Fries, James F.; Bloch, Daniel A.; Williams, Catherine A.; Spitz, Patricia W.; Haga, May et al. (April 1994). "The mortality of rheumatoid arthritis". <i>Arthritis Rheum.</i> <b>37</b> (4): 481–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.1780370408">10.1002/art.1780370408</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8147925">8147925</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+mortality+of+rheumatoid+arthritis&amp;rft.au=Bloch%2C+Daniel+A.&amp;rft.au=Cathey%2C+Mary+Ann&amp;rft.au=Fries%2C+James+F.&amp;rft.au=Haga%2C+May&amp;rft.au=Kleinheksel%2C+Sue+M.&amp;rft.aulast=Wolfe+F&amp;rft.au=Mitchell+DM&amp;rft.au=Sibley+JT&amp;rft.au=Spitz%2C+Patricia+W.&amp;rft.au=Williams%2C+Catherine+A.&amp;rft.au=Wolfe+F&amp;rft.date=April+1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780370408&amp;rft_id=info%3Apmid%2F8147925&amp;rft.issue=4&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=481%E2%80%9394&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Aviña-Zubieta JA; Choi HK; Sadatsafavi M; Etminan, Mahyar; Esdaile, John M.; Lacaille, Diane (2008). "Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies". <i>Arthritis Rheum.</i> <b>59</b> (12): 1690–1697. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.24092">10.1002/art.24092</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19035419">19035419</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Risk+of+cardiovascular+mortality+in+patients+with+rheumatoid+arthritis%3A+a+meta-analysis+of+observational+studies&amp;rft.au=Avi%C3%B1a-Zubieta+JA&amp;rft.au=Choi+HK&amp;rft.au=Esdaile%2C+John+M.&amp;rft.au=Etminan%2C+Mahyar&amp;rft.au=Lacaille%2C+Diane&amp;rft.aulast=Avi%C3%B1a-Zubieta+JA&amp;rft.au=Sadatsafavi+M&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.24092&amp;rft_id=info%3Apmid%2F19035419&amp;rft.issue=12&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=1690%E2%80%931697&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=59" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gupta-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gupta_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gupta_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gupta A and Fomberstein B (2009). <a rel="nofollow" class="external text" href="http://www.musculoskeletalnetwork.com/rheumatoid-arthritis/content/article/1145622/1433094">"Evaluating cardiovascular risk in rheumatoid arthritis"</a>. <i>Journal of Musculoskeletal Medicine</i> <b>26</b> (8): 481–94.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Evaluating+cardiovascular+risk+in+rheumatoid+arthritis&amp;rft.au=Gupta+A+and+Fomberstein+B&amp;rft.aulast=Gupta+A+and+Fomberstein+B&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.musculoskeletalnetwork.com%2Frheumatoid-arthritis%2Fcontent%2Farticle%2F1145622%2F1433094&amp;rft.issue=8&amp;rft.jtitle=Journal+of+Musculoskeletal+Medicine&amp;rft.pages=481%E2%80%9394&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text">Citation: H. Rehman&#160;: Hemolytic Anemia following Mycoplasma Infection . The Internet Journal of Hematology. 2008 Volume 4 Number 1 <a rel="nofollow" class="external autonumber" href="http://www.ispub.com/journal/the_internet_journal_of_hematology/volume_4_number_1_22/article/hemolytic_anemia_following_mycoplasma_infection.html">[1]</a></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Baecklund, E.; Iliadou, A.; Askling, J.; Ekbom, A.; Backlin, C.; Granath, F.; Catrina, A. I.; Rosenquist, R.; Feltelius, N.; Sundström, C.; Klareskog, L. (2006). "Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis". <i>Arthritis &amp; Rheumatism</i> <b>54</b> (3): 692–701. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.21675">10.1002/art.21675</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16508929">16508929</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Association+of+chronic+inflammation%2C+not+its+treatment%2C+with+increased+lymphoma+risk+in+rheumatoid+arthritis&amp;rft.au=Askling%2C+J.&amp;rft.au=Backlin%2C+C.&amp;rft.au=Baecklund%2C+E.&amp;rft.au=Catrina%2C+A.+I.&amp;rft.au=Ekbom%2C+A.&amp;rft.au=Feltelius%2C+N.&amp;rft.aufirst=E.&amp;rft.au=Granath%2C+F.&amp;rft.au=Iliadou%2C+A.&amp;rft.au=Klareskog%2C+L.&amp;rft.aulast=Baecklund&amp;rft.au=Rosenquist%2C+R.&amp;rft.au=Sundstr%C3%B6m%2C+C.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.21675&amp;rft_id=info%3Apmid%2F16508929&amp;rft.issue=3&amp;rft.jtitle=Arthritis+%26+Rheumatism&amp;rft.pages=692%E2%80%93701&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/16508929&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Franklin, J.; Lunt, M.; Bunn, D.; Symmons, D.; Silman, A. (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1798140">"Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis"</a>. <i>Annals of the Rheumatic Diseases</i> <b>65</b> (5): 617–622. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fard.2005.044784">10.1136/ard.2005.044784</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1798140">1798140</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16249224">16249224</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Incidence+of+lymphoma+in+a+large+primary+care+derived+cohort+of+cases+of+inflammatory+polyarthritis&amp;rft.au=Bunn%2C+D.&amp;rft.aufirst=J.&amp;rft.au=Franklin%2C+J.&amp;rft.aulast=Franklin&amp;rft.au=Lunt%2C+M.&amp;rft.au=Silman%2C+A.&amp;rft.au=Symmons%2C+D.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1798140&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2005.044784&amp;rft_id=info%3Apmc%2F1798140&amp;rft_id=info%3Apmid%2F16249224&amp;rft.issue=5&amp;rft.jtitle=Annals+of+the+Rheumatic+Diseases&amp;rft.pages=617%E2%80%93622&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/16249224&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Edwards JC, Cambridge G, Abrahams VM (1999). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2326840">"Do self-perpetuating B lymphocytes drive human autoimmune disease?"</a>. <i>Immunology</i> <b>97</b> (2): 188–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1046%2Fj.1365-2567.1999.00772.x">10.1046/j.1365-2567.1999.00772.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2326840">2326840</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10447731">10447731</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Do+self-perpetuating+B+lymphocytes+drive+human+autoimmune+disease%3F&amp;rft.au=Edwards+JC%2C+Cambridge+G%2C+Abrahams+VM&amp;rft.aulast=Edwards+JC%2C+Cambridge+G%2C+Abrahams+VM&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2326840&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2567.1999.00772.x&amp;rft_id=info%3Apmc%2F2326840&amp;rft_id=info%3Apmid%2F10447731&amp;rft.issue=2&amp;rft.jtitle=Immunology&amp;rft.pages=188%E2%80%9396&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lancet2010-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet2010_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Lancet2010_22-15"><sup><i><b>p</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Scott, DL; Wolfe, F; Huizinga, TW (Sep 25, 2010). "Rheumatoid arthritis". <i>Lancet</i> <b>376</b> (9746): 1094–108. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2810%2960826-4">10.1016/S0140-6736(10)60826-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20870100">20870100</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis&amp;rft.aufirst=DL&amp;rft.aulast=Scott&amp;rft.au=Scott%2C+DL&amp;rft.date=Sep+25%2C+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2810%2960826-4&amp;rft_id=info%3Apmid%2F20870100&amp;rft.issue=9746&amp;rft.jtitle=Lancet&amp;rft.pages=1094%E2%80%93108&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=376" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Plenge, Robert M.; Seielstad, Padyukov (05-09-2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867">"TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study"</a>. <i>The New England Journal of Medicine</i> <b>357</b> (12): 1199–209. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa073491">10.1056/NEJMoa073491</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867">2636867</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17804836">17804836</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=TRAF1%E2%80%93C5+as+a+Risk+Locus+for+Rheumatoid+Arthritis+%E2%80%94+A+Genomewide+Study&amp;rft.aufirst=Robert+M.&amp;rft.aulast=Plenge&amp;rft.au=Plenge%2C+Robert+M.&amp;rft.date=05-09-2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2636867&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa073491&amp;rft_id=info%3Apmc%2F2636867&amp;rft_id=info%3Apmid%2F17804836&amp;rft.issue=12&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.pages=1199%E2%80%93209&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=357" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>);</span> <span style="display:none;font-size:100%" class="error citation-comment">Check date values in: <code>|date=</code> (<a href="/wiki/Help:CS1_errors#bad_date" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation journal">Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, Utiyama SR (Aug 2010). "Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil". <i>Rheumatology (Oxford)</i> <b>49</b> (8): 1590–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Frheumatology%2Fkeq134">10.1093/rheumatology/keq134</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20457731">20457731</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Anti-cyclic+citrullinated+peptide+antibodies+and+rheumatoid+factor+in+rheumatoid+arthritis+patients+and+relatives+from+Brazil&amp;rft.au=Goeldner+I%2C+Skare+TL%2C+de+Messias+Reason+IT%2C+Nisihara+RM%2C+Silva+MB%2C+Utiyama+SR&amp;rft.aulast=Goeldner+I%2C+Skare+TL%2C+de+Messias+Reason+IT%2C+Nisihara+RM%2C+Silva+MB%2C+Utiyama+SR&amp;rft.date=Aug+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fkeq134&amp;rft_id=info%3Apmid%2F20457731&amp;rft.issue=8&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.pages=1590%E2%80%933&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.arthritis.org/genetics-ra.php">"The Genetics Behind Rheumatoid Arthritis"</a>. Arthritis Foundation<span class="reference-accessdate">. Retrieved 17 December 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=The+Genetics+Behind+Rheumatoid+Arthritis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.arthritis.org%2Fgenetics-ra.php&amp;rft.pub=Arthritis+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation journal">Silman, A.; MacGregor, A.; Thomson, W.; Holligan, S.; Carthy, D.; Farhan, A.; Ollier, W. (1993). "Twin concordance rates for rheumatoid arthritis: Results from a nationwide study". <i>British journal of rheumatology</i> <b>32</b> (10): 903–907. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Frheumatology%2F32.10.903">10.1093/rheumatology/32.10.903</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8402000">8402000</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Twin+concordance+rates+for+rheumatoid+arthritis%3A+Results+from+a+nationwide+study&amp;rft.au=Carthy%2C+D.&amp;rft.au=Farhan%2C+A.&amp;rft.aufirst=A.&amp;rft.au=Holligan%2C+S.&amp;rft.aulast=Silman&amp;rft.au=MacGregor%2C+A.&amp;rft.au=Ollier%2C+W.&amp;rft.au=Silman%2C+A.&amp;rft.au=Thomson%2C+W.&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2F32.10.903&amp;rft_id=info%3Apmid%2F8402000&amp;rft.issue=10&amp;rft.jtitle=British+journal+of+rheumatology&amp;rft.pages=903%E2%80%93907&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/8402000&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Bellamy, N.; Duffy, D.; Martin, N.; Mathews, J. (1992). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1005687">"Rheumatoid arthritis in twins: A study of aetiopathogenesis based on the Australian Twin Registry"</a>. <i>Annals of the rheumatic diseases</i> <b>51</b> (5): 588–593. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1005687">1005687</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1616321">1616321</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis+in+twins%3A+A+study+of+aetiopathogenesis+based+on+the+Australian+Twin+Registry&amp;rft.au=Bellamy%2C+N.&amp;rft.au=Duffy%2C+D.&amp;rft.aufirst=N.&amp;rft.aulast=Bellamy&amp;rft.au=Martin%2C+N.&amp;rft.au=Mathews%2C+J.&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1005687&amp;rft_id=info%3Apmc%2F1005687&amp;rft_id=info%3Apmid%2F1616321&amp;rft.issue=5&amp;rft.jtitle=Annals+of+the+rheumatic+diseases&amp;rft.pages=588%E2%80%93593&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/1616321&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-Sugiyama2010-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sugiyama2010_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sugiyama2010_28-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, Kumagai S (2010). <a rel="nofollow" class="external text" href="http://ard.bmj.com/content/69/01/70.abstract">"Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies"</a>. <i>Ann Rheum Dis.</i> <b>69</b> (1): 70–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fard.2008.096487">10.1136/ard.2008.096487</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19174392">19174392</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Impact+of+smoking+as+a+risk+factor+for+developing+rheumatoid+arthritis%3A+a+meta-analysis+of+observational+studies&amp;rft.aulast=Sugiyama+D%2C+Nishimura+K%2C+Tamaki+K%2C+Tsuji+G%2C+Nakazawa+T%2C+Morinobu+A%2C+Kumagai+S&amp;rft.au=Sugiyama+D%2C+Nishimura+K%2C+Tamaki+K%2C+Tsuji+G%2C+Nakazawa+T%2C+Morinobu+A%2C+Kumagai+S&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fard.bmj.com%2Fcontent%2F69%2F01%2F70.abstract&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2008.096487&amp;rft_id=info%3Apmid%2F19174392&amp;rft.issue=1&amp;rft.jtitle=Ann+Rheum+Dis.&amp;rft.pages=70%E2%80%9381&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Liao, KP; Alfredsson, L; Karlson, EW (May 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2898190">"Environmental influences on risk for rheumatoid arthritis"</a>. <i>Current Opinion in Rheumatology</i> <b>21</b> (3): 279–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FBOR.0b013e32832a2e16">10.1097/BOR.0b013e32832a2e16</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2898190">2898190</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19318947">19318947</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Environmental+influences+on+risk+for+rheumatoid+arthritis&amp;rft.aufirst=KP&amp;rft.aulast=Liao&amp;rft.au=Liao%2C+KP&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2898190&amp;rft_id=info%3Adoi%2F10.1097%2FBOR.0b013e32832a2e16&amp;rft_id=info%3Apmc%2F2898190&amp;rft_id=info%3Apmid%2F19318947&amp;rft.issue=3&amp;rft.jtitle=Current+Opinion+in+Rheumatology&amp;rft.pages=279%E2%80%9383&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Alvarez-Lafuente R; Fernández-Gutiérrez B; de Miguel S; Jover, JA; Rollin, R; Loza, E; Clemente, D; Lamas, JR (September 2005). <a rel="nofollow" class="external text" href="http://ard.bmj.com/cgi/content/abstract/64/9/1357">"Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction"</a>. <i>Ann. Rheum. Dis.</i> <b>64</b> (9): 1357–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fard.2004.033514">10.1136/ard.2004.033514</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1755640">1755640</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16100341">16100341</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Potential+relationship+between+herpes+viruses+and+rheumatoid+arthritis%3A+analysis+with+quantitative+real+time+polymerase+chain+reaction&amp;rft.au=Alvarez-Lafuente+R&amp;rft.au=Clemente%2C+D&amp;rft.au=de+Miguel+S&amp;rft.au=Fern%C3%A1ndez-Guti%C3%A9rrez+B&amp;rft.au=Jover%2C+JA&amp;rft.au=Lamas%2C+JR&amp;rft.aulast=Alvarez-Lafuente+R&amp;rft.au=Loza%2C+E&amp;rft.au=Rollin%2C+R&amp;rft.date=September+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fabstract%2F64%2F9%2F1357&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2004.033514&amp;rft_id=info%3Apmc%2F1755640&amp;rft_id=info%3Apmid%2F16100341&amp;rft.issue=9&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.pages=1357%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Balandraud N, Roudier J, Roudier C (2004). "Epstein-Barr virus and rheumatoid arthritis". <i>Autoimmun Rev</i> <b>3</b> (5): 362–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.autrev.2004.02.002">10.1016/j.autrev.2004.02.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15288002">15288002</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Epstein-Barr+virus+and+rheumatoid+arthritis&amp;rft.au=Balandraud+N%2C+Roudier+J%2C+Roudier+C&amp;rft.aulast=Balandraud+N%2C+Roudier+J%2C+Roudier+C&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2004.02.002&amp;rft_id=info%3Apmid%2F15288002&amp;rft.issue=5&amp;rft.jtitle=Autoimmun+Rev&amp;rft.pages=362%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Wen2011-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wen2011_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wen2011_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Wen, H; Baker, JF (March 2011). "Vitamin D, immunoregulation, and rheumatoid arthritis". <i>Journal of clinical rheumatology&#160;: practical reports on rheumatic &amp; musculoskeletal diseases</i> <b>17</b> (2): 102–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FRHU.0b013e31820edd18">10.1097/RHU.0b013e31820edd18</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21364350">21364350</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Vitamin+D%2C+immunoregulation%2C+and+rheumatoid+arthritis&amp;rft.aufirst=H&amp;rft.aulast=Wen&amp;rft.au=Wen%2C+H&amp;rft.date=March+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FRHU.0b013e31820edd18&amp;rft_id=info%3Apmid%2F21364350&amp;rft.issue=2&amp;rft.jtitle=Journal+of+clinical+rheumatology+%3A+practical+reports+on+rheumatic+%26+musculoskeletal+diseases&amp;rft.pages=102%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-AlbanoSantana-Sahagun2001-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-AlbanoSantana-Sahagun2001_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Albano, Shirley A.; Santana-Sahagun, Ernesto; Weisman, Michael H. (2001). "Cigarette smoking and rheumatoid arthritis". <i>Seminars in Arthritis and Rheumatism</i> <b>31</b> (3): 146–159. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1053%2Fsarh.2001.27719">10.1053/sarh.2001.27719</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11740796">11740796</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Cigarette+smoking+and+rheumatoid+arthritis&amp;rft.au=Albano%2C+Shirley+A.&amp;rft.aufirst=Shirley+A.&amp;rft.aulast=Albano&amp;rft.au=Santana-Sahagun%2C+Ernesto&amp;rft.au=Weisman%2C+Michael+H.&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fsarh.2001.27719&amp;rft_id=info%3Apmid%2F11740796&amp;rft.issue=3&amp;rft.jtitle=Seminars+in+Arthritis+and+Rheumatism&amp;rft.pages=146%E2%80%93159&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20060807074858/http://www.path.sunysb.edu/coursemat/hbp310immun.htm">"HBP310 Immunology"</a>. <i>SUNY Stony Brook Pathology Department</i>. Archived from <a rel="nofollow" class="external text" href="http://www.path.sunysb.edu/coursemat/hbp310immun.htm">the original</a> on 2006-08-07<span class="reference-accessdate">. Retrieved September 20, 2008</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=HBP310+Immunology&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.path.sunysb.edu%2Fcoursemat%2Fhbp310immun.htm&amp;rft.jtitle=SUNY+Stony+Brook+Pathology+Department&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><span class="citation web">Ghaffar, Abdul. <a rel="nofollow" class="external text" href="http://pathmicro.med.sc.edu/ghaffar/hyper00.htm">"Hypersensitivity reactions"</a>. <i>University of South Carolina School of Medicine</i><span class="reference-accessdate">. Retrieved September 20, 2008</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Hypersensitivity+reactions&amp;rft.au=Ghaffar%2C+Abdul&amp;rft.aulast=Ghaffar%2C+Abdul&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fpathmicro.med.sc.edu%2Fghaffar%2Fhyper00.htm&amp;rft.jtitle=University+of+South+Carolina+School+of+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation web">Holmes, N. (1999). <a rel="nofollow" class="external text" href="http://web.archive.org/web/20060206220202/http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html">"Lecture 14: Hypersensitivity"</a>. <i>Immunology Division, Department of Pathology, University of Cambridge</i>. Archived from <a rel="nofollow" class="external text" href="http://www-immuno.path.cam.ac.uk/~immuno/part1/lec13/lec13_97.html">the original</a> on 2006-02-06<span class="reference-accessdate">. Retrieved September 20, 2008</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Lecture+14%3A+Hypersensitivity&amp;rft.au=Holmes%2C+N.&amp;rft.aulast=Holmes%2C+N.&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww-immuno.path.cam.ac.uk%2F~immuno%2Fpart1%2Flec13%2Flec13_97.html&amp;rft.jtitle=Immunology+Division%2C+Department+of+Pathology%2C+University+of+Cambridge&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation journal">Plenge RM; Seielstad M; Padyukov L; Lee, Annette T.; Remmers, Elaine F.; Ding, Bo; Liew, Anthony; Khalili, Houman et al. (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867">"TRAF1-C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study"</a>. <i>N. Engl. J. Med.</i> <b>357</b> (12): 1199–209. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa073491">10.1056/NEJMoa073491</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2636867">2636867</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17804836">17804836</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=TRAF1-C5+as+a+Risk+Locus+for+Rheumatoid+Arthritis+%E2%80%94+A+Genomewide+Study&amp;rft.au=Alfredsson%2C+Lars&amp;rft.au=Altshuler%2C+David&amp;rft.au=Amos%2C+Christopher+I.&amp;rft.au=Beckman%2C+Evan+M.&amp;rft.au=Bonnard%2C+Carine&amp;rft.au=Carulli%2C+John+P.&amp;rft.au=Chandrasekaran%2C+Alamelu&amp;rft.au=Chen%2C+Wei+V.&amp;rft.au=Criswell%2C+Lindsey+A.&amp;rft.au=Davies%2C+Leela+R.L.&amp;rft.au=Ding%2C+Bo&amp;rft.au=Gregersen%2C+Peter+K.&amp;rft.au=Kastner%2C+Daniel+L.&amp;rft.au=Khalili%2C+Houman&amp;rft.au=Klareskog%2C+Lars&amp;rft.aulast=Plenge+RM&amp;rft.au=Lee%2C+Annette+T.&amp;rft.au=Li%2C+Wentian&amp;rft.au=Liew%2C+Anthony&amp;rft.au=Liu%2C+Chunyu&amp;rft.au=Ong%2C+Rick+T.H.&amp;rft.au=Padyukov+L&amp;rft.au=Pettersson%2C+Sven&amp;rft.au=Plenge+RM&amp;rft.au=Remmers%2C+Elaine+F.&amp;rft.au=Seielstad+M&amp;rft.au=Seldin%2C+Michael+F.&amp;rft.au=Tan%2C+Adrian+K.S.&amp;rft.au=Thalamuthu%2C+Anbupalam&amp;rft.au=Tian%2C+Chao&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2636867&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa073491&amp;rft_id=info%3Apmc%2F2636867&amp;rft_id=info%3Apmid%2F17804836&amp;rft.issue=12&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1199%E2%80%93209&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=357" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation journal">Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (2004). "A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis". <i>Arthritis Rheum.</i> <b>50</b> (10): 3085–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.20553">10.1002/art.20553</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15476204">15476204</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+gene-environment+interaction+between+smoking+and+shared+epitope+genes+in+HLA-DR+provides+a+high+risk+of+seropositive+rheumatoid+arthritis&amp;rft.aulast=Padyukov+L%2C+Silva+C%2C+Stolt+P%2C+Alfredsson+L%2C+Klareskog+L&amp;rft.au=Padyukov+L%2C+Silva+C%2C+Stolt+P%2C+Alfredsson+L%2C+Klareskog+L&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.20553&amp;rft_id=info%3Apmid%2F15476204&amp;rft.issue=10&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=3085%E2%80%9392&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text">Boldt AB, Goeldner I, de Messias-Reason IJ. Relevance of the lectin pathway of complement in rheumatic diseases. Adv Clin Chem. 2012;56:105-53. Review. <a href="/wiki/PMID" title="PMID" class="mw-redirect">PMID</a>: <a href="/w/index.php?title=22397030&amp;action=edit&amp;redlink=1" class="new" title="22397030 (page does not exist)">22397030</a></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text">Schueller-Weidekamm C. <a rel="nofollow" class="external text" href="http://www.diagnosticimaging.com/ultrasound/content/article/113619/1561958">Modern ultrasound methods yield stronger arthritis work-up</a>. Diagnostic Imaging. May 2010:20–22.</span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><span class="citation journal">Westwood OM, Nelson PN, Hay FC (2006). "Rheumatoid factors: what's new?". <i>Rheumatology (Oxford)</i> <b>45</b> (4): 379–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Frheumatology%2Fkei228">10.1093/rheumatology/kei228</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16418203">16418203</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+factors%3A+what%27s+new%3F&amp;rft.aulast=Westwood+OM%2C+Nelson+PN%2C+Hay+FC&amp;rft.au=Westwood+OM%2C+Nelson+PN%2C+Hay+FC&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fkei228&amp;rft_id=info%3Apmid%2F16418203&amp;rft.issue=4&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.pages=379%E2%80%9385&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nishimura-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nishimura_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nishimura_42-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Nishimura K; Sugiyama D; Kogata Y; Tsuji, G; Nakazawa, T; Kawano, S; Saigo, K; Morinobu, A et al. (2007). "Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis". <i>Ann. Intern. Med.</i> <b>146</b> (11): 797–808. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.7326%2F0003-4819-146-11-200706050-00008">10.7326/0003-4819-146-11-200706050-00008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17548411">17548411</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Meta-analysis%3A+diagnostic+accuracy+of+anti-cyclic+citrullinated+peptide+antibody+and+rheumatoid+factor+for+rheumatoid+arthritis&amp;rft.au=Kamae%2C+I&amp;rft.au=Kawano%2C+S&amp;rft.au=Kogata+Y&amp;rft.au=Koshiba%2C+M&amp;rft.au=Kumagai%2C+S&amp;rft.au=Kuntz%2C+K.+M.&amp;rft.aulast=Nishimura+K&amp;rft.au=Morinobu%2C+A&amp;rft.au=Nakazawa%2C+T&amp;rft.au=Nishimura+K&amp;rft.au=Saigo%2C+K&amp;rft.au=Sugiyama+D&amp;rft.au=Tsuji%2C+G&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-146-11-200706050-00008&amp;rft_id=info%3Apmid%2F17548411&amp;rft.issue=11&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.pages=797%E2%80%93808&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=146" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><span class="citation journal">Renger F, Bang H, Fredenhagen G, Natusch A, Backhaus M, Feist E, Egerer K, Burmester GR. <a rel="nofollow" class="external text" href="http://acr.confex.com/acr/2008/webprogram/Paper2009.html">"Anti-MCV Antibody Test for the Diagnosis of Rheumatoid Arthritis Using a POCT-Immunoassay"</a>. <i>American College of Rheumatology, 2008 Annual Scientific Meeting, poster presentation</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Anti-MCV+Antibody+Test+for+the+Diagnosis+of+Rheumatoid+Arthritis+Using+a+POCT-Immunoassay&amp;rft.aulast=Renger+F%2C+Bang+H%2C+Fredenhagen+G%2C+Natusch+A%2C+Backhaus+M%2C+Feist+E%2C+Egerer+K%2C+Burmester+GR&amp;rft.au=Renger+F%2C+Bang+H%2C+Fredenhagen+G%2C+Natusch+A%2C+Backhaus+M%2C+Feist+E%2C+Egerer+K%2C+Burmester+GR&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Facr.confex.com%2Facr%2F2008%2Fwebprogram%2FPaper2009.html&amp;rft.jtitle=American+College+of+Rheumatology%2C+2008+Annual+Scientific+Meeting%2C+poster+presentation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><span class="citation journal">Luime JJ, Colin EM, Hazes JM, Lubberts E. (2009). <a rel="nofollow" class="external text" href="http://ard.bmj.com/cgi/rapidpdf/ard.2008.103283v1">"Does anti-MCV has additional value as serological marker in the diagnostic and prognostic work-up of patients with rheumatoid arthritis? A systematic review"</a>. <i>Ann Rheum Dis</i> <b>69</b> (2): 337–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fard.2008.103283">10.1136/ard.2008.103283</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19289382">19289382</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Does+anti-MCV+has+additional+value+as+serological+marker+in+the+diagnostic+and+prognostic+work-up+of+patients+with+rheumatoid+arthritis%3F+A+systematic+review&amp;rft.aulast=Luime+JJ%2C+Colin+EM%2C+Hazes+JM%2C+Lubberts+E.&amp;rft.au=Luime+JJ%2C+Colin+EM%2C+Hazes+JM%2C+Lubberts+E.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fard.bmj.com%2Fcgi%2Frapidpdf%2Fard.2008.103283v1&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2008.103283&amp;rft_id=info%3Apmid%2F19289382&amp;rft.issue=2&amp;rft.jtitle=Ann+Rheum+Dis&amp;rft.pages=337%E2%80%9344&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-acr-eular-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-acr-eular_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-acr-eular_45-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Aletaha D; Neogi T; Silman AJ; Funovits, J.; Felson, D. T.; Bingham, C. O.; Birnbaum, N. S.; Burmester, G. R. et al. (2010). <a rel="nofollow" class="external text" href="http://web.archive.org/web/20100821113205/http://www.rheumatology.org/practice/clinical/classification/ra/2010_revised_criteria_classification_ra.pdf">"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative"</a>. <i>Ann. Rheum. Dis.</i> <b>69</b> (9): 1580–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fard.2010.138461">10.1136/ard.2010.138461</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20699241">20699241</a>. Archived from <a rel="nofollow" class="external text" href="http://www.rheumatology.org/practice/clinical/classification/ra/2010_revised_criteria_classification_ra.pdf">the original</a> on 2010-08-21<span class="reference-accessdate">. Retrieved February 8, 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=2010+rheumatoid+arthritis+classification+criteria%3A+an+American+College+of+Rheumatology%2FEuropean+League+Against+Rheumatism+collaborative+initiative&amp;rft.au=Aletaha+D&amp;rft.au=Bingham%2C+C.+O.&amp;rft.au=Birnbaum%2C+N.+S.&amp;rft.au=Burmester%2C+G.+R.&amp;rft.au=Bykerk%2C+V.+P.&amp;rft.au=Cohen%2C+M.+D.&amp;rft.au=Combe%2C+B.&amp;rft.au=Costenbader%2C+K.+H.&amp;rft.au=Dougados%2C+M.&amp;rft.au=Emery%2C+P.&amp;rft.au=Felson%2C+D.+T.&amp;rft.au=Ferraccioli%2C+G.&amp;rft.au=Funovits%2C+J.&amp;rft.au=Hazes%2C+J.+M.&amp;rft.au=Hobbs%2C+K.&amp;rft.au=Huizinga%2C+T.+W.&amp;rft.au=Kavanaugh%2C+A.&amp;rft.au=Kay%2C+J.&amp;rft.au=Kvien%2C+T.+K.&amp;rft.au=Laing%2C+T.&amp;rft.aulast=Aletaha+D&amp;rft.au=Mease%2C+P.&amp;rft.au=Menard%2C+H.+A.&amp;rft.au=Moreland%2C+L.+W.&amp;rft.au=Naden%2C+R.+L.&amp;rft.au=Neogi+T&amp;rft.au=Pincus%2C+T.&amp;rft.au=Silman+AJ&amp;rft.au=Smolen%2C+J.+S.&amp;rft.au=Stanislawska-Biernat%2C+E.&amp;rft.au=Symmons%2C+D.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2Fpractice%2Fclinical%2Fclassification%2Fra%2F2010_revised_criteria_classification_ra.pdf&amp;rft_id=info%3Adoi%2F10.1136%2Fard.2010.138461&amp;rft_id=info%3Apmid%2F20699241&amp;rft.issue=9&amp;rft.jtitle=Ann.+Rheum.+Dis.&amp;rft.pages=1580%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><span class="citation journal">Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N, Healey L, Kaplan S, Liang M, Luthra H (1988). <a rel="nofollow" class="external text" href="http://web.archive.org/web/20110124173431/http://www.rheumatology.org/practice/clinical/classification/ra/1987_revised_criteria_classification_ra.pdf">"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis"</a>. <i>Arthritis Rheum</i> <b>31</b> (3): 315–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.1780310302">10.1002/art.1780310302</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3358796">3358796</a>. Archived from <a rel="nofollow" class="external text" href="http://www.rheumatology.org/practice/clinical/classification/ra/1987_revised_criteria_classification_ra.pdf">the original</a> on 2011-01-24<span class="reference-accessdate">. Retrieved February 8, 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+American+Rheumatism+Association+1987+revised+criteria+for+the+classification+of+rheumatoid+arthritis&amp;rft.au=Arnett+F%2C+Edworthy+S%2C+Bloch+D%2C+McShane+D%2C+Fries+J%2C+Cooper+N%2C+Healey+L%2C+Kaplan+S%2C+Liang+M%2C+Luthra+H&amp;rft.aulast=Arnett+F%2C+Edworthy+S%2C+Bloch+D%2C+McShane+D%2C+Fries+J%2C+Cooper+N%2C+Healey+L%2C+Kaplan+S%2C+Liang+M%2C+Luthra+H&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2Fpractice%2Fclinical%2Fclassification%2Fra%2F1987_revised_criteria_classification_ra.pdf&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780310302&amp;rft_id=info%3Apmid%2F3358796&amp;rft.issue=3&amp;rft.jtitle=Arthritis+Rheum&amp;rft.pages=315%E2%80%9324&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Merckmanual-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-Merckmanual_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Merckmanual_47-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Berkow R, ed. (1992). <i>The Merck Manual</i> (16th ed.). Merck Publishing Group. pp.&#160;1307–08. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-911910-16-6" title="Special:BookSources/0-911910-16-6">0-911910-16-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=The+Merck+Manual&amp;rft.date=1992&amp;rft.edition=16th&amp;rft.genre=book&amp;rft.isbn=0-911910-16-6&amp;rft.pages=1307%E2%80%9308&amp;rft.pub=Merck+Publishing+Group&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">Lovy MR, Starkebaum G, Uberoi S (1996). "Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis". <i><a href="/wiki/J._Rheumatol." title="J. Rheumatol." class="mw-redirect">J. Rheumatol.</a></i> <b>23</b> (6): 1238–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8782126">8782126</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Hepatitis+C+infection+presenting+with+rheumatic+manifestations%3A+a+mimic+of+rheumatoid+arthritis&amp;rft.aulast=Lovy+MR%2C+Starkebaum+G%2C+Uberoi+S&amp;rft.au=Lovy+MR%2C+Starkebaum+G%2C+Uberoi+S&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8782126&amp;rft.issue=6&amp;rft.jtitle=J.+Rheumatol.&amp;rft.pages=1238%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text">Kelly, Janis (22 February 2005) <a rel="nofollow" class="external text" href="http://www.medscape.com/viewarticle/538134">DAS28 not always a reliable indicator of treatment effect in RA</a>, Medscape Medical News.</span></li>
<li id="cite_note-Prevoo1995-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-Prevoo1995_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Prevoo1995_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Prevoo, M. L.; Van 't Hof, M. A.; Kuper, H. H.; Van Leeuwen, M. A.; Van De Putte, L. B.; Van Riel, P. L. (1995). "Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis". <i>Arthritis and rheumatism</i> <b>38</b> (1): 44–48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.1780380107">10.1002/art.1780380107</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7818570">7818570</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Modified+disease+activity+scores+that+include+twenty-eight-joint+counts.+Development+and+validation+in+a+prospective+longitudinal+study+of+patients+with+rheumatoid+arthritis&amp;rft.aufirst=M.+L.&amp;rft.au=Kuper%2C+H.+H.&amp;rft.aulast=Prevoo&amp;rft.au=Prevoo%2C+M.+L.&amp;rft.au=Van+%27t+Hof%2C+M.+A.&amp;rft.au=Van+De+Putte%2C+L.+B.&amp;rft.au=Van+Leeuwen%2C+M.+A.&amp;rft.au=Van+Riel%2C+P.+L.&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780380107&amp;rft_id=info%3Apmid%2F7818570&amp;rft.issue=1&amp;rft.jtitle=Arthritis+and+rheumatism&amp;rft.pages=44%E2%80%9348&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/7818570&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-ACR2008-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-ACR2008_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ACR2008_51-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Saag KG, Teng GG, Patkar NM, <i>et al.</i> (2008). "American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis". <i>Arthritis Rheum.</i> <b>59</b> (6): 762–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.23721">10.1002/art.23721</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18512708">18512708</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=American+College+of+Rheumatology+2008+recommendations+for+the+use+of+nonbiologic+and+biologic+disease-modifying+antirheumatic+drugs+in+rheumatoid+arthritis&amp;rft.aulast=Saag+KG%2C+Teng+GG%2C+Patkar+NM%2C+%27%27et+al.%27%27&amp;rft.au=Saag+KG%2C+Teng+GG%2C+Patkar+NM%2C+%27%27et+al.%27%27&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.23721&amp;rft_id=info%3Apmid%2F18512708&amp;rft.issue=6&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=762%E2%80%9384&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=59" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Wasserman-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wasserman_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wasserman_52-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wasserman_52-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Wasserman_52-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Amy M. Wasserman (2011). "Diagnosis and Management of Rheumatoid Arthritis". <i>American Family Physician</i> <b>84</b> (11): 1245–1252. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22150658">22150658</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Diagnosis+and+Management+of+Rheumatoid+Arthritis&amp;rft.au=Amy+M.+Wasserman&amp;rft.aulast=Amy+M.+Wasserman&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F22150658&amp;rft.issue=11&amp;rft.jtitle=American+Family+Physician&amp;rft.pages=1245%E2%80%931252&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=84" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NICEguidelines-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-NICEguidelines_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NICEguidelines_53-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Chris Deighton, Rachel O’Mahony, Jonathan Tosh, Claire Turner, Michael Rudolf, and Guideline Development Group (2009). "Management of rheumatoid arthritis: summary of NICE guidance". <i>British Medical Journal</i> <b>338</b>: 710–712. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.b702">10.1136/bmj.b702</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Management+of+rheumatoid+arthritis%3A+summary+of+NICE+guidance&amp;rft.au=Chris+Deighton%2C+Rachel+O%E2%80%99Mahony%2C+Jonathan+Tosh%2C+Claire+Turner%2C+Michael+Rudolf%2C+and+Guideline+Development+Group&amp;rft.aulast=Chris+Deighton%2C+Rachel+O%E2%80%99Mahony%2C+Jonathan+Tosh%2C+Claire+Turner%2C+Michael+Rudolf%2C+and+Guideline+Development+Group&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.b702&amp;rft.jtitle=British+Medical+Journal&amp;rft.pages=710%E2%80%93712&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=338" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><span class="citation journal">Richards, BL; Whittle, SL; Buchbinder, R (Jan 18, 2012). "Muscle relaxants for pain management in rheumatoid arthritis". In Richards, Bethan L. <i>Cochrane database of systematic reviews (Online)</i> <b>1</b>: CD008922. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD008922.pub2">10.1002/14651858.CD008922.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22258993">22258993</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Muscle+relaxants+for+pain+management+in+rheumatoid+arthritis&amp;rft.aufirst=BL&amp;rft.aulast=Richards&amp;rft.au=Richards%2C+BL&amp;rft.date=Jan+18%2C+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008922.pub2&amp;rft_id=info%3Apmid%2F22258993&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD008922&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><span class="citation journal">Hurkmans, E; van der Giesen, FJ; Vliet Vlieland, TP; Schoones, J; Van den Ende, EC (Oct 7, 2009). "Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis". In Hurkmans, Emalie. <i>Cochrane database of systematic reviews (Online)</i> (4): CD006853. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD006853.pub2">10.1002/14651858.CD006853.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19821388">19821388</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Dynamic+exercise+programs+%28aerobic+capacity+and%2For+muscle+strength+training%29+in+patients+with+rheumatoid+arthritis&amp;rft.aufirst=E&amp;rft.au=Hurkmans%2C+E&amp;rft.aulast=Hurkmans&amp;rft.date=Oct+7%2C+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD006853.pub2&amp;rft_id=info%3Apmid%2F19821388&amp;rft.issue=4&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD006853&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><span class="citation journal">Hagen, KB; Byfuglien, MG; Falzon, L; Olsen, SU; Smedslund, G (Jan 21, 2009). "Dietary interventions for rheumatoid arthritis". In Hagen, Kåre Birger. <i>Cochrane database of systematic reviews (Online)</i> (1): CD006400. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD006400.pub2">10.1002/14651858.CD006400.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19160281">19160281</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Dietary+interventions+for+rheumatoid+arthritis&amp;rft.aufirst=KB&amp;rft.au=Hagen%2C+KB&amp;rft.aulast=Hagen&amp;rft.date=Jan+21%2C+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD006400.pub2&amp;rft_id=info%3Apmid%2F19160281&amp;rft.issue=1&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD006400&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><span class="citation journal">Gramling A, O'Dell JR (2012). "Initial management of rheumatoid arthritis". <i>Rheum. Dis. Clin. North Am.</i> <b>38</b> (2): 311–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.rdc.2012.05.003">10.1016/j.rdc.2012.05.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22819086">22819086</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Initial+management+of+rheumatoid+arthritis&amp;rft.au=Gramling+A%2C+O%27Dell+JR&amp;rft.aulast=Gramling+A%2C+O%27Dell+JR&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.rdc.2012.05.003&amp;rft_id=info%3Apmid%2F22819086&amp;rft.issue=2&amp;rft.jtitle=Rheum.+Dis.+Clin.+North+Am.&amp;rft.pages=311%E2%80%9325&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-chapter94-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-chapter94_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-chapter94_58-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-chapter94_58-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-chapter94_58-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">DiPiro, Joseph T., Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, and L. Michael Posey (2008) Pharmacotherapy: a pathophysiologic approach. 7th ed. New York: McGraw-Hill, <a href="/wiki/Special:BookSources/9780071478991" class="internal mw-magiclink-isbn">ISBN 978-0-07-147899-1</a>.</span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation journal">Shea, B; Swinden, MV; Tanjong Ghogomu, E; Ortiz, Z; Katchamart, W; Rader, T; Bombardier, C; Wells, GA; Tugwell, P (May 31, 2013). "Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.". <i>The Cochrane database of systematic reviews</i> <b>5</b>: CD000951. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD000951.pub2">10.1002/14651858.CD000951.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23728635">23728635</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Folic+acid+and+folinic+acid+for+reducing+side+effects+in+patients+receiving+methotrexate+for+rheumatoid+arthritis.&amp;rft.aufirst=B&amp;rft.aulast=Shea&amp;rft.au=Shea%2C+B&amp;rft.date=May+31%2C+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000951.pub2&amp;rft_id=info%3Apmid%2F23728635&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD000951&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-ACR2002-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-ACR2002_60-0">^</a></b></span> <span class="reference-text"><span class="citation journal">American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002). "Guidelines for the management of rheumatoid arthritis: 2002 Update". <i>Arthritis &amp; Rheumatism</i> <b>46</b> (2): 328–346. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.10148">10.1002/art.10148</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Guidelines+for+the+management+of+rheumatoid+arthritis%3A+2002+Update&amp;rft.au=American+College+of+Rheumatology+Subcommittee+on+Rheumatoid+Arthritis+Guidelines&amp;rft.aulast=American+College+of+Rheumatology+Subcommittee+on+Rheumatoid+Arthritis+Guidelines&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.10148&amp;rft.issue=2&amp;rft.jtitle=Arthritis+%26+Rheumatism&amp;rft.pages=328%E2%80%93346&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><span class="citation journal">Task Force for the Diagnosis and Management of, Syncope; European Society of Cardiology, (ESC); European Heart Rhythm Association, (EHRA); Heart Failure Association, (HFA); Heart Rhythm Society, (HRS); Moya, A; Sutton, R; Ammirati, F; Blanc, JJ; Brignole, M; Dahm, JB; Deharo, JC; Gajek, J; Gjesdal, K; Krahn, A; Massin, M; Pepi, M; Pezawas, T; Ruiz Granell, R; Sarasin, F; Ungar, A; van Dijk, JG; Walma, EP; Wieling, W (November 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3295536">"Guidelines for the diagnosis and management of syncope (version 2009)"</a>. <i>European heart journal</i> <b>30</b> (21): 2631–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Feurheartj%2Fehp298">10.1093/eurheartj/ehp298</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3295536">3295536</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19713422">19713422</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Guidelines+for+the+diagnosis+and+management+of+syncope+%28version+2009%29&amp;rft.aufirst=Syncope&amp;rft.aulast=Task+Force+for+the+Diagnosis+and+Management+of&amp;rft.au=Task+Force+for+the+Diagnosis+and+Management+of%2C+Syncope&amp;rft.date=November+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3295536&amp;rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehp298&amp;rft_id=info%3Apmc%2F3295536&amp;rft_id=info%3Apmid%2F19713422&amp;rft.issue=21&amp;rft.jtitle=European+heart+journal&amp;rft.pages=2631%E2%80%9371&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><span class="citation journal">Edwards J, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close D, Stevens R, Shaw T (2004). "Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis". <i>N Engl J Med</i> <b>350</b> (25): 2572–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa032534">10.1056/NEJMoa032534</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15201414">15201414</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Efficacy+of+B-cell-targeted+therapy+with+rituximab+in+patients+with+rheumatoid+arthritis&amp;rft.au=Edwards+J%2C+Szczepanski+L%2C+Szechinski+J%2C+Filipowicz-Sosnowska+A%2C+Emery+P%2C+Close+D%2C+Stevens+R%2C+Shaw+T&amp;rft.aulast=Edwards+J%2C+Szczepanski+L%2C+Szechinski+J%2C+Filipowicz-Sosnowska+A%2C+Emery+P%2C+Close+D%2C+Stevens+R%2C+Shaw+T&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa032534&amp;rft_id=info%3Apmid%2F15201414&amp;rft.issue=25&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=2572%E2%80%9381&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=350" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><span class="citation journal">Aaltonen KJ, Virkki LM, Malmivaara A, Konttinen YT, Nordström DC, Blom M (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264">"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis"</a>. In Hernandez, Adrian V. <i>PLoS ONE</i> <b>7</b> (1): e30275. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1371%2Fjournal.pone.0030275">10.1371/journal.pone.0030275</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264">3260264</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22272322">22272322</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Systematic+review+and+meta-analysis+of+the+efficacy+and+safety+of+existing+TNF+blocking+agents+in+treatment+of+rheumatoid+arthritis&amp;rft.au=Aaltonen+KJ%2C+Virkki+LM%2C+Malmivaara+A%2C+Konttinen+YT%2C+Nordstr%C3%B6m+DC%2C+Blom+M&amp;rft.aulast=Aaltonen+KJ%2C+Virkki+LM%2C+Malmivaara+A%2C+Konttinen+YT%2C+Nordstr%C3%B6m+DC%2C+Blom+M&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3260264&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0030275&amp;rft_id=info%3Apmc%2F3260264&amp;rft_id=info%3Apmid%2F22272322&amp;rft.issue=1&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e30275&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation journal">Maxwell, L; Singh, JA (Oct 7, 2009). "Abatacept for rheumatoid arthritis". In Maxwell, Lara. <i>Cochrane database of systematic reviews (Online)</i> (4): CD007277. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD007277.pub2">10.1002/14651858.CD007277.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19821401">19821401</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Abatacept+for+rheumatoid+arthritis&amp;rft.aufirst=L&amp;rft.aulast=Maxwell&amp;rft.au=Maxwell%2C+L&amp;rft.date=Oct+7%2C+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007277.pub2&amp;rft_id=info%3Apmid%2F19821401&amp;rft.issue=4&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD007277&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><span class="citation journal">Singh, JA; Christensen, R; Wells, GA; Suarez-Almazor, ME; Buchbinder, R; Lopez-Olivo, MA; Tanjong Ghogomu, E; Tugwell, P (Oct 7, 2009). "Biologics for rheumatoid arthritis: an overview of Cochrane reviews". In Singh, Jasvinder A. <i>Cochrane database of systematic reviews (Online)</i> (4): CD007848. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD007848.pub2">10.1002/14651858.CD007848.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19821440">19821440</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Biologics+for+rheumatoid+arthritis%3A+an+overview+of+Cochrane+reviews&amp;rft.aufirst=JA&amp;rft.aulast=Singh&amp;rft.au=Singh%2C+JA&amp;rft.date=Oct+7%2C+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007848.pub2&amp;rft_id=info%3Apmid%2F19821440&amp;rft.issue=4&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD007848&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><span class="citation journal">Tarp, S; Bartels, EM; Bliddal, H; Furst, DE; Boers, M; Danneskiold-Samsøe, B; Rasmussen, M; Christensen, R (November 2012). "Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials". <i>Arthritis and rheumatism</i> <b>64</b> (11): 3511–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fart.34644">10.1002/art.34644</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22833186">22833186</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Effect+of+nonsteroidal+antiinflammatory+drugs+on+the+C-reactive+protein+level+in+rheumatoid+arthritis%3A+a+meta-analysis+of+randomized+controlled+trials&amp;rft.aufirst=S&amp;rft.aulast=Tarp&amp;rft.au=Tarp%2C+S&amp;rft.date=November+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.34644&amp;rft_id=info%3Apmid%2F22833186&amp;rft.issue=11&amp;rft.jtitle=Arthritis+and+rheumatism&amp;rft.pages=3511%E2%80%9321&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation journal">Radner, H; Ramiro, S; Buchbinder, R; Landewé, RB; van der Heijde, D; Aletaha, D (Jan 18, 2012). "Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity". In Radner, Helga. <i>Cochrane database of systematic reviews (Online)</i> <b>1</b>: CD008951. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD008951.pub2">10.1002/14651858.CD008951.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22258995">22258995</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Pain+management+for+inflammatory+arthritis+%28rheumatoid+arthritis%2C+psoriatic+arthritis%2C+ankylosing+spondylitis+and+other+spondylarthritis%29+and+gastrointestinal+or+liver+comorbidity&amp;rft.aufirst=H&amp;rft.aulast=Radner&amp;rft.au=Radner%2C+H&amp;rft.date=Jan+18%2C+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008951.pub2&amp;rft_id=info%3Apmid%2F22258995&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD008951&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><span class="citation journal">McCormack, PL (Dec 24, 2011). "Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis". <i>Drugs</i> <b>71</b> (18): 2457–89. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F11208240-000000000-00000">10.2165/11208240-000000000-00000</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22141388">22141388</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Celecoxib%3A+a+review+of+its+use+for+symptomatic+relief+in+the+treatment+of+osteoarthritis%2C+rheumatoid+arthritis+and+ankylosing+spondylitis&amp;rft.aufirst=PL&amp;rft.aulast=McCormack&amp;rft.au=McCormack%2C+PL&amp;rft.date=Dec+24%2C+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F11208240-000000000-00000&amp;rft_id=info%3Apmid%2F22141388&amp;rft.issue=18&amp;rft.jtitle=Drugs&amp;rft.pages=2457%E2%80%9389&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=71" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation journal">Marks, JL; Colebatch, AN; Buchbinder, R; Edwards, CJ (Oct 5, 2011). "Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity". In Marks, Jonathan L. <i>Cochrane database of systematic reviews (Online)</i> (10): CD008952. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD008952.pub2">10.1002/14651858.CD008952.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21975789">21975789</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Pain+management+for+rheumatoid+arthritis+and+cardiovascular+or+renal+comorbidity&amp;rft.aufirst=JL&amp;rft.aulast=Marks&amp;rft.au=Marks%2C+JL&amp;rft.date=Oct+5%2C+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008952.pub2&amp;rft_id=info%3Apmid%2F21975789&amp;rft.issue=10&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD008952&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Job2008-70"><span class="mw-cite-backlink">^ <a href="#cite_ref-Job2008_70-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Job2008_70-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Chen, YF; Jobanputra, P; Barton, P; Bryan, S; Fry-Smith, A; Harris, G; Taylor, RS (April 2008). "Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation". <i>Health technology assessment (Winchester, England)</i> <b>12</b> (11): 1–278, iii. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18405470">18405470</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Cyclooxygenase-2+selective+non-steroidal+anti-inflammatory+drugs+%28etodolac%2C+meloxicam%2C+celecoxib%2C+rofecoxib%2C+etoricoxib%2C+valdecoxib+and+lumiracoxib%29+for+osteoarthritis+and+rheumatoid+arthritis%3A+a+systematic+review+and+economic+evaluation&amp;rft.au=Chen%2C+YF&amp;rft.aufirst=YF&amp;rft.aulast=Chen&amp;rft.date=April+2008&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F18405470&amp;rft.issue=11&amp;rft.jtitle=Health+technology+assessment+%28Winchester%2C+England%29&amp;rft.pages=1%E2%80%93278%2C+iii&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><span class="citation journal">Wang, X; Tian, HJ; Yang, HK; Wanyan, P; Peng, YJ (October 2011). "Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis". <i>European journal of gastroenterology &amp; hepatology</i> <b>23</b> (10): 876–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FMEG.0b013e328349de81">10.1097/MEG.0b013e328349de81</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21900785">21900785</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Meta-analysis%3A+cyclooxygenase-2+inhibitors+are+no+better+than+nonselective+nonsteroidal+anti-inflammatory+drugs+with+proton+pump+inhibitors+in+regard+to+gastrointestinal+adverse+events+in+osteoarthritis+and+rheumatoid+arthritis&amp;rft.aufirst=X&amp;rft.aulast=Wang&amp;rft.au=Wang%2C+X&amp;rft.date=October+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FMEG.0b013e328349de81&amp;rft_id=info%3Apmid%2F21900785&amp;rft.issue=10&amp;rft.jtitle=European+journal+of+gastroenterology+%26+hepatology&amp;rft.pages=876%E2%80%9380&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><span class="citation journal">Mallen, SR; Essex, MN; Zhang, R (July 2011). "Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs". <i>Current medical research and opinion</i> <b>27</b> (7): 1359–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1185%2F03007995.2011.581274">10.1185/03007995.2011.581274</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21561397">21561397</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Gastrointestinal+tolerability+of+NSAIDs+in+elderly+patients%3A+a+pooled+analysis+of+21+randomized+clinical+trials+with+celecoxib+and+nonselective+NSAIDs&amp;rft.aufirst=SR&amp;rft.aulast=Mallen&amp;rft.au=Mallen%2C+SR&amp;rft.date=July+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1185%2F03007995.2011.581274&amp;rft_id=info%3Apmid%2F21561397&amp;rft.issue=7&amp;rft.jtitle=Current+medical+research+and+opinion&amp;rft.pages=1359%E2%80%9366&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><span class="citation journal">"Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs". <i>Prescrire Int</i> <b>20</b> (119): 216–9. 2011. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21954519">21954519</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Nonsteroidal+anti-inflammatory+drugs%3A+add+an+anti-ulcer+drug+for+patients+at+high+risk+only.+Always+limit+the+dose+and+duration+of+treatment+with+NSAIDs&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F21954519&amp;rft.issue=119&amp;rft.jtitle=Prescrire+Int&amp;rft.pages=216%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ACRCAM-74"><span class="mw-cite-backlink">^ <a href="#cite_ref-ACRCAM_74-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ACRCAM_74-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.rheumatology.org/Practice/Clinical/Patients/Diseases_And_Conditions/Herbal_Remedies,_Supplements_and_Acupuncture_for_Arthritis/">"Herbal Remedies, Supplements and Acupuncture for Arthritis"</a>. American College of Rheumatology<span class="reference-accessdate">. Retrieved 3 May 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Herbal+Remedies%2C+Supplements+and+Acupuncture+for+Arthritis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2FPractice%2FClinical%2FPatients%2FDiseases_And_Conditions%2FHerbal_Remedies%2C_Supplements_and_Acupuncture_for_Arthritis%2F&amp;rft.pub=American+College+of+Rheumatology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><span class="citation journal">Pirotta, M (September 2010). "Arthritis disease – the use of complementary therapies". <i>Australian family physician</i> <b>39</b> (9): 638–40. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20877766">20877766</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Arthritis+disease+%E2%80%93+the+use+of+complementary+therapies&amp;rft.aufirst=M&amp;rft.aulast=Pirotta&amp;rft.au=Pirotta%2C+M&amp;rft.date=September+2010&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F20877766&amp;rft.issue=9&amp;rft.jtitle=Australian+family+physician&amp;rft.pages=638%E2%80%9340&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><span class="citation journal">Miles, EA; Calder, PC (June 2012). "Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis". <i>The British journal of nutrition</i>. 107 Suppl 2: S171–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1017%2FS0007114512001560">10.1017/S0007114512001560</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22591891">22591891</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Influence+of+marine+n-3+polyunsaturated+fatty+acids+on+immune+function+and+a+systematic+review+of+their+effects+on+clinical+outcomes+in+rheumatoid+arthritis&amp;rft.aufirst=EA&amp;rft.aulast=Miles&amp;rft.au=Miles%2C+EA&amp;rft.date=June+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0007114512001560&amp;rft_id=info%3Apmid%2F22591891&amp;rft.jtitle=The+British+journal+of+nutrition&amp;rft.pages=S171%E2%80%9384&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=107+Suppl+2" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><span class="citation journal">Ruggiero, C; Lattanzio, F; Lauretani, F; Gasperini, B; Andres-Lacueva, C; Cherubini, A (2009). <a rel="nofollow" class="external text" href="http://www.researchgate.net/publication/40818808_Omega-3_polyunsaturated_fatty_acids_and_immune-mediated_diseases_inflammatory_bowel_disease_and_rheumatoid_arthritis/file/d912f50eefc97a4450.pdf">"Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis"</a>. <i>Current pharmaceutical design</i> <b>15</b> (36): 4135–48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2174%2F138161209789909746">10.2174/138161209789909746</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20041815">20041815</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Omega-3+polyunsaturated+fatty+acids+and+immune-mediated+diseases%3A+inflammatory+bowel+disease+and+rheumatoid+arthritis&amp;rft.aufirst=C&amp;rft.aulast=Ruggiero&amp;rft.au=Ruggiero%2C+C&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.researchgate.net%2Fpublication%2F40818808_Omega-3_polyunsaturated_fatty_acids_and_immune-mediated_diseases_inflammatory_bowel_disease_and_rheumatoid_arthritis%2Ffile%2Fd912f50eefc97a4450.pdf&amp;rft_id=info%3Adoi%2F10.2174%2F138161209789909746&amp;rft_id=info%3Apmid%2F20041815&amp;rft.issue=36&amp;rft.jtitle=Current+pharmaceutical+design&amp;rft.pages=4135%E2%80%9348&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><span class="citation web">Soeken, K L; Miller, S A; Ernst, E. <a rel="nofollow" class="external text" href="http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?AccessionNumber=12003000980">"Herbal medicines for the treatment of rheumatoid arthritis: a systematic review"</a>. <i><a href="/wiki/Centre_for_Reviews_and_Dissemination" title="Centre for Reviews and Dissemination">Centre for Reviews and Dissemination</a></i>. <a href="/wiki/National_Institute_for_Health_Research" title="National Institute for Health Research">National Institute for Health Research</a><span class="reference-accessdate">. Retrieved March 23, 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Herbal+medicines+for+the+treatment+of+rheumatoid+arthritis%3A+a+systematic+review&amp;rft.au=Ernst%2C+E&amp;rft.aufirst=K+L&amp;rft.aulast=Soeken&amp;rft.au=Miller%2C+S+A&amp;rft.au=Soeken%2C+K+L&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.crd.york.ac.uk%2FCRDWeb%2FShowRecord.asp%3FAccessionNumber%3D12003000980&amp;rft.jtitle=Centre+for+Reviews+and+Dissemination&amp;rft.pub=National+Institute+for+Health+Research&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><span class="citation journal">Abdel-Tawab, M; Werz, O; Schubert-Zsilavecz, M (June 2011). "Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data". <i>Clinical pharmacokinetics</i> <b>50</b> (6): 349–69. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F11586800-000000000-00000">10.2165/11586800-000000000-00000</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21553931">21553931</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Boswellia+serrata%3A+an+overall+assessment+of+in+vitro%2C+preclinical%2C+pharmacokinetic+and+clinical+data&amp;rft.au=Abdel-Tawab%2C+M&amp;rft.aufirst=M&amp;rft.aulast=Abdel-Tawab&amp;rft.date=June+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F11586800-000000000-00000&amp;rft_id=info%3Apmid%2F21553931&amp;rft.issue=6&amp;rft.jtitle=Clinical+pharmacokinetics&amp;rft.pages=349%E2%80%9369&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=50" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><span class="citation journal">White, B; Judkins, DZ (March 2011). "Clinical Inquiry. Does turmeric relieve inflammatory conditions?". <i>The Journal of family practice</i> <b>60</b> (3): 155–6. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21369559">21369559</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Clinical+Inquiry.+Does+turmeric+relieve+inflammatory+conditions%3F&amp;rft.aufirst=B&amp;rft.aulast=White&amp;rft.au=White%2C+B&amp;rft.date=March+2011&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F21369559&amp;rft.issue=3&amp;rft.jtitle=The+Journal+of+family+practice&amp;rft.pages=155%E2%80%936&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><span class="citation journal">Wegener, T. (1999). "Therapy of degenerative diseases of the musculoskeletal system with South African devil's claw (Harpagophytum procumbens DC)". <i>Wiener medizinische Wochenschrift (1946)</i> <b>149</b> (8–10): 254–257. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10483693">10483693</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Therapy+of+degenerative+diseases+of+the+musculoskeletal+system+with+South+African+devil%27s+claw+%28Harpagophytum+procumbens+DC%29&amp;rft.aufirst=T.&amp;rft.aulast=Wegener&amp;rft.au=Wegener%2C+T.&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F10483693&amp;rft.issue=8%E2%80%9310&amp;rft.jtitle=Wiener+medizinische+Wochenschrift+%281946%29&amp;rft.pages=254%E2%80%93257&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=149" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/10483693&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><span class="citation journal">Denner, S. S. (2007). "A review of the efficacy and safety of devil's claw for pain associated with degenerative musculoskeletal diseases, rheumatoid, and osteoarthritis". <i>Holistic nursing practice</i> <b>21</b> (4): 203–207. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2F01.HNP.0000280932.65581.72">10.1097/01.HNP.0000280932.65581.72</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17627199">17627199</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+review+of+the+efficacy+and+safety+of+devil%27s+claw+for+pain+associated+with+degenerative+musculoskeletal+diseases%2C+rheumatoid%2C+and+osteoarthritis&amp;rft.au=Denner%2C+S.+S.&amp;rft.aufirst=S.+S.&amp;rft.aulast=Denner&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.HNP.0000280932.65581.72&amp;rft_id=info%3Apmid%2F17627199&amp;rft.issue=4&amp;rft.jtitle=Holistic+nursing+practice&amp;rft.pages=203%E2%80%93207&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/17627199&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><span class="citation journal">Zhang, LF; Zhao, JX (December 2005). "The recent research situation of Euonymus alatus". <i>Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica</i> <b>30</b> (24): 1895–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16494017">16494017</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+recent+research+situation+of+Euonymus+alatus&amp;rft.aufirst=LF&amp;rft.aulast=Zhang&amp;rft.au=Zhang%2C+LF&amp;rft.date=December+2005&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F16494017&amp;rft.issue=24&amp;rft.jtitle=Zhongguo+Zhong+yao+za+zhi+%3D+Zhongguo+zhongyao+zazhi+%3D+China+journal+of+Chinese+materia+medica&amp;rft.pages=1895%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><span class="citation journal">Bao, J.; Dai, S. M. (2011). "A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: Mechanism, efficacy, and safety". <i>Rheumatology International</i> <b>31</b> (9): 1123–1129. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00296-011-1841-y">10.1007/s00296-011-1841-y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21365177">21365177</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+Chinese+herb+Tripterygium+wilfordii+Hook+F+in+the+treatment+of+rheumatoid+arthritis%3A+Mechanism%2C+efficacy%2C+and+safety&amp;rft.au=Bao%2C+J.&amp;rft.au=Dai%2C+S.+M.&amp;rft.aufirst=J.&amp;rft.aulast=Bao&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00296-011-1841-y&amp;rft_id=info%3Apmid%2F21365177&amp;rft.issue=9&amp;rft.jtitle=Rheumatology+International&amp;rft.pages=1123%E2%80%931129&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/21365177&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee MS, Shin B-C, Ernst E (2008). "Acupuncture for rheumatoid arthritis: a systematic review". <i>Rheumatology</i> <b>47</b> (12): 1747–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Frheumatology%2Fken330">10.1093/rheumatology/ken330</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18710899">18710899</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Acupuncture+for+rheumatoid+arthritis%3A+a+systematic+review&amp;rft.aulast=Lee+MS%2C+Shin+B-C%2C+Ernst+E&amp;rft.au=Lee+MS%2C+Shin+B-C%2C+Ernst+E&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fken330&amp;rft_id=info%3Apmid%2F18710899&amp;rft.issue=12&amp;rft.jtitle=Rheumatology&amp;rft.pages=1747%E2%80%9353&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation journal">Macfarlane, GJ; Paudyal, P; Doherty, M; Ernst, E; Lewith, G; MacPherson, H; Sim, J; Jones, GT (2012). "A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: rheumatoid arthritis". <i>Rheumatology</i> <b>51</b> (9): 1707–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Frheumatology%2Fkes133">10.1093/rheumatology/kes133</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22661556">22661556</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=A+systematic+review+of+evidence+for+the+effectiveness+of+practitioner-based+complementary+and+alternative+therapies+in+the+management+of+rheumatic+diseases%3A+rheumatoid+arthritis&amp;rft.aufirst=GJ&amp;rft.aulast=Macfarlane&amp;rft.au=Macfarlane%2C+GJ&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fkes133&amp;rft_id=info%3Apmid%2F22661556&amp;rft.issue=9&amp;rft.jtitle=Rheumatology&amp;rft.pages=1707%E2%80%9313&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.nice.org.uk/nicemedia/live/12131/43326/43326.pdf">http://www.nice.org.uk/nicemedia/live/12131/43326/43326.pdf</a></span></li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><span class="citation journal">Atzeni, F.; Turiel, M.; Caporali, R.; Cavagna, L.; Tomasoni, L.; Sitia, S.; Sarzi-Puttini, P. (2010). "The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases". <i>Autoimmunity Reviews</i> <b>9</b> (12): 835–839. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.autrev.2010.07.018">10.1016/j.autrev.2010.07.018</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20678592">20678592</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=The+effect+of+pharmacological+therapy+on+the+cardiovascular+system+of+patients+with+systemic+rheumatic+diseases&amp;rft.au=Atzeni%2C+F.&amp;rft.au=Caporali%2C+R.&amp;rft.au=Cavagna%2C+L.&amp;rft.aufirst=F.&amp;rft.aulast=Atzeni&amp;rft.au=Sarzi-Puttini%2C+P.&amp;rft.au=Sitia%2C+S.&amp;rft.au=Tomasoni%2C+L.&amp;rft.au=Turiel%2C+M.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2010.07.018&amp;rft_id=info%3Apmid%2F20678592&amp;rft.issue=12&amp;rft.jtitle=Autoimmunity+Reviews&amp;rft.pages=835%E2%80%93839&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20678592&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text">Kitas, George (4 April 2006) <a rel="nofollow" class="external text" href="http://web.archive.org/web/20060924153339/http://www.rheumatoid.org.uk/article.php?article_id=112">Why is life span shortened by Rheumatoid Arthritis?</a> National Rheumatoid Arthritis Society</span></li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20050306030726/http://mayoclinic.org/news2005-rst/2654.html">Rheumatoid Arthritis Patients Have Double the Risk of Heart Failure</a>. mayoclinic.org (3 February 2005).</span></li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20061009112820/http://www.hopkins-arthritis.org/news-archive/2002/cardiac.html">"Cardiac disease in rheumatoid arthritis"</a>. Johns Hopkins University. 2002. Archived from <a rel="nofollow" class="external text" href="http://www.hopkins-arthritis.org/news-archive/2002/cardiac.html">the original</a> on 2006-10-09.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Cardiac+disease+in+rheumatoid+arthritis&amp;rft.date=2002&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.hopkins-arthritis.org%2Fnews-archive%2F2002%2Fcardiac.html&amp;rft.pub=Johns+Hopkins+University&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html">"WHO Disease and injury country estimates"</a>. <i>World Health Organization</i>. 2009<span class="reference-accessdate">. Retrieved November 11, 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=WHO+Disease+and+injury+country+estimates&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fhealthinfo%2Fglobal_burden_disease%2Festimates_country%2Fen%2Findex.html&amp;rft.jtitle=World+Health+Organization&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Loz2012-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-Loz2012_93-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lozano, 1R; Naghavi, M; Foreman, K; Lim, S; Shibuya, K; Aboyans, V; Abraham, J; Adair, T et al. (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". <i>Lancet</i> <b>380</b> (9859): 2095–128. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2812%2961728-0">10.1016/S0140-6736(12)61728-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23245604">23245604</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Global+and+regional+mortality+from+235+causes+of+death+for+20+age+groups+in+1990+and+2010%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2010&amp;rft.au=Abdulhak%2C+Aref+Bin&amp;rft.au=Aboyans%2C+V&amp;rft.au=Abraham%2C+J&amp;rft.au=Adair%2C+T&amp;rft.au=Aggarwal%2C+R&amp;rft.au=Ahn%2C+Stephanie+Y&amp;rft.au=Almazroa%2C+Mohammad+A&amp;rft.au=Alvarado%2C+Miriam&amp;rft.au=Anderson%2C+H+Ross&amp;rft.au=Anderson%2C+Laurie+M&amp;rft.au=Andrews%2C+Kathryn+G&amp;rft.au=Atkinson%2C+Charles&amp;rft.au=Baddour%2C+Larry+M&amp;rft.au=Barker-Collo%2C+Suzanne&amp;rft.au=Bartels%2C+David+H&amp;rft.au=Bell%2C+Michelle+L&amp;rft.au=Benjamin%2C+Emelia+J&amp;rft.au=Bennett%2C+Derrick&amp;rft.au=Bhalla%2C+Kavi&amp;rft.au=Bikbov%2C+Boris&amp;rft.au=Birbeck%2C+Gretchen&amp;rft.au=Blyth%2C+Fiona&amp;rft.au=Bolliger%2C+Ian&amp;rft.au=Boufous%2C+Soufiane&amp;rft.au=Bucello%2C+Chiara&amp;rft.aufirst=1R&amp;rft.au=Foreman%2C+K&amp;rft.aulast=Lozano&amp;rft.au=Lim%2C+S&amp;rft.au=Lozano%2C+1R&amp;rft.au=Naghavi%2C+M&amp;rft.au=Shibuya%2C+K&amp;rft.date=Dec+15%2C+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2812%2961728-0&amp;rft_id=info%3Apmid%2F23245604&amp;rft.issue=9859&amp;rft.jtitle=Lancet&amp;rft.pages=2095%E2%80%93128&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=380" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><span class="citation journal">Alamanos Y, Voulgari PV, Drosos AA (2006). "Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review". <i>Semin. Arthritis Rheum.</i> <b>36</b> (3): 182–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.semarthrit.2006.08.006">10.1016/j.semarthrit.2006.08.006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17045630">17045630</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Incidence+and+prevalence+of+rheumatoid+arthritis%2C+based+on+the+1987+American+College+of+Rheumatology+criteria%3A+a+systematic+review&amp;rft.au=Alamanos+Y%2C+Voulgari+PV%2C+Drosos+AA&amp;rft.aulast=Alamanos+Y%2C+Voulgari+PV%2C+Drosos+AA&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semarthrit.2006.08.006&amp;rft_id=info%3Apmid%2F17045630&amp;rft.issue=3&amp;rft.jtitle=Semin.+Arthritis+Rheum.&amp;rft.pages=182%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><span class="citation web">Rothschild, Bruce M. <a rel="nofollow" class="external text" href="http://web.archive.org/web/20120202085715/http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm">"Tennessee Origins of Rheumatoid Arthritis"</a>. Mcclungmuseum.utk.edu. Archived from <a rel="nofollow" class="external text" href="http://mcclungmuseum.utk.edu/research/renotes/rn-05txt.htm">the original</a> on 2012-02-02<span class="reference-accessdate">. Retrieved March 3, 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.aulast=Rothschild%2C+Bruce+M.&amp;rft.au=Rothschild%2C+Bruce+M.&amp;rft.btitle=Tennessee+Origins+of+Rheumatoid+Arthritis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fmcclungmuseum.utk.edu%2Fresearch%2Frenotes%2Frn-05txt.htm&amp;rft.pub=Mcclungmuseum.utk.edu&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20030219095659/http://www.arc.org.uk/newsviews/arctdy/104/bones.htm">"Bones of contention"</a>. <i>Arthritis Research UK</i>. April 1999. Archived from <a rel="nofollow" class="external text" href="http://www.arc.org.uk/newsviews/arctdy/104/bones.htm">the original</a> on 2003-02-19<span class="reference-accessdate">. Retrieved 2013-02-05</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Bones+of+contention&amp;rft.date=April+1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.arc.org.uk%2Fnewsviews%2Farctdy%2F104%2Fbones.htm&amp;rft.jtitle=Arthritis+Research+UK&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid14528501-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14528501_97-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rothschild BM, Rothschild C, Helbling M (2003). "Unified theory of the origins of erosive arthritis: conditioning as a protective/directing mechanism?". <i><a href="/wiki/J._Rheumatol." title="J. Rheumatol." class="mw-redirect">J. Rheumatol.</a></i> <b>30</b> (10): 2095–102. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14528501">14528501</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Unified+theory+of+the+origins+of+erosive+arthritis%3A+conditioning+as+a+protective%2Fdirecting+mechanism%3F&amp;rft.aulast=Rothschild+BM%2C+Rothschild+C%2C+Helbling+M&amp;rft.au=Rothschild+BM%2C+Rothschild+C%2C+Helbling+M&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14528501&amp;rft.issue=10&amp;rft.jtitle=J.+Rheumatol.&amp;rft.pages=2095%E2%80%93102&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text">Patel, Sunil (1 February 2005). <a rel="nofollow" class="external text" href="http://www.michigandaily.com/content/scientist-finds-surprising-links-between-arthritis-and-tuberculosis">Scientist finds surprising links between arthritis and tuberculosis</a>. <i>Michigan Daily</i>.</span></li>
<li id="cite_note-pmid7005475-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7005475_99-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Appelboom T, de Boelpaepe C, Ehrlich GE, Famaey JP (1981). "Rubens and the question of antiquity of rheumatoid arthritis". <i>JAMA</i> <b>245</b> (5): 483–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Fjama.245.5.483">10.1001/jama.245.5.483</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7005475">7005475</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rubens+and+the+question+of+antiquity+of+rheumatoid+arthritis&amp;rft.au=Appelboom+T%2C+de+Boelpaepe+C%2C+Ehrlich+GE%2C+Famaey+JP&amp;rft.aulast=Appelboom+T%2C+de+Boelpaepe+C%2C+Ehrlich+GE%2C+Famaey+JP&amp;rft.date=1981&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.245.5.483&amp;rft_id=info%3Apmid%2F7005475&amp;rft.issue=5&amp;rft.jtitle=JAMA&amp;rft.pages=483%E2%80%936&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=245" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><span class="citation web">Kelly, Janis (14 June 2005). <a rel="nofollow" class="external text" href="http://www.medscape.com/viewarticle/538251">"Did RA travel from New World to Old? The Rubens connection"</a>. Medscape<span class="reference-accessdate">. Retrieved March 3, 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Kelly%2C+Janis&amp;rft.aulast=Kelly%2C+Janis&amp;rft.btitle=Did+RA+travel+from+New+World+to+Old%3F+The+Rubens+connection&amp;rft.date=14+June+2005&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F538251&amp;rft.pub=Medscape&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><span class="citation journal">Dequeker J. and Rico H. (1992). "Rheumatoid arthritis-like deformities in an early 16th-century painting of the Flemish-Dutch school". <i>JAMA</i> <b>268</b> (2): 249–251. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Fjama.268.2.249">10.1001/jama.268.2.249</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1608144">1608144</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=Rheumatoid+arthritis-like+deformities+in+an+early+16th-century+painting+of+the+Flemish-Dutch+school&amp;rft.au=Dequeker+J.+and+Rico+H.&amp;rft.aulast=Dequeker+J.+and+Rico+H.&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.268.2.249&amp;rft_id=info%3Apmid%2F1608144&amp;rft.issue=2&amp;rft.jtitle=JAMA&amp;rft.pages=249%E2%80%93251&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=268" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><span class="citation book">Garrod AB (1859). <i>The Nature and Treatment of Gout and Rheumatic Gout</i>. London: Walton and Maberly.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Garrod+AB&amp;rft.aulast=Garrod+AB&amp;rft.btitle=The+Nature+and+Treatment+of+Gout+and+Rheumatic+Gout&amp;rft.date=1859&amp;rft.genre=book&amp;rft.place=London&amp;rft.pub=Walton+and+Maberly&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><span class="citation journal">Hart FD (1976). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1639217">"History of the treatment of rheumatoid arthritis"</a>. <i>Br Med J</i> <b>1</b> (6012): 763–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.1.6012.763">10.1136/bmj.1.6012.763</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1639217">1639217</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/177148">177148</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.atitle=History+of+the+treatment+of+rheumatoid+arthritis&amp;rft.au=Hart+FD&amp;rft.aulast=Hart+FD&amp;rft.date=1976&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1639217&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.1.6012.763&amp;rft_id=info%3Apmc%2F1639217&amp;rft_id=info%3Apmid%2F177148&amp;rft.issue=6012&amp;rft.jtitle=Br+Med+J&amp;rft.pages=763%E2%80%935&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text">Fresenius HemoCare, Inc., "New Hope for Rheumatoid Arthritis Patients," press release, September 17, 1999.</span></li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://arthritis.about.com/od/arthqa/f/prosorba.htm">"Prosorba Column – Which Rheumatoid Arthritis Patients Are Good Candidates for the Prosorba Column?"</a>. Arthritis.about.com<span class="reference-accessdate">. Retrieved March 3, 2011</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=Prosorba+Column+%E2%80%93+Which+Rheumatoid+Arthritis+Patients+Are+Good+Candidates+for+the+Prosorba+Column%3F&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Farthritis.about.com%2Fod%2Farthqa%2Ff%2Fprosorba.htm&amp;rft.pub=Arthritis.about.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit&amp;section=32" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata mbox-small plainlinks" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" width="30" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" /></td>
<td class="mbox-text plainlist" style="">Wikimedia Commons has media related to <i><b><a href="//commons.wikimedia.org/wiki/Category:Rheumatoid_arthritis" class="extiw" title="commons:Category:Rheumatoid arthritis">Rheumatoid arthritis</a></b></i>.</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.dmoz.org/Health/Conditions_and_Diseases/Musculoskeletal_Disorders/Arthritis/Rheumatoid">Rheumatoid arthritis</a> on the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><span class="citation web">Charles Weber. <a rel="nofollow" class="external text" href="http://charles_w.tripod.com/arthritis2.html">"History of rheumatoid arthritis"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.au=Charles+Weber&amp;rft.aulast=Charles+Weber&amp;rft.btitle=History+of+rheumatoid+arthritis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fcharles_w.tripod.com%2Farthritis2.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><span class="citation web"><a rel="nofollow" class="external text" href="http://www.niams.nih.gov/">"National Institute of Arthritis and Musculoskeletal and Skin Diseases"</a>. National Institute of Arthritis and Musculoskeletal and Skin Diseases.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARheumatoid+arthritis&amp;rft.btitle=National+Institute+of+Arthritis+and+Musculoskeletal+and+Skin+Diseases&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.niams.nih.gov%2F&amp;rft.pub=National+Institute+of+Arthritis+and+Musculoskeletal+and+Skin+Diseases&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:Silver;">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Arthropathies_and_related_conditions" title="Template:Arthropathies and related conditions"><span title="View this template" style=";background:Silver;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Arthropathies_and_related_conditions" title="Template talk:Arthropathies and related conditions"><span title="Discuss this template" style=";background:Silver;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Arthropathies_and_related_conditions&amp;action=edit"><span title="Edit this template" style=";background:Silver;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Musculoskeletal_disorder" title="Musculoskeletal disorder">Musculoskeletal disorders</a>: <a href="/wiki/Arthropathy" title="Arthropathy">Arthropathies</a> (<a href="/wiki/ICD-10_Chapter_XIII:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#.28M00.E2.80.93M25.29_Arthropathies" title="ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue">M00–M19</a>, <a href="/wiki/List_of_ICD-9_codes_710%E2%80%93739:_diseases_of_the_musculoskeletal_system_and_connective_tissue#Arthropathies_and_related_disorders_.28710.E2.80.93719.29" title="List of ICD-9 codes 710–739: diseases of the musculoskeletal system and connective tissue">711–719</a>)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: WhiteSmoke;"><a href="/wiki/Arthritis" title="Arthritis">Arthritis</a><br />
(<a href="/wiki/Monoarthritis" title="Monoarthritis">monoarthritis</a> /<br />
<a href="/wiki/Polyarthritis" title="Polyarthritis">polyarthritis</a>)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a><br />
(<a href="/wiki/Neutrophilia" title="Neutrophilia">Neutrophilia</a>)</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Septic_arthritis" title="Septic arthritis">Infectious</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Septic_arthritis" title="Septic arthritis">Septic arthritis</a></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis arthritis</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a> (indirectly)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;">Noninfectious</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i><a href="/wiki/Seronegative_spondyloarthropathy" title="Seronegative spondyloarthropathy" class="mw-redirect">Seronegative spondyloarthropathy</a>:</i> <a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li>
<li><a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">Psoriatic arthritis</a></li>
</ul>
<ul>
<li><a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">Ankylosing spondylitis</a></li>
</ul>
<ul>
<li><i><strong class="selflink">Rheumatoid arthritis</strong>:</i> <a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">Juvenile idiopathic arthritis</a></li>
<li><a href="/wiki/Adult-onset_Still%27s_disease" title="Adult-onset Still's disease">Adult-onset Still's disease</a></li>
<li><a href="/wiki/Felty%27s_syndrome" title="Felty's syndrome">Felty's syndrome</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Crystal_arthropathy" title="Crystal arthropathy">Crystal arthropathy</a>:</i> <a href="/wiki/Gout" title="Gout">Gout</a></li>
<li><a href="/wiki/Chondrocalcinosis" title="Chondrocalcinosis">Chondrocalcinosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;">Noninflammatory</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i><a href="/wiki/Osteoarthritis" title="Osteoarthritis">Osteoarthritis</a>:</i> <a href="/wiki/Heberden%27s_node" title="Heberden's node">Heberden's node</a></li>
<li><a href="/wiki/Bouchard%27s_nodes" title="Bouchard's nodes">Bouchard's nodes</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: WhiteSmoke;">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i><a href="/wiki/Hemorrhage" title="Hemorrhage" class="mw-redirect">hemorrhage</a></i>
<ul>
<li><a href="/wiki/Hemarthrosis" title="Hemarthrosis">Hemarthrosis</a></li>
</ul>
</li>
<li><i><a href="/wiki/Pain" title="Pain">pain</a></i>
<ul>
<li><a href="/wiki/Arthralgia" title="Arthralgia">Arthralgia</a></li>
</ul>
</li>
<li><a href="/wiki/Osteophyte" title="Osteophyte">Osteophyte</a></li>
<li><i><a href="/wiki/Villonodular_synovitis" title="Villonodular synovitis">villonodular synovitis</a></i>
<ul>
<li><a href="/wiki/Pigmented_villonodular_synovitis" title="Pigmented villonodular synovitis">Pigmented villonodular synovitis</a></li>
</ul>
</li>
<li><a href="/wiki/Joint_stiffness" title="Joint stiffness">Joint stiffness</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:WhiteSmoke;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Joint" title="Joint">JNT</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Joints" title="Template:Joints">anat</a> (<a href="/wiki/Template:Joints_of_head_and_neck" title="Template:Joints of head and neck">h</a>/<a href="/wiki/Template:Cranial_fibrous_joints" title="Template:Cranial fibrous joints">c</a>, <a href="/wiki/Template:Joints_of_upper_limbs" title="Template:Joints of upper limbs">u</a>, <a href="/wiki/Template:Joints_of_torso" title="Template:Joints of torso">t</a>, <a href="/wiki/Template:Joints_of_lower_limbs" title="Template:Joints of lower limbs">l</a>)/<a href="/wiki/Template:Bone/cartilage_physiology" title="Template:Bone/cartilage physiology">phys</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver;;width:10em;">
<div>
<p>noco (<a href="/wiki/Template:Arthropathies_and_related_conditions" title="Template:Arthropathies and related conditions">arth</a>/<a href="/wiki/Template:Acquired_musculoskeletal_deformities" title="Template:Acquired musculoskeletal deformities">defr</a>/<a href="/wiki/Template:Dorsopathies" title="Template:Dorsopathies">back</a>/<a href="/wiki/Template:Soft_tissue_disorders" title="Template:Soft tissue disorders">soft</a>)/<a href="/wiki/Template:Congenital_malformations_and_deformations_of_musculoskeletal_system" title="Template:Congenital malformations and deformations of musculoskeletal system">cong</a>, <a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_skeletal_system_and_joints" title="Template:Eponymous medical signs for skeletal system and joints">epon</a>, <a href="/wiki/Template:Dislocations,_sprains_and_strains" title="Template:Dislocations, sprains and strains">injr</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Bone,_cartilage,_and_joint_procedures" title="Template:Bone, cartilage, and joint procedures">proc</a>, drug (<a href="/wiki/Template:Antirheumatic_products" title="Template:Antirheumatic products">M01C</a>, <a href="/wiki/Template:Antigout_preparations" title="Template:Antigout preparations">M4</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:Silver;">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases"><span title="View this template" style=";background:Silver;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Hypersensitivity_and_autoimmune_diseases" title="Template talk:Hypersensitivity and autoimmune diseases"><span title="Discuss this template" style=";background:Silver;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Hypersensitivity_and_autoimmune_diseases&amp;action=edit"><span title="Edit this template" style=";background:Silver;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Immune_disorder" title="Immune disorder">Immune disorders</a>: <a href="/wiki/Hypersensitivity" title="Hypersensitivity">hypersensitivity</a> and <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a> (<a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">279.5–6</a>)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;"><a href="/wiki/Type_I_hypersensitivity" title="Type I hypersensitivity">Type I</a>/<a href="/wiki/Allergy" title="Allergy">allergy</a>/<a href="/wiki/Atopy" title="Atopy">atopy</a><br />
(<a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">IgE</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Atopic_eczema" title="Atopic eczema" class="mw-redirect">Atopic eczema</a></li>
<li><a href="/wiki/Urticaria" title="Urticaria">Allergic urticaria</a></li>
<li><a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">Allergic rhinitis</a> (Hay fever)</li>
<li><a href="/wiki/Asthma" title="Asthma">Allergic asthma</a></li>
<li><a href="/wiki/Anaphylaxis" title="Anaphylaxis">Anaphylaxis</a></li>
<li><a href="/wiki/Food_allergy" title="Food allergy">Food allergy</a>
<ul>
<li><a href="/wiki/Milk_allergy" title="Milk allergy">Milk</a></li>
<li><a href="/wiki/Egg_allergy" title="Egg allergy">Egg</a></li>
<li><a href="/wiki/Peanut_allergy" title="Peanut allergy">Peanut</a></li>
<li><a href="/wiki/Tree_nut_allergy" title="Tree nut allergy">Tree nut</a></li>
<li><a href="/wiki/Seafood_allergy" title="Seafood allergy">Seafood</a></li>
<li><a href="/wiki/Soy_allergy" title="Soy allergy">Soy</a></li>
<li><a href="/wiki/Wheat_allergy" title="Wheat allergy">Wheat</a></li>
</ul>
</li>
<li><a href="/wiki/Penicillin_drug_reaction" title="Penicillin drug reaction">Penicillin allergy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>none</i></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;"><a href="/wiki/Type_II_hypersensitivity" title="Type II hypersensitivity">Type II</a>/<a href="/wiki/Antibody-dependent_cell-mediated_cytotoxicity" title="Antibody-dependent cell-mediated cytotoxicity">ADCC</a><br />
<ul>
<li>
<ul>
<li><a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a></li>
<li><a href="/wiki/Immunoglobulin_G" title="Immunoglobulin G">IgG</a></li>
</ul>
</li>
</ul>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a></li>
<li><a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;"><a href="/wiki/Cytotoxicity" title="Cytotoxicity">Cytotoxic</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune hemolytic anemia</a></li>
<li><a href="/wiki/Idiopathic_thrombocytopenic_purpura" title="Idiopathic thrombocytopenic purpura">Idiopathic thrombocytopenic purpura</a></li>
<li><a href="/wiki/Bullous_pemphigoid" title="Bullous pemphigoid">Bullous pemphigoid</a></li>
<li><a href="/wiki/Pemphigus_vulgaris" title="Pemphigus vulgaris">Pemphigus vulgaris</a></li>
<li><a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></li>
<li><a href="/wiki/Goodpasture%27s_syndrome" title="Goodpasture's syndrome" class="mw-redirect">Goodpasture's syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">"<a href="/wiki/Hypersensitivity#Type_V" title="Hypersensitivity">Type V</a>"/<a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a></li>
<li><a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">Myasthenia gravis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;"><a href="/wiki/Type_III_hypersensitivity" title="Type III hypersensitivity">Type III</a><br />
(<a href="/wiki/Immune_complex" title="Immune complex">Immune complex</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Henoch%E2%80%93Sch%C3%B6nlein_purpura" title="Henoch–Schönlein purpura">Henoch–Schönlein purpura</a></li>
<li><a href="/wiki/Cutaneous_small-vessel_vasculitis" title="Cutaneous small-vessel vasculitis">Hypersensitivity vasculitis</a></li>
<li><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive arthritis</a></li>
<li><a href="/wiki/Farmer%27s_lung" title="Farmer's lung">Farmer's lung</a></li>
<li><a href="/wiki/Acute_proliferative_glomerulonephritis" title="Acute proliferative glomerulonephritis">Post-streptococcal glomerulonephritis</a></li>
<li><a href="/wiki/Serum_sickness" title="Serum sickness">Serum sickness</a></li>
<li><a href="/wiki/Arthus_reaction" title="Arthus reaction">Arthus reaction</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a></li>
<li><a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a></li>
<li><strong class="selflink">Rheumatoid arthritis</strong></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;"><a href="/wiki/Type_IV_hypersensitivity" title="Type IV hypersensitivity">Type IV</a>/<a href="/wiki/Cell-mediated_immunity" title="Cell-mediated immunity">cell-mediated</a><br />
(<a href="/wiki/T_cell" title="T cell">T cells</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Allergic_contact_dermatitis" title="Allergic contact dermatitis">Allergic contact dermatitis</a></li>
<li><a href="/wiki/Mantoux_test" title="Mantoux test">Mantoux test</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">Diabetes mellitus type 1</a></li>
<li><a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's thyroiditis</a></li>
<li><a href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" title="Guillain–Barré syndrome">Guillain–Barré syndrome</a></li>
<li><a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a></li>
<li><a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac disease</a></li>
<li><a href="/wiki/Giant-cell_arteritis" title="Giant-cell arteritis">Giant-cell arteritis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;"><a href="/wiki/Graft-versus-host_disease" title="Graft-versus-host disease">GVHD</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Transfusion-associated_graft_versus_host_disease" title="Transfusion-associated graft versus host disease">Transfusion-associated graft versus host disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Unknown/<br />
multiple</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Foreign</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Hypersensitivity_pneumonitis" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a>
<ul>
<li><a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">Allergic bronchopulmonary aspergillosis</a></li>
</ul>
</li>
<li><a href="/wiki/Transplant_rejection" title="Transplant rejection">Transplant rejection</a></li>
<li><a href="/wiki/Latex_allergy" title="Latex allergy">Latex allergy</a> (I+IV)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:LightGreen;;">Autoimmune</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a>
<ul>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a></li>
</ul>
</li>
<li><a href="/wiki/Addison%27s_disease" title="Addison's disease">Autoimmune adrenalitis</a></li>
<li><a href="/wiki/Autoimmune_disease" title="Autoimmune disease">Systemic autoimmune disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:LightGreen;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Lymphocyte" title="Lymphocyte">LMC</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Lymphocytes" title="Template:Lymphocytes">cell</a>/<a href="/wiki/Template:Lymphocytic_immune_system" title="Template:Lymphocytic immune system">phys</a>/<a href="/wiki/Template:Autoantigens" title="Template:Autoantigens">auag</a>/<a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies">auab</a>/<a href="/wiki/Template:Complement_system" title="Template:Complement system">comp</a>, <a href="/wiki/Template:Immunoglobulin_superfamily_immune_receptors" title="Template:Immunoglobulin superfamily immune receptors">igrc</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver;;width:10em;">
<div>
<p><a href="/wiki/Template:Lymphoid_and_complement_immunodeficiency" title="Template:Lymphoid and complement immunodeficiency">imdf</a>/<a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">ipig</a>/<a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases">hyps</a>/<a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy">tumr</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Immunologic_techniques_and_tests" title="Template:Immunologic techniques and tests">proc</a>, drug (<a href="/wiki/Template:Immunostimulants" title="Template:Immunostimulants">L3</a>/<a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants">4</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1025
CPU time usage: 5.424 seconds
Real time usage: 5.714 seconds
Preprocessor visited node count: 10370/1000000
Preprocessor generated node count: 40328/1500000
Post‐expand include size: 405108/2048000 bytes
Template argument size: 13292/2048000 bytes
Highest expansion depth: 13/40
Expensive parser function count: 22/500
Lua time usage: 0.433/10.000 seconds
Lua memory usage: 3.58 MB/50 MB
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:25875-0!*!0!!en!4!*!math=0 and timestamp 20140330015656
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>								<div class="printfooter">
				Retrieved from "<a href="http://en.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;oldid=601395711">http://en.wikipedia.org/w/index.php?title=Rheumatoid_arthritis&amp;oldid=601395711</a>"				</div>
												<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Connective_tissue_diseases" title="Category:Connective tissue diseases">Connective tissue diseases</a></li><li><a href="/wiki/Category:Arthritis" title="Category:Arthritis">Arthritis</a></li><li><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></li><li><a href="/wiki/Category:Diseases_involving_the_fasciae" title="Category:Diseases involving the fasciae">Diseases involving the fasciae</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_links_needing_disambiguation_from_February_2014" title="Category:Articles with links needing disambiguation from February 2014">Articles with links needing disambiguation from February 2014</a></li><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:CS1_errors:_dates" title="Category:CS1 errors: dates">CS1 errors: dates</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2013" title="Category:Articles with unsourced statements from October 2013">Articles with unsourced statements from October 2013</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_November_2009" title="Category:Articles with unsourced statements from November 2009">Articles with unsourced statements from November 2009</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2010" title="Category:Articles with unsourced statements from December 2010">Articles with unsourced statements from December 2010</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_March_2014" title="Category:Articles with unsourced statements from March 2014">Articles with unsourced statements from March 2014</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2008" title="Category:Articles with unsourced statements from July 2008">Articles with unsourced statements from July 2008</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_September_2010" title="Category:Articles with unsourced statements from September 2010">Articles with unsourced statements from September 2010</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_February_2014" title="Category:Articles needing additional references from February 2014">Articles needing additional references from February 2014</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_using_fixed_number_of_columns_in_reflist" title="Category:Articles using fixed number of columns in reflist">Articles using fixed number of columns in reflist</a></li><li><a href="/wiki/Category:Commons_category_with_local_link_same_as_on_Wikidata" title="Category:Commons category with local link same as on Wikidata">Commons category with local link same as on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_Open_Directory_Project_links" title="Category:Articles with Open Directory Project links">Articles with Open Directory Project links</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>
			<div id="mw-head">
				<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
	<h3 id="p-personal-label">Personal tools</h3>
	<ul>
<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Rheumatoid+arthritis&amp;type=signup">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Rheumatoid+arthritis" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>	</ul>
</div>
				<div id="left-navigation">
					<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
	<h3 id="p-namespaces-label">Namespaces</h3>
	<ul>
					<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Rheumatoid_arthritis"  title="View the content page [c]" accesskey="c">Article</a></span></li>
					<li  id="ca-talk"><span><a href="/wiki/Talk:Rheumatoid_arthritis"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
			</ul>
</div>
<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
	<h3 id="mw-vector-current-variant">
		</h3>
	<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
				</div>
				<div id="right-navigation">
					<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
	<h3 id="p-views-label">Views</h3>
	<ul>
					<li id="ca-view" class="selected"><span><a href="/wiki/Rheumatoid_arthritis" >Read</a></span></li>
					<li id="ca-edit"><span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=edit"  title="You can edit this page. &#10;Please review your changes before saving. [e]" accesskey="e">Edit</a></span></li>
					<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
			</ul>
</div>
<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
	<h3 id="p-cactions-label"><span>Actions</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
<div id="p-search" role="search">
	<h3><label for="searchInput">Search</label></h3>
	<form action="/w/index.php" id="searchform">
					<div id="simpleSearch">
					<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />		</div>
	</form>
</div>
				</div>
			</div>
			<div id="mw-panel">
					<div id="p-logo" role="banner"><a style="background-image: url(//upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
				<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
	<h3 id='p-navigation-label'>Navigation</h3>
	<div class="body">
		<ul>
			<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
			<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
			<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
			<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
			<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
			<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
	<h3 id='p-interaction-label'>Interaction</h3>
	<div class="body">
		<ul>
			<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
			<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
			<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
			<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
	<h3 id='p-tb-label'>Tools</h3>
	<div class="body">
		<ul>
			<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Rheumatoid_arthritis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
			<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Rheumatoid_arthritis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
			<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
			<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
			<li id="t-permalink"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;oldid=601395711" title="Permanent link to this revision of the page">Permanent link</a></li>
			<li id="t-info"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;action=info">Page information</a></li>
			<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q187255" title="Link to connected data repository item [g]" accesskey="g">Data item</a></li>
<li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Rheumatoid_arthritis&amp;id=601395711" title="Information on how to cite this page">Cite this page</a></li>		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
	<h3 id='p-coll-print_export-label'>Print/export</h3>
	<div class="body">
		<ul>
			<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Rheumatoid+arthritis">Create a book</a></li>
			<li id="coll-download-as-rl"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Rheumatoid+arthritis&amp;oldid=601395711&amp;writer=rl">Download as PDF</a></li>
			<li id="t-print"><a href="/w/index.php?title=Rheumatoid_arthritis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
	<h3 id='p-lang-label'>Languages</h3>
	<div class="body">
		<ul>
			<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%A7%D9%84%D9%85%D9%81%D8%A7%D8%B5%D9%84_%D8%A7%D9%84%D8%B1%D9%88%D9%85%D8%A7%D8%AA%D9%88%D9%8A%D8%AF%D9%8A" title="التهاب المفاصل الروماتويدي – Arabic" lang="ar" hreflang="ar">العربية</a></li>
			<li class="interlanguage-link interwiki-bg"><a href="//bg.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%B5%D0%BD_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82" title="Ревматоиден артрит – Bulgarian" lang="bg" hreflang="bg">Български</a></li>
			<li class="interlanguage-link interwiki-bs"><a href="//bs.wikipedia.org/wiki/Reumatoidni_artritis" title="Reumatoidni artritis – Bosnian" lang="bs" hreflang="bs">Bosanski</a></li>
			<li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Artritis_reumatoide" title="Artritis reumatoide – Catalan" lang="ca" hreflang="ca">Català</a></li>
			<li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Revmatoidn%C3%AD_artritida" title="Revmatoidní artritida – Czech" lang="cs" hreflang="cs">Čeština</a></li>
			<li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Leddegigt" title="Leddegigt – Danish" lang="da" hreflang="da">Dansk</a></li>
			<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Rheumatoide_Arthritis" title="Rheumatoide Arthritis – German" lang="de" hreflang="de">Deutsch</a></li>
			<li class="interlanguage-link interwiki-et"><a href="//et.wikipedia.org/wiki/Reumatoidartriit" title="Reumatoidartriit – Estonian" lang="et" hreflang="et">Eesti</a></li>
			<li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%A1%CE%B5%CF%85%CE%BC%CE%B1%CF%84%CE%BF%CE%B5%CE%B9%CE%B4%CE%AE%CF%82_%CE%B1%CF%81%CE%B8%CF%81%CE%AF%CF%84%CE%B9%CE%B4%CE%B1" title="Ρευματοειδής αρθρίτιδα – Greek" lang="el" hreflang="el">Ελληνικά</a></li>
			<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Artritis_reumatoide" title="Artritis reumatoide – Spanish" lang="es" hreflang="es">Español</a></li>
			<li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%B1%D9%88%D9%85%D8%A7%D8%AA%DB%8C%D8%B3%D9%85_%D9%85%D9%81%D8%B5%D9%84%DB%8C" title="روماتیسم مفصلی – Persian" lang="fa" hreflang="fa">فارسی</a></li>
			<li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Polyarthrite_rhumato%C3%AFde" title="Polyarthrite rhumatoïde – French" lang="fr" hreflang="fr">Français</a></li>
			<li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Airtr%C3%ADteas_r%C3%A9amat%C3%B3ideach" title="Airtríteas réamatóideach – Irish" lang="ga" hreflang="ga">Gaeilge</a></li>
			<li class="interlanguage-link interwiki-gl"><a href="//gl.wikipedia.org/wiki/Artrite_reumatoide" title="Artrite reumatoide – Galician" lang="gl" hreflang="gl">Galego</a></li>
			<li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EB%A5%98%EB%A7%88%ED%8B%B0%EC%8A%A4_%EA%B4%80%EC%A0%88%EC%97%BC" title="류마티스 관절염 – Korean" lang="ko" hreflang="ko">한국어</a></li>
			<li class="interlanguage-link interwiki-hy"><a href="//hy.wikipedia.org/wiki/%D5%8C%D6%87%D5%B4%D5%A1%D5%BF%D5%B8%D5%AB%D5%A4_%D5%A1%D6%80%D5%A9%D6%80%D5%AB%D5%BF" title="Ռևմատոիդ արթրիտ – Armenian" lang="hy" hreflang="hy">Հայերեն</a></li>
			<li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%86%E0%A4%AE%E0%A4%B5%E0%A4%BE%E0%A4%A4%E0%A5%80%E0%A4%AF_%E0%A4%B8%E0%A4%82%E0%A4%A7%E0%A4%BF%E0%A4%B6%E0%A5%8B%E0%A4%A5" title="आमवातीय संधिशोथ – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li>
			<li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Reumatoidni_artritis" title="Reumatoidni artritis – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li>
			<li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Artritis_reumatoid" title="Artritis reumatoid – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li>
			<li class="interlanguage-link interwiki-is"><a href="//is.wikipedia.org/wiki/Li%C3%B0agigt" title="Liðagigt – Icelandic" lang="is" hreflang="is">Íslenska</a></li>
			<li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Artrite_reumatoide" title="Artrite reumatoide – Italian" lang="it" hreflang="it">Italiano</a></li>
			<li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%93%D7%9C%D7%A7%D7%AA_%D7%9E%D7%A4%D7%A8%D7%A7%D7%99%D7%9D_%D7%A9%D7%99%D7%92%D7%A8%D7%95%D7%A0%D7%99%D7%AA" title="דלקת מפרקים שיגרונית – Hebrew" lang="he" hreflang="he">עברית</a></li>
			<li class="interlanguage-link interwiki-ku"><a href="//ku.wikipedia.org/wiki/Artr%C3%AEta_rumato%C3%AEd" title="Artrîta rumatoîd – Kurdish" lang="ku" hreflang="ku">Kurdî</a></li>
			<li class="interlanguage-link interwiki-lv"><a href="//lv.wikipedia.org/wiki/Reimato%C4%ABdais_artr%C4%ABts" title="Reimatoīdais artrīts – Latvian" lang="lv" hreflang="lv">Latviešu</a></li>
			<li class="interlanguage-link interwiki-mk"><a href="//mk.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%B5%D0%BD_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82%D0%B8%D1%81" title="Ревматоиден артритис – Macedonian" lang="mk" hreflang="mk">Македонски</a></li>
			<li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Reumato%C3%AFde_artritis" title="Reumatoïde artritis – Dutch" lang="nl" hreflang="nl">Nederlands</a></li>
			<li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E9%96%A2%E7%AF%80%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81" title="関節リウマチ – Japanese" lang="ja" hreflang="ja">日本語</a></li>
			<li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Leddgikt" title="Leddgikt – Norwegian (bokmål)" lang="no" hreflang="no">Norsk bokmål</a></li>
			<li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Reumatoidalne_zapalenie_staw%C3%B3w" title="Reumatoidalne zapalenie stawów – Polish" lang="pl" hreflang="pl">Polski</a></li>
			<li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Artrite_reumatoide" title="Artrite reumatoide – Portuguese" lang="pt" hreflang="pt">Português</a></li>
			<li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%BD%D1%8B%D0%B9_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82" title="Ревматоидный артрит – Russian" lang="ru" hreflang="ru">Русский</a></li>
			<li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis – Simple English" lang="simple" hreflang="simple">Simple English</a></li>
			<li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Revmatoidni_artritis" title="Revmatoidni artritis – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li>
			<li class="interlanguage-link interwiki-ckb"><a href="//ckb.wikipedia.org/wiki/%D8%A8%D8%A7%D8%AF%D8%A7%D8%B1%DB%8C%DB%8C_%D8%AC%D9%88%D9%85%DA%AF%DB%95%DA%A9%D8%A7%D9%86" title="باداریی جومگەکان – Sorani Kurdish" lang="ckb" hreflang="ckb">کوردی</a></li>
			<li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%A0%D0%B5%D1%83%D0%BC%D0%B0%D1%82%D0%BE%D0%B8%D0%B4%D0%BD%D0%B8_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82%D0%B8%D1%81" title="Реуматоидни артритис – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li>
			<li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Reumatoidni_artritis" title="Reumatoidni artritis – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li>
			<li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Nivelreuma" title="Nivelreuma – Finnish" lang="fi" hreflang="fi">Suomi</a></li>
			<li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Reumatoid_artrit" title="Reumatoid artrit – Swedish" lang="sv" hreflang="sv">Svenska</a></li>
			<li class="interlanguage-link interwiki-ta"><a href="//ta.wikipedia.org/wiki/%E0%AE%AE%E0%AF%81%E0%AE%9F%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AF%81_%E0%AE%B5%E0%AE%BE%E0%AE%A4%E0%AE%AE%E0%AF%8D" title="முடக்கு வாதம் – Tamil" lang="ta" hreflang="ta">தமிழ்</a></li>
			<li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Romatoid_artrit" title="Romatoid artrit – Turkish" lang="tr" hreflang="tr">Türkçe</a></li>
			<li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A0%D0%B5%D0%B2%D0%BC%D0%B0%D1%82%D0%BE%D1%97%D0%B4%D0%BD%D0%B8%D0%B9_%D0%B0%D1%80%D1%82%D1%80%D0%B8%D1%82" title="Ревматоїдний артрит – Ukrainian" lang="uk" hreflang="uk">Українська</a></li>
			<li class="interlanguage-link interwiki-vi"><a href="//vi.wikipedia.org/wiki/Vi%C3%AAm_kh%E1%BB%9Bp_d%E1%BA%A1ng_th%E1%BA%A5p" title="Viêm khớp dạng thấp – Vietnamese" lang="vi" hreflang="vi">Tiếng Việt</a></li>
			<li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%A1%9E%E9%A2%A8%E6%BF%95%E6%80%A7%E9%97%9C%E7%AF%80%E7%82%8E" title="類風濕性關節炎 – Chinese" lang="zh" hreflang="zh">中文</a></li>
			<li class="uls-p-lang-dummy"><a href="#"></a></li>
			<li class="wbc-editpage"><a href="//www.wikidata.org/wiki/Q187255#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></li>
		</ul>
	</div>
</div>
			</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 26 March 2014 at 19:14.<br /></li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy.</a> <br/>
Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a class="external" href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/wiki/Rheumatoid_arthritis" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
					<li id="footer-copyrightico">
						<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" width="88" height="31" alt="Wikimedia Foundation"/></a>
					</li>
					<li id="footer-poweredbyico">
						<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" width="88" height="31" /></a>
					</li>
				</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mobile.desktop","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","mw.MwEmbedSupport.style","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","skins.vector.collapsibleNav"],null,true);
}</script>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=scripts&amp;skin=vector&amp;*"></script>
<!-- Served by mw1062 in 0.483 secs. -->
	</body>
</html>
